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The  work  for  this  thesis  was'performed  at  the  Boyd  Medical  Research 
Institute,  the  Institute  of  Physiology  and  the  Department  of  Biochemistry, 
University  of  Glasgow. 
The  equipment  used  for  continuously  recording  the  venous  and  arterial 
pressures,  heart  rate  and  cardiac  output  of  perfused  frog  hearts  was  developed 
by  Professor  I.  A.  Boyd  and  Mr.  W.  R.  Eadie  over  a  period  of  several  years  and 
the  detals  of  this  equipment  are  published  (Boyd  and  Eadie,  1961).  A  description 
of  this  apparatus  is  not  intended  to  be  an  integral  part  of  this  work  and  only  'a 
very  brief  outline  of  it  will  be  given  here. 
After  a  description  of  some  preliminary  results  the  thesis  is  divided  into 
two  parts  for  convenience  of  description. 
Part  I  is  concerned  with  the  identification  of  adenosine  triphosphate  released 
from  skeletal  muscle. 
Part  II  deals  with  the  assay  of  acetylcholine  released  from  skeletal  muscle. 
An  Appendix  describes  a  technique  developed  for  the  separation'and 
purification  of  acetylcholine  which  may  be  contained  in  tissue  perfusates 
or  extracts. -2- 
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INTRODUCTION 
Bioassay  techniques  are  used  to  test  compounds  which  have  either  a  specific  action 
in  vivo  or  exist  in  such  small  concentrations  that  their  estimation  is  beyond  the 
limits  of  chemical  analysis. 
In  the  case  of  acetylcholine  (ACh),  the  chemical  synthesis  and  analysis  was 
achieved  almost  one  hundred  years  ago,  but  because  of  the  small  amounts  involved 
in  synaptic  and  neuromuscular  transmission,  any  investigator  wishing  to  measure  the 
ACh  produced  at  these  sites  must  resort  to  methods  of  bioassay.  The  response  of  a 
particular  tissue  to  ACh  must  be  evaluated  by  comparing  it  to  the  response  given  by 
a  known  amount  of  ACh. 
More  precisely,  the  bioassay  principle  consists  of  measuring  the  product  of 
one  enzyme  system  by  judging  its  effect  upon  another,  similar  enzyme  system. 
Enzyme  reactions  are  affected  by  many  factors:  hydrogen  ion  concentration, 
temperature  and  the  availability  of  energy  for  the  system.  These  reactions  can  be 
accelerated,  depressed  or  even  reversed  by  various  interfering  substances. 
Since  a  naturally-occurring  enzyme  system  is  being  used  as  a  "tool"  to 
identify  and  assess  the  concentration  of  a  particular  compound,  it  is  essential  that 
the  limitations  of  the  "tool"  are  clearly  defined.  The  point  was  put  succintly  by 
Jerne  and  Wood  -  "...  substantial  biological  research  must  precede  any  attempt 
to  set  up  a  bioassay  technique  for  routine  use  . 
In  any  quantitative  estimation  'of  ACh  which  may  be  released  at  the 
neuromuscular  junction,  three  main  factors  have  to  be  considered  in  a 
pharmacological  approach  to'  the  problem.  Firstly,  the  number  of  nerve  impulses 
passing  into  the  endplate  region  must  be  known.  Secondly,  the  diffusion  pathway  of 
ACh  from  the  endplate  regions  to  the  exterior  must  offer  the  minimum  of'obstruction 
so  that  nearly  all  of'the  ACh  will  diffuse  into'the  solution  surrounding  the 
preparation.  Thirdly,  the  method  of  measurement  of  the  released  ACh  should  be' 
reliable,  and  should  not  be  unduly  susceptible  to  interference  from  other  substances -4- 
which  might  be  released  From  the  tissues  during  stimulation  of  the  muscle.  Any  one 
of  these  unknown  substances  may  interfere  directly  with  the  assay  procedure,  or 
indirectly  by  altering  the  sensitivity  of  the  bioassay  preparation  to  the  compound 
under  survey. 
A  classical  example  of  direct  interference  in  a  bioassay  procedure  was  outlined 
by  Dale  and  Dudley  in  1929.  While  assaying  the  quantity  of  the  histamine-like 
substance  in  extracts  of  spleen  on  the  cat  blood  pressure  they  found  a  large,  but 
constant,  discrepancy  in  their  results.  Histamine  depresses  the  blood  pressure  of 
the  cat.  Dale  and  Dudley  found  that  the  spleen  extract  caused  depression  of  blood 
pressure  which  was  too  great  to  account  for  the  expected  concentration  of 
histamine.  They  found  that  an  interfering  substance,  whose  action  could  be  blocked 
by  atropine,  was  causing  the  excess  fall  in  the  cat  blood  pressure.  In  other  words, 
their  results,  obtained  with  regard  to  histamine,  were  falsely  high  because  of  the 
interference  of  the  hitherto  unrecognized  presence  of  ACh  in  the  extract. 
Other  examples  of  direct  interference  in  bioassays  have  been  noted  by 
Von  Euler  and  Gaddum  (1931),  Amin,  Crawford  and  Gaddum  (1954)  and  more 
recently  by  Lazlo  (1963). 
An  example  of  indirect  interference  has  been  shown  by  Frommel  et  al.  (1944). 
They  found  that  the  common  constituent  of  tissue  extracts,  histamine,  could 
sensitize  leech  muscle,  helix  heart  and  frog  rectus  abdominis  preparations  to  ACh, 
the  increase  in  sensitivity  being  analogous  to  that  produced  by  eserine.  Any 
quantitative  estimation  of  ACh  on  those  preparations  in  the  presence  of  histamine 
would  be  too  high,  unless  the  same  amount  of  histamine  present  in  the  test  solution 
was  deliberately  added  to  the  solutions  used  for  comparison. 
The  present  work  was  initiated  in  order  to  investigate  the  release  of  ACh 
from  the  neuromuscular  junction  and  to  produce,  if  possible,  a  more  accurate 
correlation  of  the  pharmacological  evidence  with  the  electrophysiological  evidence 
of  the  quantities  of  ACh  which  are  needed  for  the  natural  transmission  of  the  nerve 
impulse  into  skeletal  muscle.  However,  the  identification  in  this  work  of  adenosine -5- 
triphosphate  as  a  predominant  interfering  substance  released  from  skeletal  muscle 
has  raised  the  question  of  whether  previous  methods  of  measuring  released  ACh 
were  specific,  or  whether  unknown  substances  distorted  previous  bioassays  of 
ACh  liberated  from  the  neuromuscular  junction.  This  opens  up  the  broader  issue 
of  whether  other  substances  released  from  skeletal  muscle  could  also  be  acting  as 
depolarizing  agents  on  the  endplate  region. 
The  Experimental  Design 
This  work  was  initiated  with  the  intention  of  measuring  the  output  of  ACh 
from  active  frog  sartorius  muscle  on  the  very  sensitive  frog  heart  perfusion  system 
of  Boyd  and  Eadie  (1961).  The  ACh  released  from  the  muscle  would  be  collected 
in  a  surrounding  bathing  solution  and  this  solution  would  be  assayed  for  ACh  using 
the  frog  heart. 
The  frog  sartorius  muscle  was  chosen  because  (a)  the  number  and  situation 
of  the  endplates  was  known,  and  (b)  this  muscle  has  a  region  at  the  pelvic  end 
which  is  devoid  of  any  other  motor  nerves,  and  is  thus  suitable  for  direct 
stimulation  of  the  muscle  fibres  without  any  inadvertent  stimulation  of  intramuscular 
motor  nerve  fibres.  This  feature  of  the  sartorius  muscle  provided  the  opportunity 
to  investigate  whether  ACh  could  be  released  from  muscle  fibres  by  direct 
stimulation. 
The  output  of  ACh  from  a  sartorius  muscle  was  not  expected  to  be  very  great; 
the  following  calculation  was  kindly  supplied  by  Professor  Katz: 
A  frog  sartorius  muscle  contains  approximately  1,000  endplates, 
If,  say,  106  molecules  of  ACh  are  released  per  endplate  per  impulse, 
1,000  impulses  given  to  a  sartorius  muscle  would  give  1012  molecules  of 
ACh.  Collected  into  a1  ml.  volume,  this  would  give  a  concentration  of 
3x  10-10  g/mI.  ACh. 
About  30%  of  perfused  frog  hearts  are  capable  of  responding  to  10 
11 
g/ml, -6- 
or  lower  concentrations  between  the  months  of  December  and  March  in  Scotland 
(Boyd  and  Pathak,  1965).  Thus  it  was  theoretically  possible  to  assay  the  small 
quantity  of  ACh  which  was  expected  to  be  released  from  frog  sartorius  muscle  on 
"winter"  frog  hearts.  Other  conventional  preparations  used  for  the  bioassay  of 
ACh  are  either  too  insensitive,  for  example  frog  rectus  abdominis  muscle 
(threshold  10-8  g/mI.,  Chang  and  Gaddum  1933),  eserinized  leech  muscle 
(threshold  10-9  g/ml.,  Minz  1932),  too  unstable,  for  example  frog  lung  (threshold 
10-16  g/ml.,  Corsten,  1941),  or  require  a  specialized  medium  to  retain  their 
sensitivity  to  ACh,  like  clam  heart  (threshold  10-11  g/ml.,  Welsh  and  Taub,  1948), 
whelk  heart  (threshold  10-11  g/ml.,  We!  sh,  1954),  and  muscle  strips  of 
echinodermata  (threshold  10-9  g/ml.  -  10-1 
1 
g/ml.,  Bacq,  1939). 
Any  preparation  which  requires  a  special  medium  would  involve  conversion 
of  the  test  solution  obtained  from  the  frog  sartorius  muscle  and  hence  dilution  of 
the  contained  ACh.  Since  the  concentration  expected  from  the  sartorius  muscle  is 
so  small,  no  dilution  factor  could  really  be  afforded  in  an  accurate  assay 
procedure  using  some  of  the  suitably  sensitive  preparations  previously  mentioned. 
The  perfused  frog  heart  was  thus  advantageous  since  the  same  species  was  to 
be  used  for  both  the  source  and  the  measurement  of  the  ACh.  No  dilution  of  the 
test  solution  would  be  necessary  and  the  small  concentration  of  ACh  expected 
would  not  be  diluted  beyond  the  threshold  sensitivity  of  the  frog  heart. 
Although  the  frog  heart  can  respond  to  a  great  many  biological  compounds, 
the  advantages  of  its  great  sensitivity  and  long-term  stability  to  ACh  seemed  to 
outweigh  the  disadvantages  of  non-specificity. -7- 
HISTORICAL  SURVEY 
Claude  Bernard,  while  investigating  the  properties  of  curare,  showed  that 
while  curare  had  no  effect  on  the  condition  in  nerve  and  muscle  fibres,  it  blocked 
the  transmission  of  nerve  impulses  to  the  muscle.  These  observations,  made  in  the 
1840's,  first  outlined  the  special  properties  which  the  neuromuscular  junction 
possessed. 
Acetylcholine  (ACh)  was  first  prepared  artificially  by  Baeyer  in  1867.  It 
retained  a  chemical  interest  only  until  Hunt  and  Taveau  in  1909  found  that  it  had 
a  very  high  biological  activity,  much  more  so  than  choline  itself.  Three  years 
prior  to  this  Dixon  (1906)  had  demonstrated  that  inhibition  of  the  heart  by  vagal 
stimulation  was  associated  with  the  liberation  of  an  acetylcholine-like  substance 
in  intimate  relation  to  the  heart  muscle  fibres.  This  work  supported  the  then 
astonishing  suggestion  in  1877  by  Du-Bois-Reymond  who  considered  that  the 
excitation  of  a  muscle  fibre  might  be  due  to  the  release  of  a  chemical  stimulant 
when  the  impulse  arrived  at  the  nerve  ending. 
In  1907  Langley  found  that  the  junctional  region  of  a  muscle  was  highly 
sensitive  to  many  substances  and  Reisser  and  Neuschloss  (1921)  found  that  when  a 
gastrocnemius  muscle  of  a  frog  was  exposed  to  a  solution  containing  ACh  it  gave  a 
transient  contraction,  but  this  only  happened  when  the  ACh  was  applied  to  the 
junctional  region;  the  ACh  had  no  effect  when  applied  separately  to  the  nerve 
or  the  muscle. 
In  1921  Le  Heux  observed  that  the  action  of  choline  on  an  isolated  loop  of 
intestine  was  enhanced  by  the  presence  of  acetates  and  thought  that  ACh  could 
be  the  final  activator.  It  was  also  in  1921  that  Loewi  initiated  his  classical 
experiments  on  frog  heart  perfusates  after  vagal  stimulation  and  suggested  that 
a  substance  was  released  which  had  the  properties  of  a  choline  ester. 
In  1923  -  1926  several  observers  (Hess,  1923,  Brinkman  and  Ruiter,  1924  - 
1925;  Shimidzu,  1926)  had  obtained  evidence  of  the  liberation  of  an  acetylcholine- -8- 
like  substance  from  perfused  frog  skeletal  muscles  when  these  were  stimulated 
through  the  nerve.  However,  all  of  them  had  stimulated  a  mixed  nerve  and  they 
did  not  definitely  associate  the  effect  with  the  motor  fibres,  or  with  the 
transmission  of  the  impulse  to  the  muscle  fibres  from  nerve.  Hoet  in  1925  observed 
that  the  atropine-sensitive  rhythm  of  isolated  intestinal  muscle  was  enhanced  by 
strong  post  mortem  stimulation  of  the  vagus  nerves  before  excision  of  the  intestine. 
While  investigating  the  identity  of  the  histamine-like  constituent  of  spleen 
extracts,  Dale  and  Dudley  (1929)  found  a  large  but  constant  discrepancy  in  their 
results.  They  used  for  their  bioassay  object  the  blood  pressure  of  the  cat  under 
ether  or  urethane  anaesthetic.  They  found  that  a  surprisingly  large  proportion  of 
the  original  effect  of  the  extract  was  eliminated  in  the  presence  of  atropine.  The 
activity  of  this  proportion  could  also  be  eliminated  by  raising  the  pH  of  the  extract. 
They  found  also  that  this  some  proportion  of  activity  was  lost  when  the  extract  was 
brought  into  contact  with  "the  cells  and  juices  of  the  whole  minced  organ". 
Dale  and  Dudley  were  eventually  able  to  extract  chemically  fairly  constant 
amounts  of  ACh  from  ox  and  horse  spleens.  This  was  the  first  occasion  on  which  ACh 
had  been  found  to  occur  naturally  in  the  animal  body. 
Earlier,  Dale,  working  with  Ewins  (1914),  had  become  interested  in  ACh 
because  it  was  able  to  reproduce  parasympathetic  effects  intensely  and  faithfully 
in  various  organs.  When  these  effects  were  blocked  with  atropine  the  ACh  in 
larger  doses  stimulated  ganglion  cells  in  a  manner  similar  to  nicotine.  This  led 
Dale  and  Dudley  to  speculate  on  the  possibility  that  ACh  might  occur  in  the  body 
and  be  physiologically  functional;  however,  they  could  not  explain  the  function 
of  large  amounts  of  ACh  found  in  the  spleens. 
In  1930  Dale  and  Gaddum  examined  the  evidence  for  a  chemical  intermediary 
in  the  parasympathetic  nerve  endings  and  for  its  identification  as  ACh.  They 
concluded  that  the  vasodilator  effects  of  parasympathetic  nerves  and  of  sensory 
fibres  stimulated  antidromically  (and  the  contractions  of  denervated  muscle 
accompanying  these  actions)  were  due  to  peripheral  liberation  of  ACh. -9- 
In  1933  Adrian  wrote  -  "It  is  by  no  means  certain  that  the  humoral 
transmission  of  the  vagal  effect  differs  in  kind  from  the  transmission  of  activity 
from  the  motor  nerve  to  striated  muscle.  An  exciting  substance  liberated  at  a 
nerve  ending  but  destroyed  within  a  few  thousandths  of  a  second  would  have  little 
chance  of  spreading  by  diffusion  and  would  account  well  enough  for  the  known 
properties  of  the  nerve  ending.  It  is  equally  likely  that  the  more  direct  kinds  of 
transmission  depend,  as  in  nerve  fibre,  on  electric  forces  disturbing  the  balanced 
reactions  of  surface  membranes". 
These  views  were  at  least  one  year  in  advance  of  any  experimental  evidence 
in  favour  of  a  chemical  transmitter  of  excitation  from  motor  nerve  to  skeletal 
muscle. 
In  1934  a  preliminary  note  appeared  from  Dale  and  Feldberg  stating  that  they 
had  identified  ACh  in  the  perfusate  of  cat  tongue  and  dog  leg  muscles  in  the 
presence  of  eserine  whilst  stimulating  the  motor  nerves.  About  the  some  time 
Feldberg,  Minz  and  Tsudzimura  produced  strong  evidence  that  ACh  was  liberated 
when  a  nerve  impulse  reached  the  adrenal  medulla.  Also  at  this  time  it  was  shown 
that  ACh  was  released  from  ganglia  when  nervous  impulses  reached  them  (Feldberg 
and  Gaddum,  1934;  Feldberg  and  Vartiainen,  1934;  Barsoum,  Gaddum  and 
Khayyal,  1934).  Thus  the  classical  work  performed  by  Dale,  Feldberg  and  Vogt 
and  published  in  1936  formed  a  natural  link  in  the  sequence  of  events  leading  to  the 
modern  conceptions  of  neuromuscular  transmission. 
Previously  it  had  been  assumed  by  Frank  and  his  co-workers  (Frank  and 
Katz,  1921;  Frank,  Nothmann  and  Hirch-Kauffman,  1922)  that  there  was  a 
secondary  parasympathetic  nerve  supply  to  the  skeletal  muscle  fibres  themselves, 
responsible  for  maintenance  of  muscle  tone.  They  regarded  the  release  of  ACh 
from  skeletal  muscle  as  perhaps  having  little  connection  with  motor  nerve  impulses, 
since  al  I  the  fibres  of  a  mixed  nerve  had  been  stimulated  previously. 
Dale,  Feldberg  and  Vogt  set  out  to  find  whether  stimulation  of  the  motor 
nerve  fibres  innervating  skeletal  muscle  (excluding  antonomic  and  sensory  fibres) -  10  - 
caused  the  liberation  of  ACh  in  appreciable  quantities,  and,  if  so,  set  out  to 
define  a  site  of  release.  They  were  aware  of  the  difficulties  involved  in  the 
identification  and  possible  quantitative  estimation  of  ACh  if  indeed  it  was 
released  at  the  neuromuscular  junction.  They  anticipated  that  any  ACh  obtained 
from  a  perfused  muscle  mass  would  inevitably  be  greatly  diluted.  This  was  in 
contrast  to  previous  investigations  involving  ganglia  where  the  small  perfusion 
volume  together  with  the  large  concentration  of  synapses  helped  to  raise  the 
ACh  level  up  to  easily  estimable  concentrations. 
Another  unexpected  difficulty  arose  during  the  course  of  their  investigation. 
To  ensure  successful  recovery  of  ACh  they  found  that  perfusion  with  an  eserinized 
saline  solution  was  necessary.  Previously  Feldberg  (1933)  had  failed  to  detect 
any  ACh  in  the  lingual  vein  when  he  stimulated  the  motor  hypoglossal  nerve  of 
the  dog.  Franel  (1935)  also  failed  to  detect  ACh  in  venous  blood  or  in  eserinized 
Locke's  solution  coming  from  a  perfused  limb.  Dale  et  al.  (1936)  at  that  time 
thought  it  possible  that  perfusion  with  saline  facilitated  in  some  unknown  way  the 
release  of  ACh  from  the  site  of  its  origin  in  the  blood  vessels.  Later,  Dale 
supported  the  work  of  F.  C.  Macintosh  (1938)  who  found  that  the  doses  of 
physostigmine  used  were  insufficient  to  counteract  the  blood  cholinesterase  (see 
below). 
Dale  et  al.  also  encountered  irregular  results  at  the  commencement  of  their 
perfusion  experiments.  This  is  best  reviewed  in  their  own  words:  -  "After  the  rather 
prolonged  dissection  and  manipulation  the  early  perfusion  samples  usually  showed 
detectable  amounts  of  a  substance  acting  like  ACh  as  Hess  (1923)  observed  in  his 
perfusions  of  frog  muscles".  Only  after  half-an-hour  of  perfusion  did  this  activity 
disappear.  This  happened  during  the  perfusion  of  the  cat  tongue,  cat  gastrocnemius 
muscle,  dog  gastrocnemius  muscle  and  frog  hind  limbs.  This  aspect  of  the  perfusion 
experiments  with  saline  aroused  some  criticism  at  that  time.  There  were  suggestions 
that  the  release  of  ACh  under  such  conditions  was  unphysiological  and  could  perhaps 
be  equated  with  tissue  damage.  (Fleisch,  Sibul  and  Kaelin,  1936;  Lorente  de  No, 1938;  and  more  recently,  Nachmansohn  1946).  However,  only  after  the  perfusate 
showed  no  ACh-like  activity  did  Dale  et  al.  commence  stimulation  and  collection 
of  ACh. 
A  disadvantage  of  saline  perfusion,  they  stated,  was  the  increasing 
insensitivity  of  the  muscles  to  motor  impulses  developed  over  a  long  period  of  time. 
When  perfused  for  a  further  period  the  muscles  became  oedematous. 
In  the  case  of  frog  hind  limbs,  during  the  period  of  stimulation  a  rapid 
decline  in  twitch  was  evident  in  2-3  minutes.  The  muscle  was  rested  and 
stimulation  again  resumed  at  a  frequency  of  five  impulses  per  second.  Fatigue 
followed  more  quickly  than  in  the  first  period  of  stimulation.  They  noticed  that 
as  the  muscle  twitch  grew  weaker,  so  the  amount  of  acetylcholine-like  activity 
of  the  perfusate,  tested  on  leech  muscle,  grew  less. 
In  order  to  ensure  that  the  ACh  was  indeed  coming  from  the  motor  nerve 
terminals  and  was  not  being  released  directly  from  active  skeletal  muscle,  Dale 
paralysed  the  musculature  of  a  perfused  cat  tongue  with  curare  and  found  that 
stimulation  of  the  motor  nerve  still  had  the  effect  of  releasing  a  similar  quantity  of 
ACh  into  the  perfusing  fluid. 
It  is  interesting  to  note  at  this  point  the  observations  of  Dale  et  al.  on  the 
vasodilatation  occurring  during  the  muscle  perfusion.  They  noted  that  the  venous 
outflow  from  perfused  muscle  was  accelerated  at  the  onset  of  motor  nerve 
stimulation.  This  was  taken  as  an  index  of  increased  vasodilatation.  The  presence 
of  eserine  enhanced  this  phenomenon.  In  order  to  separate  the  vasodilatation  due 
to  muscle  "metabolites"  from  vasodilatation  caused  by  ACh  released  from  the  motor 
nerve  terminals,  they  used  curare  to  block  the  contraction  process.  It  was  found 
that  90%  of  the  increase  in  bloodflow  was  abolished  by  this  procedure,  indicating 
that  the  vasodilatation  observed  was  principally  due  to  "products  of  the  contractile 
mechanism". 
The  tests  employed  by  Dale  et  al.  in  1936  for  the  identification  of  ACh  have 
not  been  improved  upon  since  that  time.  With  concentrations  of  the  order  of -  12  - 
10-8  g/ml.  ACh  available  it  was  possible  for  them  to  use  multiple  bioassay 
techniques. 
They  established  that  the  unknown  substance  was: 
(a)  stable  in  acid  solution  but  was  destroyed  in  solutions  of  dilute  alkali; 
(b)  consistently  protected  from  the  tissue  esterases  by  eserine; 
(c)  effective  in  reducing  the  blood  pressure  of  a  cat;  this  effect  was 
enhanced  by  eserine  and  blocked  by  atropine; 
(d)  capable  of  producing  a  contraction  of  leech  muscle  in  the  presence  of 
eserine;  this  action  could  be  blocked  by  curare. 
These  tests  were  taken  to  indicate  that  the  hitherto  unknown  compound  released  from 
active  motor  nerve  terminals  was  ACh,  or  a  substance  very  similar  to  it. 
One  of  the  initial  problems  of  the  ACh  transmitter  theory  was  whether  the 
ACh  could  be  removed  quickly  enough  to  subserve  its  function  as  the  transmitter  of 
discrete,  high  frequency  nerve  impulses  into  the  muscle  fibre.  Hydrolysis  of  ACh 
occurs  in  many  tissues  by-the  enzyme  acetylcholinesterase  (Stedman,  Stedman  and 
Easson,  1932).  Marnay  and  Nachmansohn  (1937)  showed  that  the  concentration  of 
cholinesterase  at  the  endplates  was  many  thousands  of  times  higher  than  that  found 
in  muscle  tissue.  They  estimated  that  the  ACh  could  be  split  by  this  concentration 
of  cholinesterase  within  the  refractory  period  of  the  muscle,  i.  e.  around  one 
millisecond.  Histochemical  methods  have  revealed  cholinesterase  at  the  motor 
endplate  (Koelle  and  Friedenwald,  1949),  and  more  recently  Couteaux  (1958)  has 
shown  that  it  is  concentrated  on  the  subsynaptic  membrane  of  the  neuromuscular 
junction,  especially  in  the  region  of  the  junctional  folds. 
In  1938  Gopfert  and  Schaefer  established  the  existence  of  an  endplate 
potential  using  an  extracellular  recording  technique.  Kuffler  (1942)  suggested  that 
the  threshold  for  the  initiation  of  a  propagated  action  potential  was  about  a  third 
of  the  normal  endplate  potential  height. 
In  1950  Fatt  and  Katz  showed  that  the  endplate  region  of  a  muscle  fibre  is 
the  site  for  many  small  electrical  changes,  the  spontaneous  "miniature"  endplate --  13  - 
potentials  (m.  e.  p.  p.  s).  These  m.  e.  p.  p.  s  closely  resemble  the  local  potentials 
which  are  produced  by  applying  ACh  to  the  endplate  region  (Fatt  and  Katz,  1952; 
del  Castillo  and  Katz,  1955,1957;  Miledi,  1962).  It  is  widely  accepted  that 
the  m.  e.  p.  p.  s  are  depolarisations  produced  by  the  result  of  packets,  or  "quanta" 
of  ACh  released  from  the  nerve  terminal  impinging  on  the  endplate  receptors.  The 
work  of  del  Castillo  and  Katz  (1954),  Boyd  and  Martin  (1956),  Liley  (1956)  and 
Katz  and  Miledi  (1965)  has  shown  that  the  endplate  potential  can  be  accurately 
equated  to  the  sum  of  the  m.  e.  p.  p.  s  which  occur  over  a  similar  period  of  time. 
This  suggested  that  all  the  quanta  of  ACh  are  simultaneously  released  from  the 
nerve  terminal  upon  the  arrival  of  the  nerve  impulse. 
The  theory  of  quantal  release  of  ACh  has  been  supported  by  the  finding  with 
the  electron  microscope  that  the  motor  nerve  terminal  is  crowded  with  "vesicles" 
all  of  approximately  500Ä  in  diameter  (Birks,  Huxley  and  Katz,  1960).  The 
process  of  release  of  a  quantum  of  ACh  must  involve  the  coalescence  of  two 
membranes,  the  one  surrounding  the  vesicle  and  the  limiting  membrane  of  the 
nerve  terminal.  Evidence  of  this  coalescence  occurring  in  a  central  synapse  has 
been  demonstrated  by  the  electron  microscope  (Gray,  1963). 
In  1951  Nastuk  applied  small  quantities  of  ACh  to  a  single  endplate  region. 
He  used  an  electrode  of  less  than  0.5ju  external  diameter  and  drove  the  ACh  out 
of  the  pipette  with  a  short,  single  electrical  pulse  (iontophoresis). 
He  noted  that  as  the  micro  jet  of  ACh  was  directed  nearer  to  the  endplate,  so  the 
depolarization  of  the  muscle  membrane  increased.  Del  Castillo  and  Katz  (1955) 
successfully  applied  ACh  to  both  sides  of  the  endplate  membrane  using  the  iontophoresis 
technique  and  showed  that  the  intracellular  application  of  ACh  did  not  produce  an 
endplate  potential. 
Two  main  experimental  approaches  have  been  used  in  an  attempt  to  find  out 
the  number  of  ACh  molecules  in  each  quantum;  the  assay  of  solutions  which  have 
surrounded  active  muscle  preparations  and  the  technique  of  iontophoresis. 
Results  obtained  from  these  two  approaches  are  in  the  same  order  of -  14  - 
magnitude.  Miledi  (1961)  has  shown  that  it  is  necessary  for  105  molecules  of  ACh 
to  be  discharged  from  a  micropipette  to  produce  a  depolarization  equal  to  that  of 
a  miniature  endplate  potential.  Krnjevic  and  Mitchell  (1961)  calculate  from  their 
assay  of  ACh  spontaneously  released  from  rat  diaphragm  that  3.6  x  105  molecules 
of  ACh  are  contained  in  each  quantum.  However,  calculations  show  that  if  a 
vesicle  of  500  Ä  in  diameter  did  in  fact  contain  105  molecules,  the  unlikely 
concentration  of  10  M  ACh  would  be  present  within  the  vesicle  (del  Castillo 
and  Katz,  1956). METHODS -  15  - 
SETTING  UP  THE  FROG  HEART  FOR  PERFUSION 
Both  Rana  temporaria  and  Rana  pipiens  of  either  sex  were  used. 
After  stunning,  decapitation  and  pithing  the  frog  was  pinned  down  in  the 
supine  position.  The  skin  of  the  abdominal  and  thoracic  walls  was  removed.  The 
abdominal  musculature  was  then  removed  and  the  thoracic  cavity  was  entered, 
avoiding  damage  to  the  pericardial  cavity.  By  cutting  through  the  shoulder 
girdle  on  both  sides  a  segment  of  the  anterior  wall  of  the  thorax  was  lifted  and 
cut  off  exposing  the  heart  lying  within  the  pericardial  cavity.  After  tying  off 
any  prominent  portal  veins,  the  venous  cannula  was  introduced  into  the  exposed 
posterior  vena  cava  through  a  small  flap  in  the  ventral  wall  of  this  vessel.  The 
cannula  was  securely  ligatured  into  the  vein.  In  order  to  prevent  excessive 
clot  formation  at  this  stage  frog  Ringer's  solution  was  perfused  into  the  posterior 
vena  cava  at  a  low  pressure. 
The  two  aortae  were  now  cannulated,  the  first  cannula  leading  to  a  mercury 
manometer,  the  other  cannula  leading  to  the  peripheral  resistance  unit,  the  drop 
counter,  and  connected  to  the  lead  from  the  first  cannula  in  order  to  preserve 
the  same  pressure  in  both  leads.  (Figure  1  ). 
The  perfusion  pressure  was  kept  between  25  -  35  mm  H2O  depending  upon 
the  particular  heart  being  perfused. 
Calibration  of  the  equipment  is  dealt  with  in  previous  work  and  is  not 
included  as  part  of  this  thesis.  (Pathak,  1962). Motor  driven  Venous  Pressure 
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Figure  1. 
A  block  diagram  to  show  the  general  layout  of  the  frog  heart  perfusion  system 
of  Boyd  and  Eadie  (1961). 
At  the  top  left  of  the  diagram  the  solutions  to  be  tested  lie  in  a  horizontal 
burette  which  leads  into  the  venous  capsule.  Because  of  the  small  amounts  of  the 
test  samples  in  this  work  a  positive  pressure  system  had  to  be  developed.  Figure  3 
shows  the  pressure  system  used  in  the  present  work  and  replaces  the  horizontal 
burette  scheme  depicted  here. -  16  - 
DISSECTION  OF  THE  FROG  SARTORIUS  MUSCLE 
The  sartorius  muscles  were  obtained  from  both  Rana  temporaria  and  Rana 
i  iens  of  either  sex.  After  stunning,  decapitation  and  pithing  the  frog  was  laid 
in  the  supine  position  and  the  skin  was  removed  from  the  lower  left  limb  and  the 
anterior  abdominal  wall.  The  inferior  part  of  the  rectus  abdominis  muscle  was 
pinched  up  and  a  V-shaped  incision  was  made  into  the  abdominal  cavity.  The 
rectus  was  then  stripped  up  towards  the  rib  margin,  exposing  the  viscera.  The 
rectum  was  cut  through  and  by  incising  the  peritoneum  and  mesentery  the  viscera 
was  carefully  stripped  off  the  posterior  abdominal  wall  towards  the  diaphragm 
until  this  procedure  could  be  followed  no  further.  This  revealed  the  large  nerve 
trunks  lying  on  either  side  of  the  spinal  column. 
Attention  was  then  turned  to  the  tendinous  insertion  of  the  left  sartorius 
muscle.  The  tendon  was  removed  from  a  point  as  near  as  possible  to  its  insertion 
using  fine  scissors  and  forceps  under  the  dissecting  microscope.  The  muscle 
belly  was  then  freed  from  underlying  structures  on  the  lateral  side.  This  was 
extended  up  the  whole  length  of  the  muscle  to  its  origin  at  the  fascia  of  the 
anterior  abdominal  wall.  The  proximal  part  of  the  muscle  belly  was  then 
mobilized  and  the  origin  of  the  muscle  was  then  removed  from  the  medial  part 
of  the  pubis  and  the  lateral  abdominal  fascia.  With  the  proximal  and  lateral 
parts  of  the  muscle  thus  mobilized,  it  was  possible  to  turn  the  muscle  over  in  a 
medial  and  downward  direction,  preserving  the  lower  and  medial  half;  this  is 
the  part  of  the  muscle  where  the  nerve  enters  the  muscle  belly  from  the  medial 
side.  With  the  muscle  turned  down  at  its  origin  and  at  a  safe  distance  from 
the  symphysis  pubis,  it  was  then  possible  to  split  the  symphysis  pubis  with  a 
strong  scalpel  blade.  The  left  half  of  the  pubic  bone  was  then  turned  laterally 
and  the  sciatic  nerve  with  its  obturator  branch  was  seen  to  hook  round  the 
sciatic  notch  of  the  split  pelvis,  passing  into  the  thigh  musculature.  The  bony 
projection  of  the  sciatic  notch  was  then  modified  with  coarse  scissors  and  the 
thigh  was  pinned  out  in  the  laterally-rotated  position.  The  course  of  the  nerve -  17  - 
to  sartorius  could  then  be  traced  backwards  to  the  exposed  nerve  trunk  by 
splitting  the  fascia  between  the  muscle  planes  with  a  blunt  probe  under  the 
dissecting  microscope.  Throughout  the  procedure  frog  Ringer's  solution  was 
poured  over  the  parts. 
The  nerve  trunks  of  L2,3,4  and  5  were  cut  as  close  to  the  spinal  column 
as  possible  and  then  mobilized  from  the  posterior  abdominal  wall  fascia  until 
the  main  branch  to  the  sartorius  muscle  was  reached.  At  this  point  the  nerve 
to  sartorius  bends  at  a  right  angle  into  the  muscle,  running  across  the  muscle 
planes.  Great  care  was  necessary  under  the  dissecting  microscope  to  free  this 
final  section  of  nerve.  Both  nerve  and  muscle  were  then  completely  free  from 
the  underlying  tissues. 
After  washing  the  muscle  thoroughly  with  Ringer's  solution  while  it  was 
still  lying  on  the  thigh,  the  nerve-muscle  preparation  was  then  immediately 
transferred  to  a  container  of  Ringer's  solution,  gently  shaken  for  a  few  moments, 
then  transferred  to  a  2ml.  container  of  Ringer's  solution  and  left  to  "equilibrate" 
for  10  minutes.  After  this  the  muscle  was  then  put  into  the  container  with  2ml, 
of  Ringer's  solution  and  its  nerve  trunk  laid  gently  over  the  stimulating 
electrodes  (see  Figure  2  ).  All  transfers  were  done  by  holding  the  sartorius  muscle 
by  its  tendon  with  fine  forceps.  This  ensured  that  no  muscle  fibres  were  damaged 
in  transit.  The  nerve  trunk  was  allowed  to  adhere  to  the  muscle  belly  by 
capillary  attraction  during  the  transfer  process.  All  Ringer's  solutions  contained 
10-6  g/ml.  eserine  sulphate. 
Stimulation  of  the  Muscle 
It  was  found  that  with  a  pulse  width  of  1  millisecond  the  threshold  of 
stimulation  required  to  make  the  muscle  twitch  was  usually  0.5  volts.  In  every 
case  the  sartorius  muscles  were  stimulated  at  4V  with  a  pulse  width  of  1  msec  at 
2  impulses  per  second  for  a  period  of  half  an  hour.  The  sartorius  muscle  usually 
responded  to  every  impulse  throughout  the  period  of  stimulation.  After  this  half 
hour  period  the  muscle  was  left  to  soak  in  the  2misolution  for  10  minutes  in  order Figure  2. 
Apparatus  used  for  the  indirect  stimulation  of  the  frog  sartorius  muscle.  The 
photograph  shows  a  pulse  generator  connected  to  a  bank  of  four  output  points 
connected  in  parallel.  Four  stimulated  muscle  solutions  could  be  obtained  at  the 
same  time.  A  muscle  is  being  stimulated  from  the  left  hand  output  point.  Two 
stimulated  muscle  solutions  are  seen  standing  on  the  right. 
The  line  drawing  shows  the  frog  sartorius  muscle  which  lies  unsupported  in 
2  ml.  Ringer's  solution.  The  nerve  to  the  muscle  lies  over  platinum  electrodes 
which  protrude  into  the  glass  container  through  a  cork  stopper.  The  electrical 
impedance  across  the  nerve  does  not  affect  the  pulse  amplitude.  Leads  from  the 
electrodes  are  inserted  into  the  stimulating  bank. 
The  rat  hemidiaphragm  preparation  was  also  stimulated  in  this  way,  oxygenation 
was  effected  via  a  capillary  tube  (not  shown)  which  passed  through  the  cork 
stopper.  An  outlet  tube  was  also  present. -  18  - 
to  allow  time  for  diffusion  of  any  released  acetylcholine  into  the  surrounding 
bathing  solution.  The  muscle  was  then  removed  with  fine  forceps  and  the  solution 
was  ready  for  assay  on  the  frog  heart  perfusion  system.  This  solution  will  be 
referred  to  as  the  "stimulated  muscle  solution"  throughout  the  text. -  19  - 
INJECTION  OF  SOLUTION  INTO  THE  FROG  HEART 
On  account  of  the  small  quantity  (lml)  of  each  test  sample  to  be  assayed, 
it  was  necessary  to  devise  a  system  of  injection  of  this  volume  into  the  frog  heart 
perfusion  system  since  dilution  of  the  test  sample  to  a  suitable  volume  for  the 
horizontal  burette  system  would  dilute  the  expected  ACh  in  this  solution  beyond 
the  threshold  of  the  frog  heart. 
A  positive  pressure  system  was  adopted  (Figure  3  ).  Air  pressure  in  a  closed 
container  was  matched  to  the  pressure  of  the  normal  perfusion  Ringer's  solution. 
A  iml.  "tuberculin"  syringe  containing  the  test  sample  was  connected  between  the 
closed  container  and  the  venous  pressure  capsule  (Figure  3  ),  so  that  the  sample 
would  be  driven  into  the  heart  by  a  similar  pressure  to  that  of  the  perfusing 
Ringer's  solution. 
As  a  precaution,  the  closed  pressure  system  was  linked  by  a  three-way  tap 
to  the  atmosphere  via  a  fine  needle,  and  to  another  closed  container  which  was 
at  a  pressure  slightly  higher  than  that  of  the  optimum  perfusion  pressure.  By 
means  of  this  tap  the  perfusion  pressure  of  the  1ml.  sample  could  be  regulated  if 
necessary  during  the  course  of  the  injection. 
Procedure  :  The  syringe  was  filled  via  a  needle  with  the  test  sample  and  fitted 
between  the  venous  pressure  capsule  and  the  air  pressure  system.  The  tap  from 
the  perfusion  reservoir  was  closed  and  at  the  same  time  the  tap  allowing  the  air 
pressure  to  reach  the  syringe  was  opened.  The  pressure  in  the  venous  capsule 
was  now  kept  constant  at  the  original  perfusion  pressure  by  the  three-way  tap, 
momentarily  turning  towards  either  the  atmosphere  or  the  high-pressure  container 
as  required.  When  the  test  sample  had  almost  completely  entered  the  venous 
capsule,  the  tap  from  the  perfusion  resevoir  was  turned  on  and  the  tap  between 
the  air-pressure  system  and  the  syringe  was  closed.  In  practice,  small 
fluctuations  in  the  perfusion  pressure  occurred  (Figure  11)  as  the  test  sample  was 
driven  from  the  syringe  into  the  capsule.  However,  these  changes  only  affected ch 
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the  cardiac  output,  heart  rate  and  blood  pressure  slightly  and  by  the  time  the 
sample  had  reached  the  heart  the  pressure  from  the  normal  perfusion  reservoir 
was  again  in  operation;,  thus  any  effect  on  the  heart  caused  by  the  test  sample 
occurred  when  the  perfusion  pressure  was  constant. 
Some  dilution  of  the  sample  in  the  venous  capsule  may  occur,  but  it  is 
probable  that  when  the  sample  is  entering  the  capsule  it  pushes  the  Ringer's 
solution  in  front  of  it  into  the  posterior  vena  cava  cannula  without  much 
mixing  taking  place  at  the  interface.  Similarly,  when  the  Ringer's  solution  from 
the  reservoir  again  flows  into  the  capsule,  it  pushes  the  last  part  of  the  sample 
into  the  cannula. 
It  has  been  assumed  that  the  amount  of  dilution  occurring  in  the  venous 
capsule  is  the  same  for  all  samples  injected  into  the  heart. -  21  - 
MEASUREMENT  OF  POTASSIUM 
Measurements  were  carried  out  by  flame  photometry.  The  sample  to  be 
measured  was  diluted  1  in  50  with  distilled  water  and  then  measured  (using  the 
E.  E.  L.  flame  photometer).  Six  readings  were  made  of  each  sampel  and  a 
mean  of  those  was  taken.  Similar  methods  were  adopted  to  measure  the 
concentration  of  potassium  of  various  Ringer  solutions  in  which  the  muscles  were 
rested  and  stimulated.  The  standard  solution  of  potassium  used  for  comparison 
was  0.1  pEq/mI.  At  this  order  of  concentration  the  response  of  the  flame 
photometer  is  directly  proportional  to  the  concentrations  of  K+  applied. 
Example 
Standard  reading  =  39  =  0.1  juEq/mI. 
Muscle  solution  readings  =  20.20.21.21.21.21.  mean  -  21. 
Concentration  of  potassium  - 
39 
x 
50 
x  To  =  2.7  mM -  22  - 
METHOD  OF  ESTIMATING  CALCIUM  CONCENTRATION 
The  complexiometric  titration  method  was  used  (Wilkinson,  1957).  The 
dyestuff  ammonium  purpurate  ('Murexide')  turns  red  in  alkaline  solution  in  the 
presence  of  calcium  ions.  When  the  calcium  is  removed  by  chelation  with 
ethyl  ene-diamine  tetra-acetic  acid  (E,  D.  T,  A.  )  the  dye  returns  to  its  normal  blue 
colour.  The  end-point  of  this  titration  cannot  be  judged  accurately  with  the  eye, 
so  that  the  use  of  a  photo-electric  titrator  is  necessary. 
Reagents 
1.  E.  D.  T.  A.  -A  stock  solution  of  0.36%  was  diluted  10  times  for  use. 
2.  Murexide  -A  stock  solution  of  0.6%  was  diluted  1  in  200  with 
distilled  water. 
3.  Sodium  hydroxide  -A  decinormal  solution  was  made  up  from  a  2N 
solution  for  each  batch  of  test  solutions. 
4.  Calcium  standard  -A  stock  di  Iution  of  100  mg  Ca++/100  mis  was 
diluted  by  10  to  give  a  2.5  mM  solution. 
Preparation  of  Solution  for  Titration 
0.5  ml.  of  test  sample  was  pipetted  into  a  10  ml.  glass  curvette  along  with 
3  ml-of  Murexide  solution  and  6.0  ml  decinormal  sodium  hydroxide  solution.  An 
electro-magnetic  stirrer  was  placed  in  the  cuvette  before  putting  it  on  the 
titrator  platform.  The  stirring  mechanism  was  switched  on. 
The  burette  containing  E.  D.  T.  A.  was  adjusted  so  that  its  tip  was  just  below 
the  meniscus  of  the  liquid  in  the  cuvette,  taking  care  not  to  obstruct  the  pathway 
of  light  through  the  solution. 
A  606  yellow  filter  was  placed  in  the  titrator;  the  galvanometer  reading 
was  adjusted  to  zero  against  a  blank.  The  calcium  standard  solution  was  then 
measured,  (mean  of  3  results,  before  and  after  the  test  samples)  followed  by  the 
test  solutions. -  23  - 
Method  of  Titration 
0.1  ml.  amounts  of  E.  D.  T.  A.  were  run  in  until  the  colour  of  the  solution 
started  to  change.  Then  0.01  ml.  amounts  were  run  in  while  another  observer 
gauged  the  movement  of  the  galvanometer  spot.  The  end-point  was  reached  when 
the  spot  was  not  deflected.  This  was  impossible  to  accomplish  with  only  one 
person  carrying  out  the  titration,  since  the  end-point  was  reached  in  effect  when 
the  spot  failed  to  move  when  more  E.  D.  T.  A.  was  run  in. 
r￿  i,., 
Standard  calcium  solution  =  2.5  mM.  Test  solution  =?  mM. 
Reading  on  galvanometer  =  1.33  Galvo.  reading  =  0.58 
millimolarity  of  test  solution  = 
0.58 
x  2.5  =  1.09  mM.  1.33 -  24  - 
THE  ESTIMATION  OF  PROTEIN 
The  method  described  by  Lowry  et  al.  (1951)  was  used.  They  recommended 
that  this  reaction  was  especially  useful  in  measuring  small  amounts  of  mixed 
tissue  proteins,  particularly  when  absolute  values  were  not  required. 
Reagents 
1.2%  Na2CO3  in  0.1  N  NaOH. 
2.0.5%  CuSO4.5H20  in  1%  sodium  tartrate. 
3.  Folin-Ciocalteu  phenol  reagent  diluted  to  1  N. 
4.  Standard  solution  of  bovine  serum  albumen  diluted  to  a  concentration 
of  50  ;  ig/m  I. 
Principle 
When  protein  is  added  to  a  copper  solution  in  an  alkaline  medium,  a  blue 
colour  is  developed.  This  colour  change  is  due  almost  entirely  to  the  tyrosine  and 
tryptophan  content  of  the  protein  chains.  When  the  Folin  reagent  is  added  to 
copper-treated  protein  at  pH  10,  reduction  of  the  reagent  takes  place  and  the 
blue  colour  is  intensified.  At  this  pH  value  the  reagent  is  only  active  for  a  very 
short  time,  so  that  even  a  few  seconds  delay  in  mixing  will  reduce  the  final  colour 
intensity.  The  colour  intensity  developed  is  proportional  to  the  concentration  of 
protein  present  in  the  test  solution. 
Method 
50  ml  of  the  alkaline  copper  reagent  is  made  up  as  follows  :  - 
49  ml  No2CO3/NaOH  reagent,  0.5  ml.  of  CuSO4.5H20  and  0.5  ml.  of 
sodium  tartrate  solution  are  mixed  together.  5  ml  of  this  alkaline  copper  solution 
is  added  to  1  ml.  of  the  solution  to  be  tested  for  protein.  This  mixture  is  allowed 
to  stand  for  exactly  10  minutes.  Then  0.5  ml.  of  1N  Folin-Ciocalteu  reagent  is 
added  and  the  whole  shaken  during  and  immediately  after  the  addition  of  the 
reagent.  The  solution  is  then  left  to  stand  for  exactly30minutes.  During  this  time 
a  blue  colour  slowly  develops,  and  this  is  compared  to  the  blue  colour  developed -  25  - 
by  the  standard  solution.  The  comparison  was  carried  out  be  measuring  the 
absorption  of  light  of  the  solutions  at  625  mit  wavelength  on  a  Zeiss  type  PMQ  11 
spectrophotometer.  The  standard  solution  of  bovine  serum  albumen  was  read 
twice,  onceat  the  beginning  of  the  series  and  once  at  the  end. 
Exam 
Reading 
Before  After 
Bovine  serum  albumen  solution  =8  10  (Mean  9) 
Test  solution  =  16 
Reading  of  9=  50  ug/m  I. 
Reading  of  16  =2x  16  ug/ml.  =  89  pg/mI.  in  test  solution. -  26  - 
THE  PREPARATION  OF  APYRASE  SOLUTIONS 
2  mg  of  potato  apyrase  (adenosine  -  5'  -  triphosphatase  and  adenosine  -  5'  - 
diphosphatase,  Sigma)  crystals  were  weighted  out  and  placed  in  a  small  watch- 
glass.  A  stimulated  muscle  solution  was  obtained,  volume  2  ml.  (see  Methods 
section).  The  apyrase  crystals  were  then  brushed  carefully  off  the  watch-glass 
surface  into  the  bottle  containing  the  stimulated  muscle  solution.  These  quickly 
dissolved  after  gentle  shaking  of  the  bottle.  The  solution  was  then  incubated  in 
a  waterbath  at  30°C  for  quarter  of  an  hour.  After  cooling  to  room  temperature, 
the  solution  was  then  perfused  through  the  frog  heart. 
On  some  occasions  the  stimulated  muscle  solution  was  divided  into  two  1  ml, 
portions.  Then  1  ml.  of  the  solution  was  incubated  with  I  mg  of  apyrase,  the 
other  1  ml.  portion  thus  being  available  as  a  control. 
Adenosine  triphosphate  solutions  of  suitable  concentrations  were  also  made 
up  in  frog  Ringer's  solution  and  incubated  with  apyrase  in  exactly  the  same 
manner. -  27  - 
THE  FIREFLY  LUMINESCENCE  PROCEDURE 
Materials 
Powdered  firefly  extract  (Sigma  FLE  50). 
Adenosine  triphosphate  solutions  made  up  in  frog  Ringer's  solution. 
Narrow-width  glass  cuvettes  of  0.5  ml.  capacity. 
Photomultiplier  tube  with  guiding  lens  system,  reflecting  cone  and  covering 
cannister. 
Powerpack  and  potentiometer. 
"Devices"  single-channel  pen  recorder. 
The  photomultiplier  tube  is  mounted  in  a  Iight-proof  alcove  and  the  whole 
procedure  is  performed  in  a  photographic  dark  room  with  illumination,  when 
necessary,  from  a  red  safety  light. 
ATP  solutions  are  made  up  in  frog  Ringer's  solution  which  match  the  expected 
concentration  of  ATP  in  the  stimulated  muscle  solution  as  measured  on  the  frog  heart 
perfusion  system  (see  Figure  1  ). 
The  powdered  firefly  extract  is  taken  out  of  the  deep  freeze  and  allowed  to 
stand  until  room  temperature  is  attained.  It  is  then  reconstituted  by  pipetting 
5  ml.  of  distilled  water  into  the  bottle.  With  gentle  shaking  the  powder  dissolves 
in  a  few  minutes  and  insoluble  parts  of  the  firefly  material  are  allowed  to  settle 
to  the  base  of  the  container. 
0.25  ml.  of  the  supernatant  is  then  pipetted  into  a  narrow-width  glass 
cuvette,  the  base  of  which  is  smeared  with  "optical  glue". 
The  pen  recorder  motor  is  switched  on,  the  speed  used  is  2.5  mm  per  second. 
All  light  sources  are  switched  off  and  the  red  safety  light  is  switched  on.  With 
the  voltage  of  the  powerpack  adjusted  to  a  low  value,  the  copper  cannister 
covering  the  top  of  the  photomultiplier  tube  is  removed,  revealing  the  reflector -  28  - 
cone. 
At  this  point  0.25  ml.  of  the  stimulated  muscle  solution  is  added  to  the 
cuvette  containing  0.25  ml.  of  the  firefly  extract.  The  reflector  cone  is  now 
removed  from  the  photomultiplier  tube  and  the  cuvette  mounted  by  hand  on  to 
the  guiding  lens.  The  "optical  glue"  smeared  on  the  base  of  the  cuvette  ensures 
that  a  good  contact  is  made  with  the  lens.  The  reflector  cone  is  then  quickly 
replaced  over  the  top  of  the  tube,  enclosing  the  mounted  cuvette.  The  red  safety 
light  is  then  switched  off  and  the  voltage  of  the  powerpack  adjusted  to  1300  V. 
After  a  trace  has  been  obtained  on  the  pen  recorder,  the  high  voltage  is  switched 
off,  the  reflecting  cone  lifted  and  the  cuvette  removed.  The  cone  is  then 
replaced  and  the  high  voltage  is  switched  on  again.  This  then  gives  the  true 
base  line  on  the  record  for  a  voltage  of  1300  V. 
From  the  time  when  the  test  solution  is  added  to  the  firefly  extract,  till  the 
time  when  a  recording  is  actually  obtained  the  procedure  is  carried  out  as  quickly 
as  possible  and  usually  takes  about  10  -  15  seconds.  This  means  that  the  record 
unfortunately  does  not  encompass  the  initial  15  seconds  of  the  I  ight  emission,  so 
that  the  initial  "flash"  of  light  emitted  when  ATP  first  contacts  the  firefly  extract 
has  not  been  recorded  by  this  method.  However,  both  stimulated  muscle  solution 
and  a  test  solution  of  ATP  have  similar  rates  of  light  signal  decay  (Figure  36  ) 
and  the  some  amplitude  of  small  scintillations,  indicating  that  although  the  light 
is  probably  being  reflected  in  a  constant  pattern  from  the  inner  surface  of  the 
relfecting  cone,  the  light-producing  reaction  is  taking  place  in  a  random  fashion. -  29  - 
COMPOSITION  OF  RINGER'S  SOLUTIONS 
Frog  Ringer's  Solution 
Stock  Concentration  Other  Components 
NaCI  70  g/l  (isotonic  x  10) 
KCI  9  g/1  (isotonic) 
NaHCO3  10  g/l  (isotonic)  Glucose  1  g/l 
Neostigmine  10  g/ml.  COO26H2O  18.8  g/I  (isotonic) 
NaH2PO42H2O  18.72  g/I  (isotonic) 
Method 
The  stock  solutions  were  made  up  from  "Analar"  reagents  supplied  by  British 
Drug  Houses  Ltd.  The  Ringer's  solution  was  made  up  in  the  following  way:  - 
400  ml.  stock  NaCl  solution  was  diluted  to  4,000  ml.  with  distilled  water. 
To  this  amount  was  added  the  other  stock  solutions:  -  100  mI.  stock  KCI,  90  ml. 
stock  NaHCO3,60  ml.  stock  CaCI26H2O  and  30  ml.  NaH2PO42H2O  and  the 
whole  shaken  thoroughly.  4.28  g  of  glucose  and  4.3  mg  of  neostigmine  were 
added  to  give  final  concentrations  of  glucose:  1  g/l  and  neostigmine;  10-6  g/ml. 
pH  adjustment  to  7.4  (if  needed)  was  made  by  adding  either  N  HCI  or  N  NaOH. 
The  final  concentrations  were  109  mM  NaCl,  4.3  mM  NaHCO3,3.8  mM  KCI, 
1.6  mM  CaCl 
2' 
0.22  mM  NoH2PO4. 
Kreb's  Solution 
Stock  Concentration 
NaCl  90  g/l 
KCI  11.5g/l 
NaHCO3  12.94  g/I 
KH2PO4  21  g/I 
MgS  O47H 
2O  18.54  g/I 
CaC  1 
26H2O  24.1  g/I -  30  - 
Method 
80  ml.  of  the  stock  NaCl  solution  was  diluted  to  ten  with  distilled  water  to 
800  ml.  To  this  was  added  32  ml.  of  stock  KC  I,  8  ml.  of  stock  NaHCO3  and 
16.8  ml.  of  stock  KH2PO4.  The  solution  was  shaken  thoroughly  and  then  bubbled 
with  a  mixture  of  95%  02  and  5%  CO2  for  fifteen  minutes.  Then  8  ml.  of  stock 
MgSO47H2O  and  24  ml.  of  stock  CaCI26H2O  were  added. 
Locke's  Solution 
Stock  Concentration 
NaC  I  250  0 
NaHCO3  509/1 
CaCI26H2O  1000 
KCI  150  g/I 
Method 
One  litre  of  solution  was  made  up  by  mixing  36  ml.  stock  NaCl,  10  ml.  stock 
NaHCO3,2.4  ml.  stock  CaCI26H2O  and  2.8  ml.  stock  KCI.  This  was  made  up  to 
1,000  ml.  with  distilled  water  and  1g  of  glucose  added.  The  final  concentrations 
were  154  mM  NaCl,  5.6  mM  KCI,  2.2  mM  CaC12,6.0  mM  NaHCO3. 
Leech  Solution 
Stock  solutions  as  for  Locke's  solution. 
Method 
1,000  ml.  of  Locke's  mammalian  solution  were  made  up  without  adding 
glucose  or  eserine.  This  solution  was  diluted  1:  1.4  by  adding  400  ml.  distilled 
water.  Glucose  was  added  to  a  concentration  of  1  g/litre  and  eserine,  10-5  g/ml. 
The  pH  of  the  resulting  solution  was  lowered  to  7.0  by  bubbling  the  solutions  for 
a  few  minutes  with  5%  CO2.  The  final  concentrations  were  110  mM  NaCl,  4.3mM 
NaHCO3,1.6  mM  CaCI2,4  mM  KCI. -  31  - 
Cleansing  of  Glassware 
All  glassware  was  cleaned  by  the  Calgon-metasilicate  method  (Boyd 
and  Pathak,  1964)  and  sterilized  in  sealed  nylon  packages  which  were  opened 
immediately  prior  to  the  use  of  their  contents. 
COMPOSITION  OF  RINGER'S  SOLUTION  USED  (mM) 
NaCl  KCI  CaCl 
2  NaHCO3  KH2PO4  NaH2PO4  MgSO4 
Krebs  119  4.7  2.5  24.8  1.2  -  1.2 
Frog  109  3.8  1.6  4.3  -  0.22  - 
Locke  154  5.6  2.2  6.0  -  -  - 
Leech  110  4.0  1.6  4.3  -  -  - -  32  - 
MAKING  UP  THE  ACETYLCHOLINE  SOLUTIONS 
Sealed  ampoules  of  200  mg  acetylcholine  chloride  (powder  form)  were 
specially  supplied  by  Roche  Products  Ltd.  Each  ampoule  of  acetylcholine 
chloride  was  accompanied  by  an  ampoule  of  distilled  water. 
Method 
Both  ampoules  were  filed  and  broken  open;  2  ml.  of  distilled  water  was 
transferred  by  syringe  into  the  ampoule  containing  200  mg  acetylcholine 
chloride.  The  powder  dissolved  quickly.  The  solution  was  then  sucked  back 
into  the  syringe  and  transferred  to  a  clean,  dry  250  ml.  graduated  cylinder.  This 
was  made  up  to  200  ml.  with  frog  Ringer's  solution,  giving  a  concentration  of 
10-3  g/ml.  of  acetylcholine  chloride  in  frog  Ringer's  solution. 
By  transferring  1  ml.  of  this  stock  solution  of  10-3  g/mI.  acetylcholine 
chlordie  to  a  100  ml.  flask  and  making  up  to  the  mark  with  frog  Ringer's  solution, 
a  concentration  of  10-5  g/ml.  was  obtained.  Dilution  of  1:  100  from  this  flask 
resulted  in  a  concentration  of  10-7  g/ml.  From  this  flask  a  dilution  of  1:  10  gave 
10-8  g/ml.,  and  a  dilution  of  1:  100  gave  10-9  g/ml.  In  this  way  a  range  of 
concentrations  from  the  stock  solution  of  10-3  g/ml.  to  10-13  g/ml.  were  obtained. 
Intermediate  Concentrations 
The  concentration  of  5x  10-5  g/ml.  was  prepared  by  making  up  5  m1.  of 
10-3  g/ml.  to  100  ml.  with  Ringer's  solution.  From  this  concentration  the  intermediate 
concentrations  of  5x  10-7  g/ml.,  5x  10-8  g/ml.,  5x  10-9  g/ml.  were  made  up. 
Further  intermediate  concentrations  of  1.5  x  10-9  g/ml.,  2.5  x  10-9  g/ml, 
3.5  x  10-9  g/ml.  and  7.5  x  10-9  g/ml.  were  made  up  when  required  in  100  ml. 
flasks. 
Acetylcholine  Solutions  for  Leech  Experiments 
The  procedure  for  making  up  graded  acetylcholine  chloride  solutions  for  the 
leech  experiments  was  essentially  the  same  as  that  for  the  frog  heart  experiments. 
Eserinized  I  eech  Ringer's  solution  was  used  throughout. -  33  - 
LIST  OF  DRUGS 
Adrenaline  British  Drug  Houses  Ltd.  In  sealed  1  ml  ampoules 
of  1:  1,000  concentration. 
Noradrenaline  :  Bayer  Products  Ltd.  Supplied  as  the  bitartrate  in 
sealed  2  ml  ampoules  of  1:  1,000  concentration. 
Adenosine  triphosphate  :  British  Drug  Houses  Ltd.  In  powder  form  as  the 
disodium  dihydrogen  salt;  also  supplied  by  Pabst 
Laboratories 
. 
Adenosine  diphosphate  :  Manufactured  by  Pabst  Laboratories. 
Adenosine  monophosphate  :  Manufactured  by  Pabst  Laboratories. 
Atropine  sulphate  :  Solution  supplied  in  1  ml.  sealed  ampoules  by 
Evans  Ltd.,  each  ampoule  containing  .6  mg. 
Acetylcholine  chloride  :  The  powder  was  supplied  specially  by  Roche  Ltd. 
in  sealed  200  mg  ampoules. 
Curare  :  50  mg  d-tubocurarine  chloride  in  5  ml.  solution. 
Supplied  by  Duncan  Lockhart  &  Co.  Ltd. 
Ergotamine  tartrate  :  Sandoz  Products  Ltd.  Sealed  ampoules  of  1  ml., 
each  ampoule  containing  0.5  mg. 
Morphine  hydrochloride  :  Supplied  in  powdered  form  by  Burroughes  Wellcome 
&  Co. 
Neostigmine  (eserine)  :  Roche  Products  Ltd.  Supplied  as  neostigmine 
methyl  sulphate  in  concentrations  of  2.5  mg  mer 
ml.  in  5  mI  ampoules. 
Physostigmine  sulphate  :  Supplied  in  powder  form  by  Macfarlan  Smith  Ltd. 
Pronethalol  :  Supplied  as  a  special  sample  in  powder  form  by 
I.  C.  I.  Ltd. -  34  - 
MOLECULAR  SIEVE  CHROMATOGRAPHY  PROCEDURE 
Introduction 
J.  Porath  (1959)  introduced  a  crossed-I  inked  dextran  gel  in  order  to 
separate  out  chromatographically  the  protein  fraction  from  the  blood  plasma.  His 
interest  lay  in  the  further  investigation  of  the  protein  and  polypeptide  molecules. 
This  column  separation  technique  has  been  adopted  commercially  ("Sephadex", 
Pharmacia,  Uppsala,  Sweden)  and  there  are  now  available  many  cross-linked 
dextran  gels  capable  of  separating  out  large  molecules  in  different  ranges  of 
molecular  weight. 
The  type  of  Sephadex  column  used  was  G-25  of  particle  size  20W  -  80.  u  in 
diameter.  It  has  the  property  of  being  able  to  separate  molecules  of  5,000  molecular 
weight  and  less  from  molecules  having  a  larger  molecular  weight. 
Principle 
The  Sephadex  particles  are  supplied  in  dry  form  and  have  to  be  soaked  in 
the  solvent  liquid  before  use.  After  the  soaking  procedure,  the  particles  swell  up, 
the  extent  of  the  swelling  depending  upon  the  nature  of  the  solvent  and  the 
architecture  of  the  gel  matrix.  Solute  molecules  can  penetrate  the  dextran 
network  according  to  the  steric  relationships  between  the  molecular  structure  of 
the  dextran  gel  and  the  solute  particles.  Thus  the  shape  and  size  of  the  solute 
molecules  largely  determine  their  penetration,  and  hence  their  distribution  between 
gel  particles,  and  solvent  lying  between  these  gel  particles,  is  determined.  If  a 
substance  is  able  to  penetrate  the  gel  matrix  completely,  it  will  be  maximally 
retarded  in  its  elution  through  the  column.  If  a  substance  has  such  a  large 
molecular  size  that  it  cannot  penetrate  the  gel  matrix  at  all,  then  no  retardation 
will  take  place  and  the  substance  will  be  eluted  through  the  column  very  quickly 
(Figure  4  ). 
Sephadex  columns  in  general  will  increase  the  retardation  as  the  molecular 
weight  of  the  solute  molecule  diminishes,  but  there  are  some  molecules  which  are Diagrammatic  representation  of  solute 
distributions  in  the  Sephadex  column. 
Maximum 
retardation 
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Figure  4.  (After  Tiselius  et  al.  1963) 
Sephadex  particles  of  cross-linked  dextran  gel  are  represented  by  equal-sized 
circles.  Solute  molecules  are  represented  by  small,  medium-sized  and  large  dots. 
The  size  of  the  gaps  (pores)  between  the  cross-linkages  in  the  particles  vary 
according  to  the  type  of  Sephadex.  Sephadex  G-25  has  a  pore  size  which  will 
just  prevent  admission  of  molecules  of  molecular  weight  5000  or  over.  The  shape 
of  the  solute  molecule  will  also  determine  whether  penetration  into  the  dextran 
matrix  is  possible. -  35  - 
specifically  retarded  more  than  they  should  be  according  to  their  molecular  weight 
(e.  g.  adenosine  compounds).  These  anomalies  can  be  due  to  one  or  both  of  the 
following:  - 
1.  the  shape  of  the  molecule  does  not  fit  the  gap  in  the  dextran  matrix 
2.  the  molecule  is  highly  charged  and  the  gel  is  repellant. 
It  is  generally  better  not  to  elute  the  column  with  distilled  water,  since 
charged  solutes  then  exhibit  inconsistent  behaviour.  In  the  present  work  done  with 
Sephadex  G-25,  various  Ringer's  solutions  were  used  for  elution. 
Construction  of  Glass  Column  Container 
Three  problems  naturally  arise  during  the  task  of  setting  up  a  fractionating 
column. 
1.  The  column  material  must  be  packed  evenly. 
2.  The  material  supporting  the  base  of  the  column  must  be  rigid,  porous 
to  water  but  not  to  the  column  material. 
3.  The  top  of  the  column  must  be  perfectly  horizontal  and  preserved  as 
such. 
The  second  requirement  was  met  by  the  adaptation  of  a  special  glass  tube. 
This  contained  a  disc  of  sintered  glass  with  a  suitable  pore  size  which  was  welded 
across  the  lumen  of  the  tube.  The  glass  tube  was  cut  as  near  to  the  partition  of 
sintered  glass  as  possible  and  a  spout  was  fashioned  on  one  side.  On  to  the  other 
side  was  welded  a  glass  column  container  of  1.4  cms  diameter  and  length  17  cms. 
The  third  problem  was  dealt  with  in  the  following  way.  A  circle  of  filter 
paper  (Whatman's  No.  1)  of  slightly  smaller  diameter  than  that  of  the  glass  tube 
was  allowed  to  sink  gently  on  to  the  surface  of  the  column  through  the  fluid  above 
it.  This  was  found  to  give  adequate  stability  to  the  column  surface  when  test 
solutions  were  added  carefully  by  Pasteur  pipette. 
Packing  the  Column 
The  Sephadex  particles  are  put  into  a  beaker  with  Ringer's  solution  and 
allowed  to  stand  for  half-an-hour  during  which  time  they  swell  up. -  36  - 
After  vigorous  stirring  the  mixture  is  poured  into  the  large  filter  funnel  with 
the  connection  between  the  funnel  and  the  glass  tube  closed  (Figure  5  ).  The 
stirring  mechanism  is  now  switched  on.  This  swirls  the  Sephadex  particles  around 
in  the  funnel,  allowing  a  few  of  them  to  descend  into  the  neck  of  the  funnel. 
The  glass  column  container  is  now  attached  to  the  rubber  tubing  around  the  filter 
funnel  neck  and  the  connection  is  opened.  This  creates  a  continuous  column  of 
liquid  from  the  sintered  glass  bottom  to  the  surface  of  the  liquid  in  the  funnel. 
When  the  stirrer  is  switched  on,  Sephadex  particles  swirl  around  in  the  funnel  and 
descend  infrequently  into  the  glass  tube.  When  the  stirrer  is  switched  off,  the 
descent  of  particles  down  into  the  tube  increases  rapidly.  The  rate  of  packing 
and  the  length  of  the  column  could  be  adequately  controlled  by  this  regulating 
method.  This  method  ensures  that  the  particles  are  packed  in  an  even  fashion  so 
that  separations  effected  by  the  column  can  be  repeated  and  standardized. 
When  the  appropriate  height  was  reached  (13.5  cm),  the  rubber  connecting 
tubing  was  closed  off  and  gei  tly  removed  from  the  top  of  the  glass  column 
container.  This  procedure  usually  caused  some  disturbance  of  the  particles  at 
the  top  of  the  column,  but  this  settled  within  a  few  minutes  after  the  column  was 
transferred  to  another  clamp  stand. 
As  soon  as  the  Sephadex  particles  settled  in  a  horizontal  plane  at  the  top 
of  the  column,  a  disc  of  filter  paper  (Whatman's  No.  1),  cut  to  fit  the  internal 
diameter  of  the  glass  tube,  was  allowed  to  float  down  on  top  of  the  Sephadex 
particles.  This  gave  stability  to  the  column  top,  since  the  particles  are  very 
easily  disturbed  without  this  restriction.  Every  column  was  packed  to  a  height  of 
13.5  cm  in  a  tube  of  internal  diameter  1.4  cm. 
Fluid  was  eluted  through  the  column  using  the  hydrostatic  pressure  developed 
by  the  column  of  Ringer's  solution  contained  in  the  glass  tube  above  the  level  of 
the  horizontal  plane  at  the  top  of  the  column.  The  height  of  this  column  of  solvent 
varied  with  each  glass  container,  but  was  usually  of  the  order  of  4  cm. 
In  order  to  elute  a2  ml.  test  sample  through  the  column,  the  fluid  above  the Electric 
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Figure  5.  Apparatus  for  Packing  the  Sephadex  Column 
Sintered 
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a)  The  glass  tube  to  contain  the  Sephadex  is  inserted  into  a  rubber  tube  which 
connects  it  with  the  filter  funnel  containing  solvent  +  Sephadex  particles. 
Solvent  -  the  particles  pass  through  the  sintered  glass  partition  into  a  beaker. 
With  the  rubber  connecting  tube  open  and  the  electric  stirrer  switched  on, 
Sephadex  particles  swirl  round  in  the  funnel  and  descent  infrequently  into  the 
glass  tube.  When  the  stirrer  is  switched  off,  the  descent  of  particles  down  into 
the  tube  increases  rapidly.  When  the  appropriate  height  of  Sephadex  was 
reached  (13.5  cm),  the  connecting  tube  was  then  closed  and  the  glass  tube 
removed  from  the  rubber  connecting  tube. 
b)  The  dimensions  of  the  completed  column  are  shown.  Discs  of  filter  paper 
ensure  that  the  extremities  of  the  column  are  kept  horizontal. 
---ýJ -  37  - 
column  was  allowed  to  run  down  through  the  Sephadex  particles  until  the  base  of 
the  meniscus  just  reached  the  level  of  the  filter  paper.  Then  the  2  ml.  sample  was 
carefully  pipetted  on  to  the  surface  of  the  filter  paper  by  Pasteur  pipette.  The 
sample  was  allowed  to  run  into  the  Sephadex  until  the  meniscus  reached  the 
filter  paper  level,  at  which  time  the  Ringer's  solution  was  added  carefully  until 
the  glass  column  container  was  filled  completely  with  the  solvent.  During  the 
elution  and  collection  of  the  fractions,  the  column  container  was  constantly 
topped  up  with  Ringer's  solution. 
After  collection  of  the  fractions,  the  elution  was  stopped  by  inserting  rubber 
bungs  into  the  basal  spout  and  the  top  of  the  glass  tube. 
Equilibration  of  the  Column 
Before  each  experiment  the  column  was  eluted  with  Ringer's  solution 
either  leech  or  frog  Ringer's  solution,  for  two  hours  before  a  test  sample  was 
put  through.  This  ensured  that  the  ionic  composition  of  the  Ringer's  solution  was 
not  altered  in  any  way,  since  over  a  period  of  two  hours  presumably  the  solute 
ions  completely  penetrate  the  dextran  matrix  and  are  distributed  evenly  between 
the  inside  of  the  particles  and  the  space  surrounding  them. 
Standardizing  the  Sephadex  Column 
In  order  to  facilitate  the  procedure  of  standardizing  the  column,  the 
properties  of  the  substance  "blue  dextran"  (Dextran  2000,  Pharmacia)  were 
utilized.  This  substance  has  a  molecular  weight  of  around  two  million  and  is 
therefore  eluted  through  the  Sephadex  column  at  a  maximum  rate.  Even  when  it 
is  present  in  very  small  concentrations,  blue  dextran  imparts  a  distinct  blue  colour 
to  a  solution.  The  makers  recommend  a  2%  solution  for  the  measurement  of  void 
volumes  inSephadex  column  chromatography.  Blue  dextran  does  not  react  in  any 
way  with  the  column  material,  although  it  is  said  to  be  slightly  adsorbed  on  to 
Sephadex  G-25  particles.  The  recommended  way  to  remove  this  adsorbed  blue 
dextran  is  to  run  a  solution  of  serum  albumin  through  the  column. 
Presuming  that  the  blue  dextran  does  not  react  in  any  way  with  the  test -  38  - 
solution,  it  is  convenient  to  elute  a  mixture  of  the  two  through  the  column. 
Adsorption  of  the  blue  dextran  on  to  the  particles  of  Sephadex  will  be  counter- 
acted  by  the  protein  in  the  test  solution  (See  protein  section). 
The  volume  of  the  solution  surrounding  the  active  sartorius  muscle  was 
2  ml;  by  a  process  of  trial  and  error  it  was  found  that  when  a  solution  of  2  ml.  of 
blue  dextran  was  put  through  a  column  of  dimensions  13.5  cm  x  1.4  cm  the  blue 
dextran  was  eluted  into  a  volume  of  exactly  3  ml.  The  passage  of  the  blue 
dextran  through  the  column  is  easily  followed  (See  Figure  6  ). 
The  volume  of  fluid  required  to  elute  the  2  ml.  solution  of  blue  dextran 
(or  any  substance  which  does  not  enter  the  pores  in  the  Sephadex  particles)  through 
the  column  is  termed  the  "void  volume".  Nine  columns  of  height  13.5  cm  were 
packed  in  distilled  water  and  2  ml.  solutions  of  blue  dextran  (approximately  5% 
concentration)  were  put  through  them. 
The  mean  void  volume  of  the  nine  columns  was  11.4  mI.  (range  10.75  ml.  - 
11 
. 
75  ml).  Thus,  for  any  substance  of  molecular  weight  greater  than  5,000,  it 
would  take  approximately  11 
.4  ml.  of  Ringer's  solution  to  carry  it  through  the 
column  when  it  was  contained  in  an  initial  volume  of  2  ml.  A  newly-packed 
column  was  only  accepted  for  use  when  2  ml.  of  blue  dextran  solution  was  eluted 
into  a3  ml.  fraction. 
Because  of  the  slight  variation  in  the  void  volume  from  column  to  column, 
it  was  decided  to  mix  the  blue  dextran  with  the  test  solution  and  then  to  follow 
the  course  of  the  blue  dextran  through  the  column  visually.  Only  after  the  column 
was  seen  to  be  clear  of  the  blue  dextran  were  subsequent  fractions  collected. 
The  initial  3  ml.  fraction  containing  the  blue  dextran  is  termed  the  "blue 
dextran  fraction",  and  contains  any  substances  of  molecular  weight  greater  than 
5,000  that  are  present  in  the  test  solution  e.  g.  protein  molecules. 
It  was  for  the  purpose  of  isolating  ACh  from  other  substances  found  in  the 
test  solution  that  the  properties  of  the  Sephadex  column  were  adopted.  The 
fractions  collected  after  the  initial  blue  dextran  fraction  were  deliberately  adjusted -  39  - 
in  volume  so  that  most  of  the  ACh  could  be  recovered  in  one  fraction.  It  was 
found  that  a3  ml.  fraction  coming  4.5  ml.  after  the  blue  dextran  fraction 
contained  most  of  the  ACh  present  in  an  initial  2  ml.  volume  eluted  through  the 
column. 
The  behaviour  of  the  other  substances  in  the  column  was  studied  to 
ensure  that  a  column  of  this  dimension  could  effect  a  different  pattern  of  elution 
with  substances  of  different  molecular  weights.  It  was  convenient  to  use  coloured 
substances  for  this  study.  Figure  6  (coloured  plate)  shows  the  various  stages  in 
one  such  experiment.  2  ml.  of  potassium  ferricyanide  in  a  concentration  of 
20mg/ml.  were  mixed  with  0.1  ml.  of  blue  dextran.  This  mixture  was  then  put 
through  the  column.  The  fractions  collected  were  those  normally  collected  for 
the  ACh  recovery.  The  estimation  of  the  potassium  ferricyanide  was  made  by 
comparing  the  intensity  of  the  fraction  colours  with  known  concentrations  of 
potassium  ferricyanide  using  a  Hawksley  colorimeter. 
The  right  hand  column  of  Figure  7  shows  the  percentage  recovery  of  the 
substances  cupric  sulphate,  cobalt  sulphate  and  potassium  ferricyanide.  The  left 
hand  column  indicates  for  comparison  the  percentage  recovery  of  ACh-chloride  in 
the  same  fractions  as  measured  on  the  leech  muscle  from  five  Sephadex  columns. F 
Figure  6. 
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The  separation  of  a  substance  of  large  molecular  weight  (blue  dextran  :  M.  W. 
5,000)  from  a  substance  of  small  molecular  weight  (potassium  ferricyanide  :  M.  W.  _ 
329)  by  the  Sephadex  column. 
On  the  left  of  the  plate  are  cylinders  containing  solutions  of  potassium 
ferricyanide  (yellow)  and  blue  dextran.  The  cylinder  in  the  foreground  contains  a 
2  ml.  mixture  of  the  two  substances.  When  this  mixture  is  placed  at  the  top  of  the 
column  and  allowed  to  gravitate  through,  the  blue  dextran  is  seen  to  advance 
immediately  ahead  of  the  potassium  ferricyanide.  The  second  column  shows  the 
separation  at  a  later  stage.  When  the  subsequent  fractions  are  collected,  the  blue 
dextran  is  eluted  into  the  first  3  ml.  and  the  potassium  ferricyanide  comes  into 
fractions  2,3  and  4,  most  of  it  being  in  fraction  3.  Neither  substance  appears  in 
fraction  1. Figure  7. 
Left  Hand  Column 
The  percentage  recovery  of  ACh-chloride  in  column  fractions  which  were 
pdjusted  to  contain  most  of  the  ACh  in  fraction  3.  Each  histogram  is  constructed 
from  a  separate  column  experiment.  The  columns  were  eluted  with  leech  Ringer's 
solution  and  the  initial  ACh  solution  was  made  up  in  the  same  type  of  Ringer's 
solution.  Assay  of  these  fractions  was  done  on  the  leech  muscle  strip.  Note 
that  no  acetylcholine  appears  in  fractions  1,4,5  and  6. 
The  volume  of  fractions  1-6  was,  respectively,  2  ml.,  2.5  ml.,  3  ml.,  2.5 
ml,,  2  ml￿  2  ml.. 
Right  Hand  Column 
Substances  of  different  molecular  weight  were  put  through  the  column  and 
the  same  fractions  were  collected.  Note  the  different  distribution  of  the  some 
substance  when  distilled  water  is  used  as  the  solvent. too  100, 
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SETTING  UP  THE  LEECH  PREPARATION 
The  method  used  is  a  modified  version  of  that  used  by  Murnaghan  (1958),  who 
noted  that  morphine  facilitates  the  quicker  relaxation  of  the  leech  strip  of  muscle. 
The  leech  muscle  was  soaked  in  solutions  of  morphine  before  being  set  up  in  the 
bath.  This  differs  from  the  original  method  in  that  Murnaghan  set  up  the  leech 
strip  ready  to  record  contractions  at  the  beginning  of  the  morphinization 
procedure. 
A  live  leech  is  taken  from  a  tank  where  the  store  of  leeches  were  kept  in 
loch  water.  After  crushing  the  ganglia  just  posterior  to  the  anterior  sucker,  the 
leech  is  pinned  out  on  a  cork  board  with  the  ventral  side  lying  upwards.  A  midline 
ventral  incision  is  made  starting  caudally  and  ending  by  opening  the  anterior 
sucker.  Thus  the  whole  of  the  muscular  body  wall  is  eventually  pinned  flat  out 
with  the  outside  surface  next  to  the  cork  board.  This  position  displays  the  grey- 
white  walls  of  the  coelom.  Using  fine  forceps  and  fine  scissors  the  coelomic  wall 
is  completely  removed,  revealing  the  dark,  chocolate  brown  inner  layer  of  the 
body  wall  musculature.  This  layer  represents  collections  of  large  cells  containing 
ingested  red  blood  corpuscles  which  have  migrated  from  the  gut.  The  dark  brown 
colour  is  presumably  caused  by  the  breakdown  products  of  the  haemoglobin  pigment 
within  the  corpuscles.  This  layer  is  very  difficult  to  remove  without  inflicting 
some  damage  upon  the  actual  muscle  layer  and  in  practice  was  never  completely 
removed. 
After  the  process  of  "cleaning"  the  inner  surface  of  the  body  wall,  the 
pinned-out  preparation  is  turned  over  and  pinned  out  again,  this  time  with  the 
outer  surface  uppermost.  It  is  convenient  to  use  the  natural  markings  on  the  dorsum 
of  the  leech  as  a  rough  guide  to  the  breadth  of  the  strip  of  muscle  removed.  On 
each  side  of  the  dorsum  of  the  leech,  running  longitudinally,  are  two  black  lines 
enclosing  a  thin  yellow  line.  The  strip  which  lies  in  between  these  longitudinal 
patterns  proved  to  be  a  suitable  breadth.  The  anterior  half  of  the  leech  was  used -  41  - 
as  a  rough  guide  to  the  length  of  the  strip  required,  to  suit  the  dimensions  of 
the  leech  bath. 
Having  removed  this  size  of  segment  from  the  dorsum  of  the  body  wall 
musculature,  the  strip  is  then  pinned  out  without  any  undue  tension,  on  a  small 
cork  board  and  floated  upside  down  in  a  Ringer's  solution  containing  5x  10-5g/ml. 
morphine  sulphate.  After  an  hour  it  was  then  transferred  to  a  Ringer's  solution 
containing  2x  10-5  g/ml.  morphine  sulphate  (see  Table  1)  and  left  to  soak  for 
a  further  hour.  The  preparation  is  now  transferred  to  the  2  ml.  leech  bath.  The 
muscle  strip  is  unpinned  and  a  loop  of  thread  is  tied  to  one  end.  A  long  thread 
is  tied  to  the  other.  The  loop  is  then  passed  around  the  hook  of  the  syringe 
needle  while  the  long  piece  of  thread  is  attached  to  the  tension  transducer.  In 
this  way  the  strip  of  leech  muscle  is  suspended  in  the  tubular  bath,  which  is 
now  filled  with  leech  Ringer's  solution.  After  the  bath  is  filled  with  the  Ringer's 
solution  the  muscle  strip  should  not  touch  the  sides  of  the  bath  (Figure  8  ). 
At  this  stage  the  tension  of  the  muscle  strip  can  be  adjusted  to  a  suitable 
value  for  the  particular  piece  of  muscle  in  the  bath  by  the  control  attached  to 
the  transducer  (Figure  8  ). 
The  tension  developed  by  the  muscle  strip  will  always  approach  an  optimum 
value,  provided  that  the  muscle  is  not  overstretched.  If  the  muscle  is  suddenly 
stretched,  then  it  will  immediately  relax  until  the  original  level  of  tension  is 
reached.  If  the  strip  is  suddenly  shortened  passively,  the  muscle  will  contract 
until  the  original  tension  value  is  achieved  once  again.  Amplification  is 
adjusted  so  that  an  excursion  of  1  mm  by  the  leech  muscle  will  cause  a  movement 
of  30  mm  on  the  pen  recorder.  The  tension  recording  is  calibrated  by  hanging 
weights  on  the  thread  attached  to  the  transducer. 
The  following  procedure  is  adopted  in  order  to  apply  a  test  solution  to  the 
muscle  strip.  The  leech  bath  is  drained  of  fluid  by  the  tap  at  the  base  of  the 
needle  (Figure  8  ).  A  new  solution  is  added  by  syringe  at  the  top  of  the  bath. 
During  the  procedure  of  changing  the  solutions  in  the  bath,  the  leech  muscle  is Table  1 
THE  PRESENT  METHOD  COMPARED  WITH  THAT  OF  MURNAGHAN 
SAME  LEECH  RINGER'S  SOLUTION  USED 
D--6  AA-4k  J 
Strip  soaked  in  morphine  sulphate  for  1  hour  Strip  soaked  in  4  or  5x  10-5  g/ml 
(concentration  =5x  10-5  g/ml)  Strip  soaked  morphine  sulphate.  Left  for  up  to  3 
for  another  hour  in  2x  10-5  g/ml  morphine  hours.  Strip  soaked  for  a  further  30  mins. 
sulphate  and  10-5  g/ml  eserine  sulphate.  in  4  or  5x  10 
5 
g/ml  morphine  sulphate 
and  10 
5 
g/ml  eserine  sulphate  solution. 
Strip  was  pinned  on  to  a  cork  board,  being  Strip  was  set  up  in  an  isotonic  fashion  in 
slightly  stretched.  Board  was  transferred  from  leech  bath.  The  tension  being  "equivalent 
one  solution  to  another  to  2  grammes"  . 
Then  solutions  above 
were  put  into  bath. 
Washing  between  acetylcholine  solutions  was  Morphine-eserine  Ringer's  solution  was 
done  with  eserinized  leech  Ringer's  solution  used  for  washing  throughout. 
(10-5  g/ml). 
Acetylcholine  solutions  made  up  in  Test  solutions  consisted  of  mammalian- 
eserinized  Ringer's  solution  (10-5  g/ml).  Ringer  perfusates  of  10 
5 
g/ml  eserine 
diluted  1:  1.4  before  assay. 
Each  solution  allowed  to  act  for  45  secs.  Solutions  allowed  to  act  for  2-3  mins. 
I 
Isometric  system,  tension  measured. 
I  Isotonic  system,  change  of  length  measured. 
Thresholds  mostly  10  -9  g/ml.  Sensitivity  Thresholds  mostly  10- 
9 
g/ml.  "In  no  case 
maintained  over  24  hr.  period.  did  the  sensitivity  fall  off  after  5  hours". 
Non-oxygenated  Ringer's  solution.  Oxygenated  Ringer's  solution.  pH  =  7.3. 
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muscle  preparation. 
The  clamp-stand  on  the  right  supports  the  force  displacement  transducer 
(type  FTO  3C,  Grass  Instrument  Co.  )  and  the  leech  muscle  bath.  The  muscle 
strip  is  attached  to  the  transducer  by  a  thread.  On  the  other  side  of  the  stand 
is  attached  the  ratchet  system  for  altering  the  length  of  the  muscle  strip.  The 
central  piece  of  apparatus  is  the  Devices  preamplifier  unit  which  is  linked  to 
a  power  supply  (not  seen).  The  Everett  Edgecumbeduo"channel  pen  recorder, 
seen  on  the  left,  records  tension  of  the  leech  muscle  strip  on  one  channel  and 
length  of  the  strip  on  the  second  channel.  Amplification  of  the  system  was 
adjusted  so  that  a  change  in  tension  of  5  mg  could  easily  be  recorded. -  42  - 
momentarily  suspended  in  air  and  usually  sticks  to  the  side  of  the  bath  until  the 
new  solution  fills  the  bath.  The  small  amount  of  tension  produced  by  the  leech 
sticking  to  the  bath  is  always  indicated  on  the  record  by  an  unusual,  but 
regular,  increment  in  tension  before  the  effect  of  each  test  solution. 
Every  test  solution  in  this  work  was  applied  to  the  muscle  strip  for  a  period 
of  45  seconds;  a  clear  response  could  be  detected  after  this  short  period  of  time 
and  the  effects  of  ACh  solutions  could  be  quickly  washed  out  after  this  period 
in  contact  with  the  muscle. RESULTS -  43  - 
THE  RESULT  OF  PERFUSING  A  STIMULATED  MUSCLE  SOLUTION  THROUGH 
A  FROG  HEART 
When  the  solution  in  which  the  frog  sartorius  muscle  twitched  was  perfused 
through  the  frog  heart,  an  unexpected  finding  occurred.  Instead  of  producing  the 
expected  slowing  of  the  heart  beat,  typical  of  ACh,  a  sharp  stimulatory  effect 
resulted  from  the  solution  (Figure  10  ).  The  cardiac  output,  systolic,  diastolic 
and  pulse  pressure  were  all  increased.  In  some  cases  a  late  increase  in  the  heart 
rate  occurred.  In  no  case,  out  of  forty-one  undiluted  test  solutions  perfused 
through  thirty-three  frog  hearts,  was  an  ACh-like  effect  seen  on  the  frog  heart 
(Table  2  ).  All  solutions  stimulated  the  frog  heart.  Clearly  the  effect  of  any 
ACh  present  in  the  test  solution  was  being  completely  masked  by  the  effect  of 
other  interfering  substances. 
Figure  10  shows  the  effect  of  perfusing  a  frog  heart  with  a  solution  in 
which  a  sartorius  muscle  has  twitched.  The  cardiac  output  (in  ml/min),  arterial 
pressure  (in  mm  Hg),  heart  rate  (in  beats/min)  and  the  venous  pressure  (in  mm 
H2O)  are  monitored  simultaneously.  The  marker  indicates  the  time  taken  for  a 
test  solution  to  be  perfused  into  the  frog  heart.  "Sx"  indicates  the  time  of 
perfusion  of  a  stimulated  muscle  solution  into  the  heart,  the  "S"  referring  to  the 
unknown  stimulatory  substance,  or  substances,  and  the  "x"  indicating  that  there 
is  an  unknown  quantity  present.  The  venous  pressure  recording  indicates  the 
pressure  at  which  the  heart  is  being  perfused  with  frog  Ringer's  solution  from  a 
large  reservoir.  The  slight  irregularity  of  the  venous,  or  perfusion,  pressure 
recorded  during  the  time  of  injection  of  the  test  solution  into  the  venous  capsule 
is  due  to  the  pressure  in  the  positive  pressure  system  being  adjusted  manually  by 
tap  in  order  to  keep  the  perfusion  pressure  during  the  injection  as  close  to  the 
original  perfusion  pressure  as  possible  (See  Methods). 
As  soon  as  the  solution  reaches  the  heart  there  is  an  initial  sharp  rise  in  the 
systolic  pressure,  not  quite  matched  by  the  sharp  rise  in  diastolic  pressure.  At  the Figure  10. 
The  effect  of  perfusing  a  frog  heart  with  a  stimulated  muscle  solution. 
Note  the  sharp  rise  in  the  systolic,  diastolic  and  pulse  pressures  in  the  arterial 
pressure  recording.  At  the  same  time  the  cardiac  output  rises  very  rapidly  to 
reach  a  peak  about  one  minute  later.  A  further  minute  later  the  heart  rate 
reaches  a  peak  value;  this  effect  is  slow  to  pass  off.  Note  the  irregularity  of 
the  perfusion  pressure  during  the  injection.  A  control  injection  of  Ringer's 
solution  is  seen  at  the  right  of  the  trace. Sx  Control 
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The  effect  of  perfusing  a  solution  in  which  a  sartorius  mucle  has  rested 
for  30  minutes  through  a  frog  heart.  "Rx"  indicates  the  time  of  perfusion  of 
the  undiluted  resting  muscle  solution.  Note  the  increase  in  cardiac  output 
and  blood  pressure.  No  effect  is  seen  on  the  heart  rate.  "Rx"  diluted  10 
times  has  no  effect  on  the  heart. R  10  % 
Rx 
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0- Table  2. 
HE  EFFECT  OF  RESTING  AND  STIMULATED  MUSCLE  SOLUTIONS  WHEN  PERFUSED 
THROUGH  FROG  HEARTS 
RESTING  MUSCLE  SOLUTIONS  STIMULATED  MUSCLE  SOLUTIONS 
Heart  %  Output  Increase  %  Rate  Increase  Heart  %  Output  Increase  %  Rate  Increase 
1  -13  1  1  25  25  same 
-14  3.5  18  25  muscle 
-13  5  2  15  7 
202.5  3 
6 
30 
5 
50 
3-77  4  32  heart  stopped 
-2  -12  100  33 
5  24  20 
400  6  6  7 
5  11  0  7  14  28 
10  0  8  7  10 
15  0  9  28  - 
31  2 
600  10  28  25 
75  33  30  14 
45  11  12  13 
8  10  20 
12 
14 
20 
4 
irregular 
7  12  13  7  23 
24  20  14  20  23 
90  16  15  45  not  recorded 
0  20  45 
54  16  38  7 
70  17  40  24 
70  18  38  17 
19  23  15 
10  -60  -40  56  irregular 
11  3  24  20  25  13 
21  32  7 
22  24  7 
--------  --------------------  ------------  23  36  20 
Mean  output  rise  of  12  =  9%ö 
24 
25 
56 
45 
4 
12 
Six  solutions  gave  a  fall  in  cardiac  output  26  12  - 
(Negative  sign) 
27 
28 
25 
1 11  1 
- 
24 
Five  solutions  gave  no  effect  29  18  10 
30  35  15 
31  28  - 
32  36  8* 
33  18  15 
*  two  pooled  solutions 
Rate  increase  was  measured  as  a  maximum  after  injection  of  the  test 
solution.  This  usually  occurred  2  minutes  afterwards. -  44  - 
same  time  the  cardiac  output  is  suddenly  increased  and  reaches  a  peak  value  about 
one  minute  later.  The  heart  rate  increases  from  30  beats/min  to  a  peak  value  of 
50  beats/min  about  two  minutes  later  and  only  returns  to  a  normal  value  a  further 
ten  minutes  later.  The  heart  beat  has  been  rendered  irregular  for  seven  minutes 
by  the  injection  of  the  test  solution,  but  soon  assumes  the  former  regular  rhythm. 
A  control  injection  of  frog  Ringer's  solution  shown  at  the  right  of  the  trace  is 
without  effect  on  any  parameter. 
This  particular  sartorius  muscle  was  stimulated  under  isometric  conditions  and 
it  was  noted  that  some  degree  of  tissue  damage  was  likely  to  occur  at  the  fixed  ends 
of  the  muscle.  This  would  contribute  unknown  products  of  tissue  damage  to  the 
surrounding  solution  which  could  markedly  affect  the  response  of  the  heart.  In  order 
to  minimise  this  risk  every  subsequent  stimulated  muscle  solution  was  obtained  from 
a  muscle  which  was  allowed  to  lie  in  the  bathing  solution  withoutlhaving  any 
support  at  the  ends  of  the  muscle  (Figure  2). 
It  was  important  to  exclude  the  possibility  that  the  effect  was  produced  by  a 
sartorius  muscle  which  had  only  soaked  in  the  bathing  solution  without  stimulation 
taking  place.  Figure  11  shows  the  effect  of  perfusing  a  solution  in  vii  ich  a 
sartorius  muscle  had  rested  for  half-an-hour  through  a  frog  heart.  "Rx"  indicates 
the  time  of  perfusion  of  the  undiluted  resting  muscle  solution.  A  slight  increase 
in  the  systolic  and  diastolic  pressures  has  occurred,  with  a  simultaneous  increase  in 
the  cardiac  output.  No  obvious  effect  is  seen  on  the  heart  rate.  When  this 
solution  was  diluted  ten  times,  "R  10-1  x",  the  effect  was  abolished.  Out  of 
twenty-three  resting  muscle  solutions  perfused  through  fourteen  hearts,  five 
solutions  gave  no  effect,  six  solutions  produced  an  inhibition  of  cardiac  output 
and  twelve  gave  a  mean  increase  in  cardiac  output  of  8%  (Table  2).  Thus  the 
substance,  or  substances,  which  cause  the  stimulation  of  the  frog  heart  does  not 
cause  as  great  an  effect  when  it  comes  from  a  resting  muscle  solution  as  it  does 
when  it  comes  from  a  stimulated  muscle  solution. 
It  seems  that  the  effect  is  produced  by  a  twitching  muscle  rather  than  by  a -  45  - 
resting  one. 
The  Effect  of  Curarizing  the  Preparation 
In  order  to  exclude  the  possibility  that  the  stimulatory  effect  was  produced 
from  substances  liberated  from  nerve  terminals,  the  sartorius  muscle  was  curarized 
and  then  stimulated  in  the  usual  way  via  the  nerve.  Thus  the  nerve  terminals 
remained  active  while  the  muscle  did  not  actually  contract.  When  the  resultant 
stimulated,  curarized  muscle  solution  was  perfused  through  the  heart,  the  effect 
produced  was  the  slight  stimulatory  one  associated  with  the  resting  muscle  solution 
(compare  Figures  11  &  15).  Although  the  curarization  procedure  did  reduce  the 
interference  phenomenon,  an  ACh-like  effect  was  still  not  apparent. 
It  was  found  that  the  effect  produced  by  the  resting  muscle  solution  could 
be  diluted  out  more  easily  than  the  effect  from  the  stimulated  muscle  solution. 
Thus  the  curarization  procedure  would  allow  less  dilution  of  any  ACh  contained 
in  the  stimulated  muscle  solution.  Since  any  test  solution  obtained  in  this  way 
would  contain  curare,  it  was  important  to  verify  that  curare  had  no  effect  on  the 
sensitivity  of  the  frog  heart  to  ACh. 
Figure  12a  shows  the  response  of  an  insensitive  frog  heart  to  graded 
concentrations  of  ACh.  The  threshold  response  occurred  when  a  concentration  of 
10-9  g/mI.  ACh  was  perfused  through  this  heart.  The  heart  was  just  arrested  by  a 
concentration  of  2.5  x  10-8  g/ml.  ACh.  It  was  found  that  a  concentration  of 
5x  10-6  g/ml.  d-tubocurarine  was  enouch  to  prevent  the  isolated  sartorius 
muscle  from  twitching.  Figure  12b  shows  the  response  of  the  same  heart  to  ACh  in 
the  presence  of  5x  10-6  g/ml  . 
d-tubocurarine.  This  concentration  of  curare  was 
present  in  both  the  perfusing  Ringer's  solution  and  in  the  solution  containing  the 
graded  concentrations  ofACh.  Again  the  threshold  response  is  at  10-9  g/ml.  ACh 
with  cardiac  arrest  occurring  when  2.5  x  10-8  g/ml.  ACh  is  perfused  through  the 
heart.  Figure  13  shows  graphs  of  the  concentration  -  response  relationship  of 
the  same  frog  heart  to  ACh  for  cardiac  output  and  heart  rate.  On  the  part  of  the 
curve  useful  for  bioassay  of  ACh,  from  10-9g/ml.  to  5x  10 
8g/ml. 
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Figure  12. 
The  response  of  an  insensitive  frog  heart  to  graded  concentrations  of  ACh. 
(a)  Shows  the  response  to  graded  concentrations  of  ACh. 
(b)  Shows  the  response  of  the  same  heart  to  ACh  in  the  presence 
of  5x  10-6  g/ml  curare.  The  response  of  the  frog  heart  to 
ACh  is  unaltered  by  the  presence  of  curare  in  the  perfusing 
Ringer's  solution. } 
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Graphs  of  the  concentration-response  relationship  of  a  frog  heart  to 
acetylcholine  in  the  absence  and  in  the  presence  of  curare.  There  is  little 
difference  in  the  response  of  the  heart  to  ACh  in  the  presence  of  curare. 
w  IQ'2  IU"  IC1  IO  ICY&  IO' Table  3. 
H  t 
Before  Curare  After  Curare 
ear 
Theshold  Arrest  Threshold  Arrest 
1.  10-9  2.5  x  10-8  10-9  2.5  x  10-8 
2.  10-9  5.0  x  10-8  10-9  5.0  x  10-8 
3.  10-9  --  10-9  2.5  x  10 
8 
Concentrations  of  ACh  (g/ml)  required  to  produce  threshold  responses  and 
cardiac  arrest  in  the  absence  and  presence  of  curare. -  46  - 
there  is  little  difference  in  response  of  the  heart  to  ACh  either  in  cardiac  output 
or  in  heart  rate  in  the  presence  of  curare.  The  threshold  response  of  two  other 
hearts  was  not  altered  in  the  presence  of  this  concentration  of  curare  (Table  3). -  47  - 
A  PILOT  ASSAY  ON  A  VERY  SENSITIVE  FROG  HEART 
One  experiment  was  done  with  an  extremely  sensitive  frog  heart  in  order 
to  find  out  whether  assay  of  the  ACh  output  from  a  frog  sartorius  muscle  was 
possible  or  not.  At  a  frequency  of  stimulation  of  2/sec  for  30  minutes,  according 
to  the  calculation  quoted  in  the  introduction,  the  theoretical  output  of  ACh  from 
a  sartorius  muscle  should  be  approximately  10-9  g.  The  muscle  was  stimulated  in 
a2  ml.  volume,  so  the  concentration  of  ACh  in  the  surrounding  bathing  solution 
should  be  5x  10-10  g/ml. 
Result 
The  response  of  a  very  sensitive  frog  heart  to  concentrations  of  ACh  in 
the  presence  of  curare  is  shown  in  Figure  14.  The  threshold  response  of  this  heart 
occurred  when  a  concentration  of  2.5  x  10-13  g/ml.  ACh  was  perfused  through 
it.  A  concentration  of  10-12  g/ml.  ACh  stopped  the  heart.  Finely-graded 
responses  are  seen  between  these  tests,  showing  an  increasing  fall  in  the  heart 
rate  and  cardiac  output  with  increasing  concentrations  of  ACh. 
The  ACh  solutions  perfused  through  the  heart  were  made  up  from  Ringer's 
solution  containing  5x  10-6  g/mI.  d-tubocurarine.  This  does  not  affect  the 
sensitivity  of  the  heart  to  ACh  (Figure  13). 
When  a  stimulated,  curarized  muscle  solution  was  perfused  through  the 
sensitive  frog  heart,  an  effect  equivalent  to  the  effect  seen  when  a  resting, 
non-curarized  muscle  solution  was  put  through  the  heart  was  evident.  This 
is  shown  in  Figure  15  (Compare  to  Figure  11).  The  solution  "Sx"  (third  test)  was 
obtained  from  a  curarized  sartorius  muscle  which  had  been  stimulated  at  2/sec 
for  30  minutes  in  2  mi.  of  frog  Ringer's  solution  containing  5x  10 
6 
g/ml. 
d-tubocurarine.  When  this  was  perfused  through  the  heart  it  produced  an 
initial  slight  bradycardia  followed  by  an  increase  in  heart  rate  and 
cardiac  output,  with  a  rise  in  systolic  and  diastolic  pressures.  When  this 
solution  was  diluted  by  half,  the  slight  stimulatory  effect  disappeared,  and  an Figure  14. 
The  response  of  a  very  sensitive  frog  heart  to  concentrations  of  ACh  in 
the  presence  of  curare.  A  concentration  of  2.5  x  10-13  g/ml.  ACh  produced  a 
threshold  response.  10-12  g/ml.  ACh  stopped  the  heart.  All  ACh  solutions  were 
made  up  containing  a  concentration  of  5x  10-6  g/ml.  d-tubocurarine. , )"SxiriIs  5x10-13  7,5x1013  X02 
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An  assay  of  a  stimulated  muscle  solution  on  the  some  frog  heart  as  in  Figure 
14.  "Sx"  =  solution  obtained  from  a  curarized  sartorius  muscle  stimulated 
indirectly  at  2/sec  for  30  minutes  in  2  ml.  Ringer's  solution.  Note  the  similarity  of 
the  effect  of  "Sx"  to  the  effect  of  the  resting  muscle  solution  in  Figure  11 
. 
"S  5x 
10-1  x"  (the  solution  diluted  bY  half)  reveals  an  ACh-like  effect  which  is  matched 
by  a  concentration  of  5x  10-13  g/ml.  ACh.  The  sudden  fall  in  the  blood  pressure 
which  occurred  during  the  effect  of  this  solution  was  due  to  a  leak  in  the  perfusion 
system  lasting  for  a  few  seconds  only.  Note  the  drop  in  the  venous,  or  perfusion 
at  this  pressure  point  also. s 
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ACh-like  effect  was  revealed  (first  test):  S5x  10-1.  This  effect  was  closely 
matched  to  a  known  concentration  of  ACh,  5x  10-13  g/ml.  (second  test).  The 
stimulated  muscle  solution  when  diluted  10  times  matched  10-13  g/ml.  ACh.  The 
standard  tests  for  the  identification  of  ACh  were  not  performed  on  this  solution, 
partly  because  of  the  small  volume  available  and  partly  because  any  "manipulation" 
of  the  ionic  content  of  such  a  test  solution  (e.  g.  raising  the  pH  to  10,  heating  the 
solution  to  90°C  and  restoring  to  the  normal  pH  and  temperature  again)  might  have 
interfered  with  the  quantitative  response  of  this  heart  to  ACh. 
Calculated  Output  of  ACh  from  the  Sartorius  Muscle 
Test  solution  diluted  by  half  -5x  10-13  g/ml.  ACh. 
therefore  undiluted  test  solution  =_  10-12  g/mI.  ACh. 
Muscle  was  stimulated  in  2  ml.  volume, 
therefore  output  of  ACh  from  muscle  =2x  10-12  g. 
Test  solution  diluted  10  times  =  10-13  g/ml.  ACh. 
therefore  undiluted  test  solution  =_  10-12  g/ml.  ACh. 
therefore  output  of  ACh  from  muscle  again  =2x  10-12  g. 
The  output  per  impulse  per  nerve  ending  is  calculated  below: 
number  of  impulses  delivered  =  3,600  (2/sec  for  30  minutes) 
amount  of  ACh  released  per  impulse  =  0.6  x  10-15  g. 
since  there  are  about  1,000  endplates  per  muscle, 
amount  of  ACh  released/impulse/ending  =  0.6  x  10-18  g=0.5  x  10-1 
moles. 
This  amount  is  considerably  less  than  that  obtained  by  other  workers  for 
mammalian  muscle.  Krnjevic  and  Mitchell  (1961)  calculated  an  output  of  10-17 
mole/impulse/ending  and  Krnjevic  and  Straughan  (1963)  calulated  an  output 
of  10-18  mole/impulse/ending  using  rat  diaphragm  muscle. -  49  - 
AN  ATTEMPTED  ASSAY  OF  ACh  RELEASED  FROM  RAT  DIAPHRAGM  ON  THE 
PERFUSED  FROG  HEART 
Since  the  output  of  ACh  had  been  estimated  by  other  workers  from  the  rat 
hemidiaphragm  preparation  (Bulbring,  1946)  the  author  was  curious  to  know  whether 
a  solution  which  had  surrounded  a  twitching  hemidiaphragm  could  produce  the 
same  interference  phenomenon  on  the  frog  heart  as  the  solution  obtained  from  the 
twitching  sartorius  muscle. 
Result 
When  a  frog  heart  is  perfused  with  Locke's  mammalian  solution,  its 
sensitivity  to  ACh  is  little  altered.  Figure  16  shows  the  comparison  of 
concentration-response  curves  of  a  frog  heart  to  ACh  for  cardiac  output  and  heart 
rate  when  it  was  perfused  with  frog  Ringer's  solution  and  Locke's  mammalian  solution. 
A  rat  hemidiaphragm  was  stimulated  via  the  phrenic  nerve  at  twenty  impulses 
per  second  for  twenty  minutes  in  4  ml  of  Locke's  solution  and  the  resulting  solution 
was  injected  into  a  frog  heart  which  was  being  continuously  perfused  with  Locke's 
solution.  No  evidence  of  an  ACh-like  effect  is  seen,  even  although  the  hemi- 
diaphragm  muscle  is  expected  to  release  3.5  x  10-8  g  ACh  (Krnjevic  and  Mitchell 
1961).  Instead  the  test  solution  caused  an  increase  in  the  force  of  contraction  of 
the  heart  with  a  concomitant  bradycardia  and  a  late  increase  in  the  heart  rate. 
Since  the  threshold  response  of  this  heart  to  ACh  was  10 
9 
g/ml,  and  the 
concentration  of  ACh  in  the  4  ml  test  solution  was  expected  to  be  10-9  g/ml, 
clearly  an  interference  phenomenon  similar  to  that  encountered  with  the  frog 
sartorius  muscle  solutions  was  taking  place  (Figure  17)  . Figure  16. 
The  response  of  a  frog  heart  to  graded  concentrations  of  ACh  when  perfused 
with  frog  and  mammalian  Ringer's  solutions.  The  upper  figure  shows  the  com- 
parison  of  the  percentage  inhibition  of  cardiac  output  caused  by  various  con- 
centrations  of  ACh  during  perfusion  of  the  heart  with  frog  Ringer's  solution  and 
Locke's  mammalian  solution.  The  lower  figure  shows  the  comparison  of  the 
percentage  inhibition  of  heart  rate.  The  sensitivity  of  the  heart  to  ACh  is  virtually 
unaffected  by  perfusion  with  Locke's  mammalian  solution. a 
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I  The  result  of  perfusing  a  solution  in  which  a  rat  hemidiaphragm  has  twitched 
through  a  frog  heart. 
The  frog  heart  is  continuously  perfused  with  Locke's  mammalian  solution. 
This  does  not  affect  the  sensitivity  of  the  heart  to  acetylcholine.  The  rat  hemi- 
diaphragm  was  stimulated  indirectly  in  4  ml.  Locke's  mammalian  solution  and  the 
resulting  solution  was  perfused  through  the  frog  heart. 
After  a  satisfactory  control  injection,  the  test  solution  is  seen  to  cause  an 
increase  in  the  force  of  contraction  of  the  heart  with  a  concomitant  bradycardia 
and  a  late  rate  increase.  No  evidence  of  an  acetylcholine  effect  is  seen. 
An  interference  phenomenon  similar  to  that  encountered  with  the  frog 
sartorius  muscle  makes  the  direct  assay  of  acetylcholine  from  diaphragm  muscle 
on  frog  heart  impossible. 
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DISCUSSION 
In  order  to  measure  the  output  of  ACh  from  the  frog  sartorius  muscle  using 
the  present  method,  an  exceedingly  sensitive  and  stable  heart  preparation  is 
required.  Obviously  the  sartorius  muscle  liberates  more  than  ACh  into  the 
surrounding  bathing  solution.  In  order  to  detect  the  ACh  present,  the  frog  heart 
must  be  sensitive  enough  to  respond  to  the  concentration  of  ACh  in  the  test 
solution  after  the  interfering  substances  have  been  diluted  to  an  ineffective 
concentration. 
However,  in  the  presence  of  a  depressant  substance  (ACh)  it  can  never  be 
wholly  guaranteed  that  a  stimulatory  substance  has  had  its  effect  completely 
abolished  by  dilution  ;  the  only  satisfactory  way  to  assay  the  ACh  without  this 
interference  would  be  to  elucidate  the  cause  of  the  stimulation  and  specifically 
remove  it. 
The  interference  phenomenon  of  heart  stimulation  in  contrast  to  the  heart 
inhibition  produced  by  ACh  may  be  the  factor  responsible  for  producing  such  a 
low  result  for  the  output  of  ACh  in  comparison  to  the  results  of  other  workers. 
The  result  obtained  with  the  rat  hemidiaphragm  muscle  also  suggests  that  a  falsely 
Iow  result  for  ACh  output  would  be  obtained  using  the  frog  heart  preparation  for 
the  assay. 
The  nature  of  this  particular  interference  phenomenon  is  an  interesting  one. 
Why  should  a  "metabolic  product"  liberated  from  contracting  muscle  be  capable  of 
stimulating  the  frog  heart?  All  known  compounds  classified  as  "metabolites"  such 
as  carbon  dioxide,  pyruvic  acid,  hydrogen  ions,  carbonic  acid,  adenylic  acid 
etc.,  would  be  expected  to  have  either  no  effect  or  perhaps  a  depressant  effect 
on  the  frog  heart. 
The  following  section  of  this  thesis  describes  investigation  into  the  cause  of 
the  stimulatory  effect,  with  a  view  to  removing  it,  thus  allowing  assay  of  the 
ACh  released  from  sartorius  muscle  to  procede  without  this  interference. PART  I 
THE  IDENTIFICATION  OF  ADENOSINE  TRIPHOSPHATE 
RELEASED  FROM  ACTIVE  SKELETAL  MUSCLE. -  51  - 
INTRODUCTION 
When  a  solution  in  which  a  frog  sartorius  muscle  has  twitched  is  perfused 
through  a  frog  heart,  a  pronounced  augmentation  of  the  heart  beat  occurs 
(Figure  10).  This  section  describes  the  identification  of  the  substance  released 
from  active  sartorius  muscle  which  was  the  cause  of  the  heart  stimulation. 
At  the  onset  of  this  investigation  it  appeared  that  any  alteration  in  the 
composition  of  the  solution  bathing  the  activesartoriusmuscle  might  be  responsible 
for  the  phenomenon,  for  example,  a  change  in  the  hydrogen  ion  concentration 
of  the  solution.  Another  obvious  change  in  the  surrounding  bathing  solution 
would  be  an  increase  in  the  concentration  of  potassium  resulting  from  the  efflux 
of  intracellular  K+  from  skeletal  muscle  during  the  active  state.  Whether 
excessive  K+  in  the  test  solution  would,  in  fact,  stimulate  the  frog  heart  is 
doubtful,  but  the  possibility  had  to  be  excluded. 
The  frog  heart  is  known  to  be  very  sensitive  to  changes  in  the  Ca  ++ 
concentration  of  perfusing  Ringer's  solutions  and  MacLean  and  Hastings  (1934) 
utilized  this  sensitivity  in  order  to  determine  the  levels  of  ionized  Ca++  in  the 
body  fluids.  They  could  detect  differences  in  Ca  ++ 
concentration  of  0.1  mM 
by  this  method.  It  was  not  known  whether  any  change  in  Ca++  concentration 
would  occur  in  the  test  solution  after  stimulation  of  the  sartorius  muscle,  or,  if 
such  a  change  took  place,  whether  it  would  cause  a  stimulatory  effect. 
Many  biologically  active  substances  can  become  protein-bound  if  they  do 
not  already  exist  in  this  form.  Also,  chemical  radicals  can  become  attached  to 
proteins  of  the  simplest  nature  by  "high-energy"  bonds.  Examples  of  this  have 
been  shown  in  the  investigations  of  Boyer  et  al.  (1962).  They  found  that  the 
histidine  component  in  a  peptide  chain  could  adopt  the  phosphate  radical  by  way 
of  a  high-energy  bond  similar  to  those  associated  with  purine  or  pyrimidine 
nucleotides.  An  investigation  into  the  protein  content,  if  any,  of  the  stimulated 
muscle  solution  was  thus  necessary  as  a  preliminary  "screening"  procedure. -  52  - 
A  class  of  biological  compounds  which  would  obviously  stimulate  the  heart 
are  the  catecholamines;  however,  it  is  unlikely  that  the  adrenergic  supply  to  the 
blood  vessels  contained  in  a  single  sartorius  muscle  could  release  quantities  of 
catecholamines  necessary  to  cause  the  typical  stimulatory  effect  seen  on  the  frog 
heart,  nevertheless  it  was  necessary  to  eliminate  this  possibility. 
Other  substances  which  could  possibly  be  liberated  from  active  skeletal 
muscle  into  a  surrounding  bathing  solution,  such  as  carnosine,  5-hydroxytryptamine, 
histamine  and  plasma  contents  such  as  bilirubin  were  excluded  as  candidates  for 
causing  stimulation  of  the  frog  heart  by  experiments  not  reported  here  and  in 
previous  work  (Pathak,  1962). 
Specific  investigations  into  pH  changes,  potassium  changes,  calcium  changes, 
protein  content  and  catecholamine  content  of  the  test  solution  now  follows. 
Changes  in  Hydrogen  Ion  Concentration  of  Fluid  Surrounding  an  Active  Sartorius 
Muscle 
In  this  work  the  pH  of  22  stimulated  muscle  solutions  was  measured  and  the 
range  was  found  to  be  7.2  -  7.9.  It  has  previously  been  established  that 
alterations  in  the  pH  of  the  perfusing  Ringer's  solution  within  this  range  do  not 
have  any  direct  effect  on  the  frog  heart  preparation  (Boyd  and  Pathak,  1965). -  53  - 
THE  OUTPUT  OF  POTASSIUM  FROM  ACTIVE  SKELETAL  MUSCLE 
Ten  sartorius  muscles  were  soaked  in  2  ml.  volumes  of  Ringer's  solution  with 
varying  concentrations  of  K+.  The  K+  concentration  did  not  alter  significantly 
after  a  30  minute  period  of  soaking  (Figure  18). 
Seventeen  sartorius  muscles  were  stimulated  at  2  impulses  per  second  in 
2  ml.  volumes  of  Ringer's  solution  and  the  concentration  of  K+  in  each  solution 
was  measured  before  and  after  the  period  of  stimulation.  An  average  increase  in 
K  concentration  in  the  surrounding  bathing  solution  of  21%  was  found  (Figure  18). 
Figure  19  shows  the  effect  of  perfusing  a  frog  heart  with  frog  Ringer's 
solution  containing  2.9  mM  K+,  a  stimulated  muscle  solution  which  contained 
3.6  mM  K  and  a  frog  Ringer's  solution  which  contained  3.7  mM  K  It  is 
clearly  seen  that  the  high  K+  Ringer's  solution  does  not  stimulate  the  heart,  whilst 
the  test  solution,  containing  a  low  concentration  of  K+,  gives  a  sharp  increase  of 
the  cardiac  output  with  a  concomitant  bradycardia.  Five  other  frog  hearts  were 
perfused  with  samples  of  Ringer's  solution  containing  up  to  twice  the  normal 
amount  of  K+  and  in  no  case  did  a  stimulatory  effect  occur  similar  to  that  caused 
by  the  test  solution. 
It  is  concluded  from  these  experiments  that  the  stimulatory  effect  is  not  due 
to  the  potassium  efflux  from  active  skeletal  muscle. Figure  18. 
(a)  The  potassium  concentrations  of  Ringer's  solutions  in  which  frog 
sartorius  muscles  were  allowed  to  rest  for  30  minutes.  Black  columns 
indicate  the  potassium  concentration  of  the  solutions  before  soaking. 
The  grey  columns  show  the  K+  concentration  after  soaking  the 
muscle.  No  change  in  the  K+  concentration  occurs.  No  difference 
occurs  in  the  K+  concentration  of  the  solution  after  a  sartorius 
muscle  rests  for  30  minutes. 
(b)  The  K+  concentrations  of  Ringer's  solutions  in  which  frog  sartorius 
muscles  have  twitched  for  30  minutes.  The  black  column  indicates 
the  K+  concentration  of  various  Ringer's  solutions.  The  grey  columns 
indicate  the  K+  concentration  after  stimulation  of  the  sartorius 
muscle. 
There  is  an  average  increase  of  21%  in  the  K+  concentration  in  17 
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The  effect  of  perfusing  a  frog  heart  with  a  Ringer's  solution  containing  a 
high  concentration  of  K+  and  a  stimulated  muscle  solution.  The  Ringer's  solution 
continually  perfusing  the  heart  contained  2.9  mM  K+.  When  the  stimulated 
muscle  solution,  "Sx"  is  perfused  through  the  heart  the  stimulatory  effect  is  clearly 
seen.  This  particular  solution  had  a  K+  concentration  of  3.6  mM.  When  a 
Ringer's  solution  containing  3.7  mM  K+  was  perfused  through  the  same  heart,  no 
effect  equivalent  to  the  stimulatory  effect  was  seen.  "Drain  and  refill"  indicates 
flushing  of  venous  capsule  in  order  to  wash  out  any  remaining  test  solution. Marker 
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CHANGES  IN  CALCIUM  CONCENTRATION  IN  THE  SOLUTION  SURROUNDING 
THE  ACTIVE  SARTORIUS  MUSCLE 
Considerable  data  has  accumulated  from  studies  on  calcium  entering  skeletal 
muscle  fibres  during  their  contraction.  Fenn,  Cobb,  Manery  and  Bloor  (1938) 
showed  that  there  is  no  change  in  the  calcium  content  of  muscle  after  stimulation. 
Bianchi  and  Shanes  (1959),  however,  indicated  that  although  there  may  be  no 
net  alternation  in  intracellular  calcium  content,  both  influx  and  efflux  take  place 
simultaneously  during  contraction.  They  also  suggested  that  perhaps  the  influx  of 
calcium  is  so  small  that  it  cannot  be  measured  accurately,  nevertheless  they 
thought  it  large  enough  to  initiate  contraction.  According  to  this  postulate,  it 
is  conceivable  that  a  significant  amount  of  Ca  ++ 
could  be  taken  up  by  an  active 
muscle,  eventually  depleting  the  bathing  solution  of  Ca++. 
Results 
Fourteen  experiments  were  performed  where  the  Ca++  concentration  of  a 
stimulated  muscle  solution  (2  ml)  was  measured  before  and  after  the  period  of 
stimulation  (2/sec  for  30  minutes).  Seven  muscles  out  of  the  fourteen  showed  no 
difference  in  Ca  ++ 
concentration  after  stimulation.  The  mean  concentration  of 
Ca++  in  Ringer's  solutions  before  stimulation  was  1.08  mM;  the  mean  concentration 
of  Ca  ++  in  the  some  solutions  after  stimulation  was  also  1.08  mM  (Figure  20a). 
The  range  of  Ca  + 
millimolarity  in  the  solutions  after  stimulation  was 
0.92  mM  -  1.22  mM.  The  effects  of  perfusing  Ringer's  solutions  containing 
0.9  mM  Ca  ++ 
and  1.4  mM  Ca  ++ 
through  the  frog  heart  are  shown  in  Figure  20b 
An  injection  control  solution  containing  1.2  mM  Ca++  has  no  effect.  The 
solution  containing  0.9  mM  Cc  ++ 
caused  a  very  slight  initial  increase  in  cardiac 
output  and  rate,  but  this  was  followed  by  a  depression  of  output  and  rate.  The 
Ringer's  solution  containing  1.4  mM  Ca  ++  did  not  have  any  effect  on  this  heart. 
A  stimulated  muscle  solution  perfused  through  the  heart  4  minutes  later  gave  a 
typical  sharp  rise  in  cardiac  output,  systolic,  diastolic  and  pulse  pressures.  This 
is  followed  by  a  rise  in  rate  2  minutes  later.  An  injection  control  after  flushing Figure  20. 
a)  Measurement  of  the  Ca  concentrations  of  Ringer's  solutions  in  which 
sarWrius  muscles  were  stimulated  indirectly..  White  columns  indicate  the 
Ca  concentrations  in  solutions  before  muscle  stimulation.  Black  columns 
indicate  the  Ca++concentrations  of  the  bathing  solutions  after  muscle 
stimulation.  Range  of  concentrations  of  Ca++  after  stimulation  were 
0.92  mM  -  1.22  mM. 
b)  Comparison  of  the  effect  of  perfusing  the  Ringer's  solutions  of  0.9  mM 
and  1.4  mM  Ca++  through  a  frog  heart  with  that  of  a  stimulated  muscle 
solution.  No  change  in  blood  pressure  is  produced  by  the  low  Ca++ 
solutions.  A  small  increase  in  the  heart  rate  is  produced  with  the  solution 
containing  0.9  mM  Ca++.  However  no  effect  on  the  force  of  concentration 
comparable  to  the  effects  of  a  stimulated  muscle  solution  is  produced  by 
either  the  high  or  low  Ca++  solutions. ý  i. 
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out  the  venous  capsule  was  satisfactory.  The  effect  of  perfusing  Ringer's  solutions 
containing  differing  Ca++  concentrations  through  three  frog  hearts  is  shown  in 
Table  4. 
The  results  of  this  small  series  can  do  no  more  than  suggest  that,  within 
the  sensitivity  of  the  method  for  measuring  Ca  concentration,  there  is  no  net 
loss  of  Co  ++  from  the  bathing  Ringer's  solution  when  a  skeletal  muscle  is  allowed 
to  contract  in  it.  However,  as  a  cause  of  the  stimulatory  effect  change  of 
calcium  concentration  in  the  Ringer's  solution  surrounding  the  sartorius  muscle 
can  now  be  discounted. 
Table  4. 
Heart  Ca  ++  Conc.  %  Change  in  %  Change  in 
in  Ringer's  Output  Rate 
so  ution 
1  0.9  mm  -  29/o 
1.3mM  -8%  -4% 
0.9  mm  -24%  -  1% 
2 
1.3mM  -8%  -  2% 
3  1.3mM  -5%  -6% 
In  each  case  the  heart  was  slowed  and  the  cardiac  output  tended  to  fall. 
Each  heart  was  being  continuously  perfused  with  Ringer's  solution  containing 
1.2mMCa+. -  56  - 
THE  LIBERATION  OF  PROTEIN  FROM  ACTIVE  SKELETAL  MUSCLE 
As  part  of  the  investigation  of  the  stimulatory  effect,  the  stimulated  muscl  e 
solution  was  tested  for  its  protein  content.  As  the  sensitive  Lowry  test  for  protein 
was  strongly  positive,  it  was  decided  to  study  further  the  liberation  of  protein 
from  resting  and  active  sartorius  muscles;  protein  itself,  or  perhaps  some  protein- 
linked  substance  could  be  the  source  of  the  stimulatory  effect. 
Results 
Protein  liberation  was  measured  from  resting  and  stimulated  muscle  every 
hour  over  a  period  of  2  hours.  In  the  resting  series  there  was  a  decrease  in  the 
liberation  from  47.  u,  g/ml.  in  the  first  I  hour  to  16,  ug/ml.  in  the  fourth  2  hour 
(Figure  21  ).  In  the  stimulated  series  there  was  a  more  noticeable  decrease  in 
efflux  from  72ugml,  in  the  first  'z  hour  to  20,.  ig/ml.  in  the  fourth  '-z  hour  (Figure  21  ). 
A  series  of  measurements  of  protein  liberation  was  also  done  where  the 
sartorius  muscles  were  placed  in  1ml.  Ringer's  solution  and  the  container  shaken 
for  I  hour  (Table  5  ).  The  mean  protein  liberation  from  these  "agitated"  muscles 
was  90ug/m  I. 
Protein  liberation  was  also  measured  every  '-z  hour  from  agitated  muscles  for  2 
hours.  The  protein  levels  in  the  solutions  became  very  high,  probably  indicating 
that  the  muscle  was  macerating. 
Subsequently  it  was  possible  to  separate  out  the  total  protein  content  of  the 
stimulated  muscle  solution  into  one  fraction  using  the  Sephadex  chromatography 
procedure  (Methods).  Since  the  type  of  column  used  (G-25)  is  able  to  differentiate 
molecules  of  molecular  weight  of  5,000  and  over  from  smaller  molecules,  the 
protein  which  is  liberated  from  the  muscle  cannot  have  peptide  chains  of  a 
molecular  weight  of  less  than  5,000,  most  probably  the  protein  molecules 
liberated  have  a  much  greater  molecular  weight. 
When  the  column  fraction  containing  the  protein  was  perfused  through  the 
frog  heart,  no  augmentation  of  the  heart  beat  occurred.  The  fractions  from  the -  57  - 
column  suceeding  the  protein-containing  fraction  did  not  contain  any  protein 
when  tested  by  the  Lowry  technique. 
It  is  clear  that  the  stimulatory  effect  is  not  due  to  protein.  It  is  unlikely 
that  the  substance  is  protein  bound,  although  it  is  conceivable  that  it  is  separated 
from  a  protein  molecule  during  the  passage  of  the  solution  through  the  Sephadex 
column. TABLE  5. 
Protein  liberation  from  resting,  active  and  "agitated"  sartorius  muscles  (Ag/ml). 
Sartorius  muscles  rested  in  2ml.  Ringer's  solution  for  '-z  hour  or  were  stimulated  at 
2/sec  for  30  minutes. 
Resting  Muscles  Stimulated  Muscles  "Agitated"  Muscles 
50  136  122 
91  167  108 
78  160  111 
50  40  57 
85  115  119 
67  138  104 
50  103  67 
60  160  69 
68  181  92 
78  150  97 
59  120  79 
74  60  69 
90  41  92 
67  97  97 
58  47  79 
57  58 
52  Mean  =  90,  ug/ml 
55  Mean  =  111  population  =  15 
28  population  =  16  range  =  57  -  122 
43  range  =  40  -  181 
Mean  =  63 
population  =  20 
range  =  28  -  91 Figure  21.  The  rate  of  protein  liberation  from  frog  sartorius  muscle. 
a)  Upper  diagram  shows  the  amount  of  protein  liberated  into  a2  ml. 
volume  from  seven  stimulated  sartorius  muscles  over  a  period  of  two 
hours.  The  muscles  were  twitching  at  a  rate  of  2/sec. 
b)  Lower  diagram  shows  the  protein  liberation  from  five  sarforius 
muscles  resting  in  bathing  solutions  for  two  hours. 
More  protein  is  liberated  from  active  muscles. I- 
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THE  ACTION  OF  CATECHOLAMINES  ON  THE  FROG  HEART 
The  stimulated  muscle  solution  was  obtained  by  twitching  a  sartorius  muscle 
in  a  bathing  solution  by  stimulation  of  the  whole  sciatic  nerve  bundle.  Under  the 
supramaximal  conditions  of  stimulation,  all  the  nerve  fibres  in  this  large  nerve 
bundle  are  probably  stimulated.  This  of  course  includes  the  efferent  post- 
ganglionic  sympathetic  nerve  supply  to  the  blood  vessels  of  the  lower  limb, 
including  the  blood  vessels  of  the  sartorius  muscle.  These  fibres  are  adrenergic 
and  their  stimulation  might  result  in  the  release  of  small  amounts  of  catecholamines 
into  the  Ringer's  solution  surrounding  the  sartorius  muscle. 
It  has  long  been  known  that  both  adrenaline  and  noradrenaline  cause  an 
increase  in  the  force  of  contraction  of  the  myocardium  (Oliver  and  Schafer,  1895). 
This  is  the  case  when  these  substances  are  perfused  through  the  frog  heart 
preparation  (Figures  22,23  and  24). 
Results 
Using  the  adrenergic  blocking  drugs  pronethalol  and  ergot,  the  following 
experiment  was  performed.  A  frog  heart  was  continuously  perfused  with  Ringer's 
solution  containing  10-6  g/ml.  pronethalol  and  10-6  g/ml.  ergotamine  tartrate 
(P/E  Ringer's  solution)  in  order  to  block  both  alpha  and  beta  adrenergic  receptors 
which  may  both  be  present  in  the  frog  heart  (Ahlquist,  1948).  The  action  of  the 
heart  was  completely  unaffected  by  this  procedure.  After  perfusion  of  the  heart 
with  this  Ringer's  solution  had  lasted  for  an  hour  or  longer,  adrenaline  (or 
noradrenaline)  was  then  perfused  into  the  heart.  It  was  found  that  the  action  of 
the  catecholamines  was  blocked  by  the  blocking  agents;  however,  when  the 
stimulated  muscle  solution  was  perfused  through  the  same  frog  heart  a  few  minutes 
later,  its  effect  on  the  heart  was  unaltered. 
Figure  22  shows  the  effect  of  perfusing  a  frog  heart  with  10-6  g/ml. 
adrenaline.  The  effect  is  obviously  a  prolonged  stimulatory  one;  the  cardiac -  59  - 
output,  blood  pressure  and  heart  rate  were  all  raised  for  6  minutes  after  the 
perfusion  of  the  adrenaline  into  the  heart.  After  perfusing  the  heart  with  P/E 
Ringer's  solution  for  1  hour,  the  effect  of  10-6  g/ml  adrenaline  was  almost 
completely  blocked. 
Figure  23  shows  the  effect  of  perfusing  a  stimulated  muscle  solution  through 
the  same  frog  heart  as  that  shown  in  Figure  22  . 
There  is  a  sharp  increase  in  the 
cardiac  output  and  blood  pressure.  A  rise  in  heart  rate  is  also  seen.  However, 
these  changes  are  short-lived,  in  contrast  to  the  action  of  the  adrenaline  on  the 
same  frog  heart.  After  perfusion  of  the  heart  with  P/E  Ringer's  solution  for  2  hours, 
the  effect  of  the  stimulated  muscle  solution  is  still  apparent.  In  this  experiment 
three  tests  were  made  from  one  stimulated  muscle  solution  of  2  ml.  volume.  The 
test  made  on  this  heart  after  the  adrenergic  blocking  seems  to  have  a  smaller 
effect  than  those  effects  previously  produced,  but  this  is  because  a  much  smaller 
amount  of  the  test  solution  was  available  for  perfusion  and  can  be  gauged  by 
comparing  the  lengths  of  the  respective  time  marker  traces,  30  seconds  for  solutions 
before  the  blocking,  15  seconds  for  the  solution  after  the  blocking. 
Figure  24  shows  the  response  of  a  frog  heart  to  a  solution  of  noradrenaline 
and  a  stimulated  muscle  solution  before  and  after  adrenergic  blockade.  The 
stimulated  muscle  solution  produced  a  sharp  rise  and  fall  of  the  cardiac  output 
and  blood  pressure;  there  was  no  obvious  rise  in  heart  rate.  Again  this  isin  contrast 
to  the  effects  of  perfusion  with  noradrenaline.  10-7  g/m  I.  noradrenaline  produced 
a  similar  increase  in  cardiac  output  to  that  of  the  stimulated  muscle  solution,  but 
this  increase  was  more  prolonged.  A  slight  increase  in  heart  rate  was  produced 
by  both.  The  effect  of  perfus  i  ng  the  heart  with  10-6  g/m  I.  noradrenal  i  ne  was 
profound.  An  exceedingly  large  and  rapid  increase  in  the  blood  pressure  and 
cardiac  output  was  accompanied  at  the  same  time  by  a  rate  increase  which  had 
two  phases;  this  effect  persisted  for  7  minutes.  The  rapid  increase  in  cardiac 
output  was  enough  to  overcome  the  drop-counting  system  of  recording. 
After  perfusion  of  the  heart  for  2  hours  with  P/E  Ringer's  solution,  the  effect ýi 
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The  response  of  a  frog  heart  to  noradrenaline  and  to  a  stimulated  muscle 
solution.  The  upper  trace  shows  the  effect  of  perfusing  the  heart  with  a 
stimulated  muscle  solution.  Note  the  sharp  rise  and  fall  of  the  cardiac  output  and 
blood  pressure;  there  is  no  obvious  rise  in  the  heart  rate.  10-7  g/ml. 
noradrenaline  did  not  produce  a  marked  stimulatory  effect,  but  10-6  g/ml.  produced 
a  very  great  effect.  The  cardiac  output  trace  is  irregular  here  because  the 
sudden  large  increase  in  the  cardiac  output  overcame  the  drop-counting  system  of 
recording. 
The  lower  trace  shows  the  modified  effect  of  10-6  g/ml.  noradrenaline 
after  perfusion  of  the  heart  with  P/E  Ringer's  solution  for  2  hours.  No  change 
occurs  in  the  effect  of  the  same  stimulated  muscle  solution. 
The  effect  of  perfusing  a  solution  of  5x  10-7  9/m  1.  adenosine  triphosphate 
(ATP)  through  the  heart  is  seen.  Note  the  similarity  of  this  effect  to  that  of  the 
stimulated  muscle  solution.  The  action  of  ATP  is  also  unaffected  by  the 
adrenergic  blocking  agents. St,  -I.  tsd 
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THE  EFFECT  OF  ADRENERGIC  BLOCKADE  ON  THE  CARDIAC  OUTPUT  WHEN 
CATECHOLAMINES  AND  STIMULATED  MUSCLE  SOLUTIONS  ARE  PERFUSED 
THROUGH  THE  FROG  HEART 
HEART  %  OUTPUT  INCREASE 
Before  Adrenergic  Blockade  After  Adrenergic  Blockade 
1.  10-7  g/ml.  adrenaline  30% 
Test  solution  - 
0% 
35% 
2.  10-7  g/m  I.  adrenal  i  ne  - 
Test  solution  36% 
0% 
38% 
3.  10-7  g/m  I.  adrenal  i  ne  -  0% 
4.  10-7  g/ml.  adrenaline  65%  - 
5.  10-6  g/m  I.  adrenaline  50% 
Test  solution  12% 
7% 
6% 
6.  10-6g/ml.  noradrenaline  200% 
Test  solution  64% 
21% 
53% 
*  half  the  amount  injected,  see  Figure  23. -  60  - 
of  10-6  g/ml.  noradrenal  ine  was  greatly  modified.  Perfusion  of  the  same 
stimulated  muscle  solution  5  minutes  later  showed  no  change  in  its  effect. 
Stimulated  muscle  solutions  were  perfused  through  two  other  hearts  and  in 
neither  case  was  the  action  of  the  stimulated  muscle  solution  reduced  by  the 
adrenergic  blocking  agents.  (Table  6,  hearts  2  and  6). 
The  evidence  from  these  experiments  that  the  stimulation  is  not  caused  by 
catecholamines  can  be  summarized:  - 
1.  The  qua!  itative  effect  of  adrenaline  and  noradrenaline  on  the  heart 
is  different  from  that  of  the  unknown  stimulating  substance.  A 
prolonged  increase  in  heart  rate  and  cardiac  output  occurs  with  the 
catecholamines  (Figures  22,23,  &  24.  Their  effect  is  generally 
longer-lasting,  whereas  the  stimulatory  substance  causes  a  sharp, 
but  transitory  increase  in  the  cardiac  output  and  rate.  With  the 
unknown  substance  the  effect  on  the  blood  pressure  is  also 
different  (Figure  24  ).  There  is  a  sharp,  regular  increase  in  the 
systolic  and  diastolic  pressures,  with  a  slight  increase  in  the  pulse 
pressure  at  the  maximum  value  of  the  systolic  blood  pressure.  These 
effects  quickly  wear  off.  With  the  catecholamines  there  is  an  initial 
sharp  increase  in  blood  pressure  similar  to  that  caused  by  the  unknown 
substance,  but  this  increase  is  sustained  and  may  last  for  many 
minutes. 
2.  In  order  for  the  catecholamines  to  produce  a  similar  effect  to  the  test 
solution  when  perfused  through  the  heart,  the  concentration  required 
must  be  no  less  than  10-7  g/ml.  in  the  test  solution.  Thus  the  isolated 
frog  sartorius  muscle,  twitching  in  2  ml.  of  the  fluid,  would  have  to 
produce  2x  10-7  g  of  catecholamine,  while  only  being  stimulated 
at  two  impulses  per  second  for  30  minutes. 
3.  Adrenergic  blocking  agents  block  the  effects  of  adrenaline  and 
noradrenaline  on  the  frog  heart,  but  they  do  not  affect  the  response  of -  61  - 
the  same  frog  heart  to  the  unknown  stimulatory  substance. 
From  that  evidence  it  can  now  be  stated  that  the  cause  of  the  stimulatory 
effect  on  the  frog  heart  is  not  release  of  catecholamines  from  the  sartorius  muscle. -  62  - 
ADENYLIC  ACID  DERIVATIVES  AND  THEIR  ACTION  ON  THE  MYOCARDIUM 
There  is  a  considerable  accumulation  of  knowledge  about  the  biological 
actions  of  adenyl  compounds  on  cardiovascular  tissues  of  many  species.  Drury 
and  Szent-Gyorgyi  (1929)  showed  that  adenylic  acid  produced  heart  block  in 
the  guineapig  and  lowered  the  blood  pressure  in  the  dog  together  with  dilating 
the  coronary  arteries.  Lindner  and  Rigler  (1933)  found  that  extracts  from  the 
bundle  of  His  from  the  calf  heart  stimulated  an  hypodynamically-acting  frog's 
heart.  On  attempting  to  isolate  this  compound  they  found  it  contained  a  pentose 
and  a  purine  base. 
Later  work  of  this  nature  suggested  that  the  biological  activity  of  many  of 
the  tissue  extracts  was  really  due  to  their  adenosine  content  (Rigler  and 
Schaumann,  1930;  Rothman,  1930).  Ostern  and  Parnas  (1932)  found  that  adenosine 
triphosphate  and  occasionally  muscle  adenylic  acid  increased  the  strength  of  the 
frog  heart  beat,  while  adenosine  failed  to  do  so;  this  result  was  also  obtained  on 
frog  heart  by  Lindner  and  Rigler  (1931)  and  by  Drury  (1932)  on  the  rabbit  heart. 
Flossner  (1934)  found  that  some  nucleic  acid  derivatives  increased  while 
others  decreased  the  amplitude  of  contraction  of  perfused  frog  hearts.  At  this  time 
most  workers  agreed  that  the  hearts  of  experimental  animals  whether  perfused  or 
in  the  intact  animal  remained  in  very  good  condition  when  subjected  to  injection 
of  nucleic  acid  derivatives.  Although  these  derivatives  were  known  to  be  powerful 
coronary  vasodilators,  it  was  difficult  for  some  workers  "  to  be  convinced  that  the 
improvement  of  the  heart  beat  was  always  due  to  the  action  upon  the  coronary 
vessels. 
In  1950  Green  and  Stoner  studied  the  action  of  the  adenine  nucleotides  on 
the  cardiovascular  system  in  some  detail.  They  found  that  adenosine  monophosphate 
and  adenosine  triphosphate  caused  a  bradycardia  in  the  perfused  isolated  rabbit 
heart-  they  found  that  these  compounds  acted  upon  the  sinu-atrial  node,  and 
that  their  action  could  be  explained  by  the  adenosine  content.  The  amplitude  of -  63  - 
contraction  they  found  to  be  unaffected  by  adenosine;  however,  when  adenosine 
triphosphate  was  perfused  through  the  heart  there  was  an  immediate  increase  in 
the  amplitude  of  the  beat,  followed  by  a  depression,  which  in  turn  was  followed  by 
a  sustained  increase  in  the  amplitude  of  contraction.  This  verified  an  earlier 
observation  by  Dubois-Ferriere  (1945)  working  on  perfused  frog  hearts.  Later  work 
has  conclusively  shown  that  adenosine  triphosphate  has  an  immediate  positive 
inotropic  effect  on  cardiac  muscle  which  is  succeeded  by  a  bradycardia  or  a 
cardiac  arrest  (Meyer,  1951;  Sekiya,  1953;  Kanda  et  al.,  1954;  Chevillard  and 
Guerin,  1955;  Buday,  Carr  and  Miya,  1961;  Versprille,  1963). 
Results 
In  order  to  test  whether  other  triphosphates  were  capable  of  stimulating  the 
frog  heart,  one  experiment  was  performed  where  solutions  of  inosine  triphosphate 
(ITP),  uridine  triphosphate  (UTP),  cytosine  triphosphate  (CTP)  and  guanosine 
triphosphate  (GTP)  were  perfused  through  the  frog  heart.  UTP  and  ITP  had  a 
marked  stimulatory  effect  on  the  heart  but  no  effect  was  produced  by  solutions 
of  CTP  or  GTP.  It  is  possible  that  these  latter  substances  had  degraded  during 
prolonged  storage. 
Solutions  of  the  bases  uridine,  cytidine,  inosine  and  adenosine  were  also 
perfused  through  the  heart  but  no  stimulation  was  produced  (Table  7)  . 
An 
interesting  finding  was  that  the  solution  of  ITP  caused  a  greater  stimulation  than 
that  caused  by  inosine  diphosphate  on  the  same  heart.  Inosine  monophosphate 
did  not  have  any  effect  on  this  heart. 
Adenosine,  in  a  concentration  of  10-5  g/ml.  caused  a  3%  fall  in  cardiac 
output  and  a  35%  fall  in  heart  rate  when  perfused  through  the  heart.  Figure  25 
shows  that  adenosine  monophosphate,  even  in  a  very  high  concentration,  did 
not  stimulate  the  heart.  A  fall  in  rate  and  output  is  produced  by  10-6  g/ml. 
and  10-5  g/ml.  AMP. 
When  a  solution  of  ATP  was  perfused  through  thefrog  heart  it  produced  a 
similar  type  of  stimulation  to  that  produced  by  the  stimulated  muscle  solution Table  7. 
The  effect  of  perfusing  various  bases  and  nucleotides  through  frog  hearts. 
Hearts  Compound  %  Output  Change  %  Rate  Change 
10-5  g/mI.  adenosine  -30  -35 
1  10-5  g/m  1.  AMP  -25  -36 
10-5  g/ml.  uridine  0  -25 
10-5  g/mI.  UTP  +220  +34 
10-6  g/mI.  inosine  0  0 
10-5  g/ml.  inosine  0  0 
10-4  g/ml.  inosine  0  0 
10-6  g/mI.  IMP  -7  0 
10-5  g/ml.  IMP  -9  0 
2  10-6  g/mI.  IDP  +10  +28 
10-6  g/ml.  ITP  +20  +31 
10-6  g/mI.  cytidine  -5  -7 
10-6  g/m  I.  CM  P  0  0 
10-6  g/mI.  CTP  0  0 
10-6  g/mI.  GTP  0  0 
10-9  g/mI.  AMP  0  0 
3  10-7  g/m  I 
. 
AMP  -5  -12 
10-5  g/m  1.  AMP  -20  -24 C 
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Figures  28&  29.  There  was  an  immediate  rise  in  systolic,  diastolic  and  pulse 
pressures,  causing  a  rapid  increase  in  cardiac  output.  With  high  concentrations 
of  ATP  the  heart  rate  was  increased,  reaching  a  peak  value  2  minutes  later.  Usually 
the  stimulated  muscle  solution  produced  a  greater  increase  in  the  heart  rate. 
A  quantitative  comparison  of  the  action  of  ATP  and  stimulated  muscle 
solutions  is  given  in  Table  10. 
Discussion 
The  only  substances  found  which  have  been  able  to  stimulate  the  frog  heart 
in  a  similar  fashion  to  that  of  the  stimulated  muscle  solution  are 
a)  the  catecholamines  and 
b)  the  triphosphates  of  various  bases. 
The  catecholamines  as  a  cause  of  the  effect  have  already  been  eliminated; 
however,  it  was  felt  necessary  to  proceed  with  further  investigation  into  the 
possibility  of  whether  the  stimulatory  substance  was  adenosine  triphosphate,  since 
this  is  probably  the  most  commonly-occurring  of  the  triphosphates  in  biological 
tissue. 
Although  there  is  evidence  to  suggest  that  ATP  is  NOT  released  from 
skeletal  muscle  (Hilton  and  Greengard,  1962),  nevertheless  the  qualitative 
similarity  of  the  stimulation  produced  by  both  ATP  and  the  test  solution 
encouraged  further  investigation. -  65  - 
COMPARISON  OF  THE  ULTRAVIOLET  ABSORPTION  OF  TEST  SOLUTIONS 
AND  SOLUTIONS  CONTAINING  ADENOSINE  COMPOUNDS 
Of  the  compounds  which  make  up  the  bulk  of  the  muscle  structure,  only 
two  types  have  a  marked  selective  light  absorption  in  the  ultraviolet  range 
(250m,  u  -  300mp),  namely  the  purine  derivatives  and  the  proteins.  The  purine 
derivatives  are  95%  adenylic  acid  derivatives  (Caspersson  and  Thorell,  1942). 
The  purine  nucleus  in  these  cases  absorbs  ultraviolet  light  strongly  at  260  mp. 
Absorption  of  ultraviolet  light  by  protein  occurs  at  280  mu  (conditioned  by  tyrosine 
and  tryptophan)  but  is  not  so  strong  as  the  ultraviolet  absorption  by  the  adenylic 
acid  derivatives. 
Results 
Figure  26  shows  the  comparison  of  UV  absorption  sepctra  of  two  resting 
muscle  solutions,  a  stimulated  muscle  solution  and  a  solution  containing  10 
5 
g/ml. 
adenosine  monophosphate  made  up  in  frog  Ringer's  solution.  The  resting  solutions 
were  obtained  from  muscles  which  had  rested  for  50  minutes  and  120  minutes  in 
2  ml.  of  Ringer's  solution.  The  50  minute  resting  solution  shows  a  low  optical 
density  in  the  range  250mW  -  280mA.  The  120  minute  resting  solution  has  a  higher 
optical  density  in  this  range.  The  optical  density  for  the  stimulated  muscle  solution 
is  markedly  raised  in  this  range.  The  increase  in  optical  density  is  due  to  the 
absorption  of  UV  light  by  protein;  more  protein  is  liberated  from  stimulated  than 
resting  muscles  (see  Protein  Section).  The  solution  containing  10-5  g/ml.  adenosine 
monophosphate  shows  a  greatly  prounounced,  sharp  peak  of  optical  density  at 
260m}l  wavelength. 
The  raised  optical  density  in  the  range  250m}.  t  -  280m»  caused  by  protein 
might  mask  small  peaks  of  UV  absorption  resulting  from  small  concentrations  of 
adenosine  compounds  perhaps  present  in  the  test  solution.  With  the  Sephadex 
column  technique  (p.  34  Methods)  it  was  possible  to  obtain  a  solution  which  was 
capable  of  stimulating  the  frog  heart  and  which  did  not  contain  any  protein 0"6  Resting  0.6  Resting  O.  6  Stimulated0.6  1O°G/ml 
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Figure  26. 
Comparison  of  absorption  spectra  obtained  from  resting  and  stimulated  muscle 
solutions  with  that  from  a  solution  of  10-5  g/ml  adenosine  monophosphate. 
(a)  A  solution  in  which  a  muscle  rested  for  120  minutes  shows  an  optical 
density  of  0.06  units  between  250  mA  and  280  mv..  t. 
(b)  A  resting  solution  of  fifty  minutes  duration  gives  a  lower  optical 
density  over  the  same  range. 
(c)  A  stimulated  muscle  solution  shows  greater  absorption  over  this 
range. 
(d)  10-5  g/ml  adenosine  monophosphate  made  up  in  frog  Ringer's 
solution  shows  a  pronounced  sharp  peak  at  260  m}t  wavelength. 
The  increased  optical  density  in  the  solutions  is  due  to  protein  liberated  from 
the  muscle.  More  protein  is  liberated  from  the  stimulated  muscle  than  the  resting 
muscle. Figure  27. 
Comparison  of  the  UV  absorption  spectra  of  a  solution  of  10-6  g/ml  ATP 
and  a  mixture  of  column  fractions  3  and  4  which  stimulated  the  frog  heart. 
Small  peaks  of  UV  absorption  appear  at  265  mjA  wavelength. 0.7 
06 
05 
O.  4 
c 
d 
O  O.  3 
r0 
U 
a-  0-2 
O.  1 
ATP  10-GG/ml.  Column  Fractions 
3  and  4. 
265  265 
Wavelength  mu -  66  - 
(Figure  27).  When  the  UV  absorption  spectrum  of  a  mixture  of  column  fractions 
3  and  4  (which  stimulated  the  frog  heart)  was  measured,  a  very  slight  peak 
appeared  at  265mýi  wavelength).  This  is  shown  in  Figure  27.  This  suggested 
that  nucleotides  were  present  in  the  test  solution,  since  these  cyclic  compounds 
absorb  UV  light  at  approximately  this  wavelength,  depending  on  the  type  of 
solvent  in  which  they  are  dissolved.  Figure  27  shows  the  UV  absorption  spectrum 
of  a  solution  of  10-6  g/ml.  adenosine  triphosphate  made  up  in  a  similar  frog 
Ringer's  solution  to  that  containing  fractions  3  and  4.  A  more  pronounced 
absorption  peak  is  evident  at  the  same  position  in  the  spectrum  as  that  of  the 
column  fractions  3  and  4. 
This  preliminary  investigation  was,  of  course,  not  in  itself  a  valid 
identification  procedure,  but  it  is  described  here  because  it  provided  the  line 
of  further  investigation. -  67  - 
COMPARISON  OF  THE  ACTION  OF  APYRASE  ON  THE  STIMULATED  MUSCLE 
SOLUTION  AND  ON  ADENOSINE  TRIPHOSPHATE 
Potato  adenosine  triphosphatase  (ATPase)  was  first  described  by  Kalckar  in 
1943.  He  was  able  to  precipitate  a  substance  out  from  watery  extracts  of  potato 
which  could  split  off  two  groups  of  phosphate  from  adenosine  triphosphate.  He 
also  found  that  this  reaction  was  activated  by  calcium  ions. 
Meyerhof  (1945)  first  suggested  the  name  "apyrase"  to  describe  those 
adenylpyrophosphatases  which  act  on  both  ADP  and  ATP,  splitting  off  two 
phosphate  groups  from  the  latter.  A  survey  of  modern  literature  shows  that  the 
two  terms  "apyrase"  and  ATPase"  are  often  used  interchangeably. 
The  findings  of  Eiler  and  Lee  (1951)  and  Van  Thoai  (1954)  suggested  that 
apyrase  split  ATP  to  ADP  and  that  only  after  this  phase  had  been  completed  did 
the  formation  of  AMP  take  place.  Traverso-Cori  and  Cori  (1962)  verified  this  and 
showed  that  AMP  was  not  produced  in  the  first  10  minutes  of  the  reaction. 
Two  enzymes  have  recently  been  separated  from  apyrase  (Liebecq,  Lallemand 
and  Degueldre-Guillaume,  1963)  which  act  on  inosine  triphosphate  (ITP), 
guanosine  triphosphate  (GTP)  uridine  triphosphate  (UTP),  cytosine  triphosphate 
(CTP)  as  well  as  on  ATP.  One  enzyme  converts  thetriphosphate  to  the  diphosphate, 
the  other  enzyme  coverts  the  diphosphate  to  the  monophosphate. 
Substrate  Specificity  of  Potato  Apyrase 
As  already  indicated  by  the  work  of  Liebecq  et  al.,  the  phosphate  groups  can 
be  split  from  variously-based  nucleotides,  so  the  enzyme  is  not  specific  for 
ADENOSINE  triphosphate.  These  workers  also  studied  the  action  of  potato  apyrase 
on  adenosine  TETRAphosphate.  It  was  found  to  be  dephosphorylated  very  slowly 
by  the  two  fractions  of  apyrase.  A  search  of  the  literature  has  failed  to  reveal  any 
other  energy-rich  substance  containing  phosphate  radicals  which  is  acted  upon  by 
apyrase.  Krishnan  (1949)  found  that  no  phosphate  was  liberated  from  muscle 
adenylic  acid,  yeast  adenylic  acid,  sodium  pyrophosphate,  hexose  1.6  diphosphate -  68  - 
and  -glycerophosphate.  He  showed  that  even  in  the  crude  stage  the  enzyme 
showed  some  degree  of  specificity  towards  ATP. 
Results 
Figure  28  shows  the  effect  of  perfusing  a  frog  heart  with  a  solution  of 
10-6  g/ml.  ATP.  The  initial  sharp,  stimulatory  effect  on  the  force  of  contraction 
is  clearly  seen  in  both  the  arterial  pressure  record  and  in  the  record  of  cardiac 
output.  Immediately  following  this  effect  is  a  slight  bradycardia.  Perfusion  of 
the  heart  with  the  same  concentration  of  ATP,  having  incubated  this  portion  with 
apyrase  for  15  minutes,  shows  that  the  initial  sharp  effect  has  been  abolished. 
Note  that  the  fall  in  rate  which  followed  the  initial  stimulatory  effect  has  not 
been  altered.  The  pure  ATP  solution  was  then  perfused  through  the  heart  again 
to  show  that  the  sensitivity  of  the  heart  to  ATP  had  not  been  affected  in  any  way 
by  apyrase. 
Figure  29  shows  the  effect  of  perfusing  0.5  ml.  of  a  stimulated  muscle 
solution  through  the  same  frog  heart  as  shown  in  Figure  28.  Once  again  an  initial 
sharp  stimulatory  effect  on  the  force  of  contraction  is  reflected  in  both  the  arterial 
pressure  and  cardiac  output  recordings.  In  this  case  a  late  increase  in  the  heart 
rate  has  occurred.  When  0.5  ml.  of  the  solution  is  incubated  with  apyrase,  the 
sharp  stimulatory  effect  is  abolished;  the  late  rise  in  the  heart  caused  by  the 
stimulatory  substance  in  the  test  solution  has  not  been  abolished  by  the  apyrase. 
Ten  solutions  of  ATP  were  perfused  through  eight  frog  hearts  before  and  after 
incubation  with  apyrase  (Table  8).  Eight  stimulated  muscle  solutions  were  perfused 
through  eight  frog  hearts  before  and  after  incubation  with  apyrase  (Table  9). 
In  every  case  the  initial  stimulatory  effect  of  both  the  ATP  solutions  and  the 
solutions  in  which  a  sartorius  muscle  had  twitched  was  abolished.  In  some  cases 
the  sharp  increase  in  cardiac  output  was  supplanted  by  a  gradual  rise  in  output, 
occurring  much  later  after  the  perfusion;  this  was  due  to  a  late  increase  in  the 
heart  rate  which  occurs  with  solutions  which  have  had  insufficient  time  for 
incubation  with  apyrase.  It  became  obvious  that  this  late  rate  effect  which 00  CO  äý 
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occurred  after  a  test  solution  was  incubated  could  cause  the  cardiac  output  to 
rise  to  an  even  greater  level  than  that  level  reached  when  the  stimulated  muscle 
solution  was  perfused  through  a  heart.  Figure  30  shows  the  result  of  perfusing  a 
frog  heart  with  a  solution  of  5x  10-8  g/ml.  ATP.  This  gave  the  usual  stimulatory 
effect.  Also  shown  is  the  result  of  perfusing  the  heart  with  solutions  of  the  same 
concentrations  of  ATP  having  been  incubated  with  apyrase  (1  mg  added  to  each 
ml,  of  ATP  solutior)  for  5,10  and  15  minutes.  The  sharp,  stimulatory  effect  is 
abolished  in  all  three  solutions  but  an  arrythmia  has  been  introduced,  the  rate 
increase  being  greater  when  the  incubation  period  is  shorter  (Table  8). 
Incubating  the  apyrase  with  frog  Ringer's  solution  alone  for  10  minutes  has 
no  effect  on  either  the  heart  rate  or  cardiac  output  when  this  solution  is  perfused 
through  the  heart. 
Clearly  some  interference  phenomenon  is  produced  from  the  reaction 
ATP  --_a_L'M!  _  ADP  when  incubation  does  not  proceed  beyond  10  minutes. 
In  this  section  it  cannot  be  ruled  out  that  this  effect  on  the  heart  rate  is  due 
to  ADP.  It  was  considered  unfruitful  to  perfuse  the  frog  heart  with  standard 
preparations  of  ADP,  since  commercially  prepared  ADP  is  almost  certain  to  contain 
a  minute  quantity  of  ATP.  Since  the  frog  heart  is  especially  sensitive  to  ATP,  any 
contamination  of  ADP  with  ATP  will  distort  the  frog  heart  response  to  perfused 
commercial  ADP.  Elaborate  purification  procedures  would  be  necessary  to  obtain 
a  pure  ADP  effect  on  the  frog  heart. 
Discussion 
The  potato  apyrase  used  in  this  work  contained  0.9  units  per  milligramme. 
One  unit  will  hydrolyse  lu  mole  of  the  substrate  per  minute  at  pH  6.5  at  30°C 
(information  supplied  by  Sigma  Company). 
Molecular  weight  of  ATP  (disodium  dihydrogen  salt)  =  623 
1,  t,  t  mole  =  0.623  x  10 
3 
9/ml.  =  6.23  x  10  g/mI. 
Since  the  test  solutions  are  incubated  with  a  concentration  of  0.9  units  of C; 
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a Table  8.  The  effect  of  perfusing  solutions  of  ATP  which  have  been  incubated 
with  apyrase  for  varying  periods  through  frog  hearts. 
Heart  Concentration  Time  of  %  Output  %  Rate 
of  ATP  Incubation  Increase  Increase 
10-8  g/ml.  --  21  20 
10-8  g/mI.  5  minutes  13  40 
10-8g/mI.  10  minutes  10  40 
10-8  g/ml.  15  minutes  0  0 
5.0  x  10-8  g/m  I.  --  24  0 
5.0  x  10-8  g/ml.  5  minutes  16  50 
2. 
5.0  x  10-8  g/ml.  10  minutes  16  52 
5.0  x  10-8  g/mI.  15  minutes  8  16 
10-6  g/mI.  --  60  0 
3' 
10 
6 
g/mI.  10  minutes  35  0 
10  6 
g/mI.  --  32  -12 
4' 
10-6  g/ml.  10  minutes  -4  -7 
10-6  g/ml.  --  37  0 
5' 
10-6  g/mI.  10  minutes  0  0 
10-7  g/mI.  50  irreg. 
6.  10-7  g/mI.  10  minutes  17  22 
2.5x107g/ml.  --  18  0 
2.5x  10-7  S/Ml.  10  minutes  11  17 
10  g/m  I.  --  12  0 
7' 
10-8  g/mI.  5  minutes  14  18 
5.0x108g/mI.  --  17  0 
5.0  x  10-8  g/mI.  5  minutes  20  20 
8.  10-7  g/mI.  --  27  0 
10 
7 
g/mI.  5  minutes  32  30 
10-7  g/mI.  10  minutes  18  24 
Small  concentrations  of  ATP  (not  incubated  with  apyrase)  only  affect; 
the  cardiac  output,  not  the  heart  rate.  When  incubated  with  apyrase,  the  initial 
stimulatory  effect  disappears,  but  if  the  time  of  incubation  is  insufficient,  then 
a  separate  rate  increase  occurs,  about  one  minute  later  in  the  perfusion;  this  is 
sufficient  to  increase  the  cardiac  output  at  the  same  time. -  70  - 
apyrase  per  ml.,  roughly  6x  10 
4 
g/ml.  of  ATP  should  be  hydrolysed  per  minute. 
The  incubation  period  required  to  abolish  the  effect  of  a  test  solution  was  one  of 
a  quarter  of  an  hour  at  pH  7at30°C.  ' 
Quantitative  comparisons  of  the  effects  of  ATP  and  the  stimulated  muscle 
solution  on  the  frog  heart  (Table  10)  would  suggest  that  if  the  stimulatory  effect 
is  due  to  ATP,  then  it  is  at  a  concentration  of  certainly  not  more  that  10-6  g/ml. 
in  the  stimulated  muscle  solution.  So  there  seems  to  be  no  theoretical  objections 
to  the  assumption  that  all  the  ATP  in  both  stimulated  muscle  solutions  and  pure 
ATP  solutions  is  hydrolysed. 
Apart  from  the  pH  being  7  instead  of  the  recommended  6.5,  the  conditions 
for  the  destruction  of  ATP  in  the  stimulated  muscle  solution  seem  to  be  ideal.  The 
reaction  is  calcium  dependant  (Kalckar,  1943)  and  calcium,  of  course,  is  present 
in  the  solution;  and  its  concentration  remains  unaltered  throughout  the  period  of 
stimulation  (see  calcium  section).  Liebecq  et  al.  (1963)  noted  that  the  activity 
of  potato  apyrase  was  doubled  in  the  presence  of  plasma  proteins.  The  stimulated 
muscle  solution  contains  150  -  200  pg/ml.  of  protein  (see  protein  section). 
The  two-stage  reaction  of  apyrase  upon  ATP  is  attributed  to  two  components, 
an  adenosine  triphosphatase  and  an  adenosine  diphosphatase.  Since  these  two 
components  have  been  separated  chromatographically  (Liebecq  et  al.  1963),  the 
possibility  that  a  single  enzyme  is  splitting  off  the  terminal  phosphate  groups  in 
two  steps  is  remote. 
The  incubation  period  for  these  components  seems  to  be  different.  Van  Thoai 
(1954)  showed  that  AMP  only  appeared  after  incubation  of  ATP  with  apyrase  for  15 
minutes.  Traverso-Cori  and  Cori  (1962)  showed  that  alI  of  the  ATP  is  converted  to 
ADP  in  the  first  stage  and  they  found  that  AMP  is  not  produced  in  the  first  10 
minutes  of  the  reaction.  So  it  seems  that  the  incubation  time  required  for  the 
adenosine  diphosphate  component  to  produce  AMP  is  at  least  ten  minutes,  at  pH 
6.5  and  30°C. 
Unfortunately,  although  the  action  of  each  test  solution  on  the  frog  heart  was Table  9. 
The  effect  of  perfusing  the  SMS  through  frog  heart  after  incubation  with 
apyrase.  Time  of  incubation  in  every  case  10  minutes. 
Before  Incubation  After  Incubation 
Heart  Solution 
%  Output  %  Rate  %  Output  %  Rate 
increase  increase  increase  increase 
1  1  25*  17+  50*  -- 
"Y  2  2  18*  0+ 
. 
18*  25 
3  3  20  *  21+  36  *  50 
4  4  36  *  28+  42  *  30 
5  5  37  *  --  65  *  -- 
6  6  24  *  4+  14  *  15 
7  7  40  *  28+  50  *  35 
8  8  32*  6+  164-  12* 
Immediately  after  perfusion 
+2  minutes  later 
Both  occurring  2  minutes  after  perfusion. 
SMS  stimulated  muscle  solution. 
In  every  case  the  initial  stimulatory  effect  was  abolished;  unfortunately  the 
late  increase  in  the  heart  rate  resulted  in  a  late  rise  of  cardiac  output  at  the 
same  time.  This  was  due  to  the  fact  that  each  test  solution  was  incubated  with 
apyrase  for  only  10  minutes. -  71  - 
radically  altered  after  incubation  with  apyrase,  the  late  increase  in  the  heart 
rate  resulted  in  a  late  rise  of  cardiac  output  at  the  same  time  (Table  9).  This 
effect  can  be  attributed  to  the  fact  that  each  test  solution  was  incubated  with 
apyrase  for  only  10  minutes;  the  ideal  time  of  incubation  for  complete 
inactivition  of  ATP  is  15  minutes  (Figure  27). 
The  sharp  increase  in  cardiac  output  before  incubation  occurred  immediately 
after  the  period  of  perfusion  into  the  heart.  In  every  case  this  effect  was 
abolished  by  apyrase  (not  evident  from  Table  9).  After  incubation  this  effect 
was  replaced  by  a  late  rise  in  the  heart  rate  which  caused  a  late  rise  in  the 
cardiac  output. 
a  ., 
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COMPARISON  OF  THE  BEHAVIOUR  OF  THE  STIMULATORY  SUBSTANCE 
AND  ADENOSINE  TRIPHOSPHATE  IN  A  SEPHADEX  COLUMN 
It  was  possible  to  perfuse  Ringer's  solution  which  had  passed  through  a 
Sephadex  column  through  a  frog  heart  without  disturbing  the  cardiac  rhythm. 
Thus  it  became  feasible  to  examine  and  compare  the  behaviour  of  ATP  and  the 
unknown  stimulatory  substance  in  the  column.  By  perfusing  fractions  collected 
from  the  column  through  the  heart  the  rate  of  elution  of  ATP  and  the  unknown 
I  substance  through  the  column  could  be  ascertained. 
Results 
A2  ml.  sample  of  stimulated  muscle  solution  was  mixed  with  blue  dextran 
and  then  eluted  through  a  column  run  on  eserinized  frog  Ringer's  solution.  The 
fractions  collected  from  the  column  were  those  standardized  for  the  maximum 
recovery  of  ACh  (see  section  on  "Behaviour  of  ACh  in  the  Sephadex  Column"). 
When  these  fractions  were  perfused  through  the  frog  heart,  it  was  found  that  the 
typical  stimulatory  effect  on  the  heart  was  produced  by  fractions  3,4  and  5. 
(Figure  31). 
The  same  procedure  was  carried  out  for  solutions  of  ATP.  A  typical  result 
is  shown  in  Figure  32  . 
Just  as  with  fractions  3,4  and  5  of  the  stimulated  muscle 
solution,  the  column  fractions  3,4  and  5  of  the  ATP  solution  stimulated  the  frog 
heart. 
In  order  to  show  that  the  elution  patterns  for  the  unknown  substance  and 
ATP  were  the  same,  smaller  fractions  were  collected  from  the  column.  Figures 
33  and  34  show  the  result  of  one  such  experiment.  5x  10-7  g/ml.  ATP  were 
made  up  in  frog  Ringer's  solution  and  2  ml.  of  this  solution  was  eluted  through 
the  column.  After  the  initial  3  ml.  fraction  containing  the  blue  dextran  came 
through  the  column,  2  ml.  fractions  were  collected  thereafter.  These  fractions 
were  then  perfused  through  a  frog  heart  (Figure  33) 
. 
The  stimulatory  effect  is 
clearly  seen  in  fractions  3,4,5,6,  and  7;  a  graded  pattern  of  stimulation  is os  0 
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Figure  35. 
Comparison  of  the  behaviour  of  the  stimulatory  substance  and  ATP  through 
five  Sephadex  columns. -  73  - 
seen,  with  the  peak  of  stimulation  occurring  in  fraction  5. 
Stimulated  muscle  solutions  were  obtained  'in  the  usual  way  from  two  frog 
sartorius  muscles.  The  solutions  of  2  ml.  each  were  thoroughly  mixed  and  2  ml. 
of  this  mixture  were  put  through  the  some  column  as  the  ATP  solution.  Once 
again  2  ml.  fractions  were  collected  from  the  column.  The  result  of  perfusing 
these  fractions  through  the  same  frog  heart  as  in  Figure  33'  is  shown  in  Figure  34 
Although  the  stimulatory  effect  is  not  so  marked,  nevertheless  it  appears  in  the 
some  fractions,  the  peak  effect  again  being  in  fraction  5. 
Figure  35  shows  a  comparison  of  elution  patterns  of  both  stimulated  muscle 
solutions  and  solutions  of  ATP  through  5  Sephadex  columns.  The  percentage 
increase  in  cardiac  output  produced  by  each  fraction  was  used  as  an  indication  of 
the  concentration  of  the  ATP  and  the  stimulatory  substance.  The  width  of  each 
block  represents  the  size  of  successive  fractions  collected,  the  height  represents 
the  percentage  increase  in  cardiac  output  produced  by  each  fraction.  It  is  clear 
that  the  elution  pattern  obtained  from  this  column  chromatography  procedure  is 
the  some  for  the  unknown  substance  as  "  it  is  for  adenosine  triphosphate. 
1 -  74  - 
THE  USE  OF  THE  FIREFLY  LUMINESCENCE  PROCEDURE  FOR  THE 
IDENTIFICATION  OF  THE  STIMULATORY  SUBSTANCE  RELEASED  FROM  ACTIVE 
SARTORIUS  MUSCLE 
When  live  fireflies  (Photinus  pyralis)  are  ground  with  sand  and  water,  the 
extract  obtained  momentarily  becomes  luminescent;  if  the  grinding  is  continued 
the  light  emission  decays  rapidly.  If  adenosine  triphosphate  (ATP)  is  added  to 
this  extract,  a  bright  flash  of  light  appears  immediately  and  lasts  for  a 
considerable  time,  the  intensity  and  duration  of  the  flash  depending  on  the 
concentration  of  the  ATP.  (McElroy,  1947).  It  was  noted  by  McElroy  that  with 
high  concentrations  of  ATP  a  bright  glow  is  maintained  for  some  time,  followed 
by  a  slow  decay,  while  with  low  concentrations  of  ATP  there  is  an  initial  burst  of 
light,  followed  by  a  prolonged  decay  in  the  light  signal. 
Strehler  and  Totter  (1952)  thought  that  the  firefly  luminescence  phenomenon 
could  be  adapted  for  the  assay  of  ATP  in  living  materials.  Using  refined  light- 
measuring  devices  they  emphasized  that  the  system  could  be  adapted  to  the 
measurement  of  ATP  in  very  minute  quantities.  With  a  quantum-counting  photo- 
multiplier  at  liquid  nitrogen  temperatures,  they  were  able  to  measure 
concentrations  of  ATP  as  low  as  10-9  g/ml.  with  an  accuracy  of 
±  5%.  They  also 
emphasized  the  simplicity  of  the  method,  and  recommended  its  use  for  rapid 
survey  of  ATP  in  many  fields  of  investigation. 
Principle  of  the  Method 
The  linear  luminescence  response  of  firefly  extracts  to  added  ATP  is  the 
basis  of  this  method  of  ATP  analysis.  The  following  reaction  is  generally  agreed 
upon: 
ATP  +  Mg  ++ 
+  02  +  luciferin-H2  +  luciferase  =  LIGHT. 
Mn++  ions  can  replace  the  Mgt  ions  and  the  oxygen  content  of  the  air  is 
sufficient  to  support  the  reaction.  In  the  presence  of  the  enzyme  luciferase  the 
substrate  for  the  reaction,  luciferin,  is  oxidized  with  the  production  of  light  when -  75  - 
oxygen,  Mg  ++  ions  and  ATP  are  present  in  excess.  The  optimum  pH  for  the 
reaction  is  7.8  and  the  maximum  light  intensity  is  observed  at  26°C  (Strehler 
and  McElroy,  1957). 
Specificity  of  the  Reaction 
The  assay  is  specific  for  ATP.  However,  precursors  of  ATP  will  also  produce 
light,  provided  that  the  appropriate  enzymes  for  ATP  formation  are  present.  The 
purified  enzyme  preparation  responds  only  to  ATP.  Adenosine  diphosphate, 
creatine  phosphate,  acetyl  phosphate,  inos'ne  triphosphate,  uridine  triphosphate, 
guanidine  triphosphate  and  inorganic  polyphosphates  do  not  produce  Iight  when 
added  to  extract  of  firefly  (Strehler  and  McElroy,  1957). 
Results 
Five  separate  stimulated  muscle  solutions  were  tested  on  the  firefly  extract. 
On,!  two  of  these  occasions  two  stimulated  muscle  solutions  were  pooled  and 
thoroughly  mixed  together  so  that  there  would  be  enough  of  the  test  sample  for 
estimation  on  the  firefly  extract  and  for  perfusion  through  the  frog  heart  before 
and  after  incubation  with  the  enzyme  apyrase. 
In  all  three  cases  the  solution  caused  light  to  be  emitted  from  firefly  extract 
(Figure  36).  In  the  cases  where  the  solutions  had  been  pooled,  the  same  solution 
stimulated  the  heart  in  a  similar  manner  to  ATP,  was  modified  in  its  action  by 
apyrase,  and  caused  light  to  be  emitted  from  a  firefly  extract.  When  the  effect 
of  a  pooled  solution  on  the  frog  heart  was  matched  with  a  solution  of  ATP  it  was 
found  that  the  some  concentration  of  ATP  caused  a  similar  light  signal  to  be 
emitted  from  the  firefly  extract.  Figure  37a  shows  the  effect  of  perfusing  graded 
concentrations  of  ATP  solutions,  ranging  from  2.5x  10-8g/ml.  to7.5x  10-7g/mI, 
through  a  frog  heart.  The  lowest  concentration  of  ATP  causes  a  sharp,  evanescent 
increase  in  the  systolic  blood  pressure  with  no  effect  on  the  heart  rate,  while  a 
concentration  of  7.5  x  10 
7 
g/ml.  causes  an  exceedingly  sharp  increase  in  the 
blood  pressure,  followed  two  minutes  alter  by.  a  gradual  increase  in  heart  rate. 
Graded  effects  are  clearly  seen  with  the  intermediate  concentrations. Figure  36. 
Comparison  of  the  effects  of  stimulated  muscle  solutions  and  solutions  of  ATP  on  extracts  of  firefly.  Deflection  upwards  from  the  baseline  =  light  emitted. 
(a)  A  solution  of  10 
8 
g/mLATP  emitted  a  similar  light  signal  to 
that  emitted  from  a  stimulated  solution. 
(b)  A  solution  of  5x  10-8  g/ml  ATP  gave  the  same  light  emission 
as  two  pooled  test  solutions  from  the  same  firefly  extract. 
(c)  The  light  emitted  from  a  solution  of  2x  10-7  g/mI.  ATP  is  shown. 
The  cuvette  was  removed  from  the  light-measuring  device  for 
a  few  seconds  and  then  replaced.  During  this  time  no  light 
was  detected.  This  verified  that  the  light  signal  was  cgming 
from  no  other  source  other  than  the  solution.  A  stimulated 
muscle  solution  gave  a  similar  emission  of  light  from  the  same 
extract.  In  each  case  the  voltage  delivered  to  the  photo- 
multiplier  tube  was  1,300  V. 10sec  lösec 
A 
(07 
L 
,6  -8 
g/ml.  Firefly  '  10-8  g/mI.  Stimulated  Firefly  Stimulated 
ATP  Extract  ATP  Muscle  Extract  Muscle 
Alone  Solution  Alone  Solution 
10  sec 
F- 
__j  B 
Firefly  Stimulated  Firefly  5x  10 
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Extract  Muscle  Extract  ATP 
Alone  Solution  Alone 
C 
Stimulated 
Muscle 
Solution 
2x  1Ö-7  Sample 
g/mi.  ATP  Removed  and 
Replaced Figure  37a. 
The  effect  of  graded  concentrations  of  ATP  solutions  when  perfused  through 
a  frog  heart.  Note  the  late  rate  increase  with  the  higher  concentrations  of  ATP. 
The  output  trace  is  irregular  due  to  a  fault  in  the  recording  mechanism. 
Figure  37b. 
A  recording  of  the  same  perfused  heart  as  in37a.  The  stimulated  muscle 
solution  has  :- 
1.  been  "bracketed"  between  solutions  of  ATP, 
2.  had  its  effect  modified  by  apyrase, 
3.  given  out  a  light  signal  from  firefly  extract  (inset). (a) 
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ATP  ATP  ATP  ATP  ATP  ATP -  76  - 
Figure  37b  is  a  recording  of  the  same  heart  as  in  37a.  The  effect  of  a 
stimulated  muscle  solution  has  been  "bracketed"  between  concentrations  of 
10-7  g/ml.  and  5x  10-8  g/m1ATP.  There  is  a  late  increase  in  the  heart  rate 
associated  with  the  test  solution,  but  not  with  the  matching  ATP  solutions 
(Figure  38  ).  This  phenomenon  has  been  noted  before  (Table  9  ).  After 
incubation  with  apyrase,  10 
7 
g/ml.  ATP  does  not  give  any  effect;  incubation 
of  the  stimulated  muscle  solution  with  apyrase  caused  a  modification  of  the  heart's 
reaction.  The  sharp  increase  in  blood  pressure  has  been  abolished,  but  the  increase 
-in 
heart  rate  persisted.  That  the  effect  has  not  been  abolished  completely  (see 
Figure  29  for  example)  is  probably  due  to  insufficient  time  for  incubation  (see 
7 
discussion  of  incubation  time  in  "apyrase"  section).  The  10  g/ml.  solution  of 
ATP-was  again  perfused  through  the  heart  in  order  to  establish  that  the  heart  still 
retained  its  sensitivity  to  ATP.  Apyrase,  1  mg/ml.,  incubated  with  frog  Ringer's 
solution  was  perfused  through  the  heart  12  minutes  later.  An  increase  in  heart 
rate  and  output  with  cardiac  irregularity  occurred.  This  again  was  probably  due 
to  insufficient  time  for  incubation. 
Figure  38  shows  an  enlargement  of  the  lower  left  quadrant  of  Figure  37b 
The  inset  shows  the  light  emission  from  firefly  tail  extract,  an  upward  deflection 
from  the  baseline  indicating  a  light  signal.  The  firefly  extract  alone  emitted  a 
small  steady  signal;  when  the  stimulated  muscle  solution  was  added  there  was  an 
increase  in  the  light  emission.  This  was  the  same  pooled  test  solution  as  that 
perfused  through  the  frog  heart  shown  in  this  figure.  When  a  concentration  of 
5x  10  -8 
g/ml.  ATP  was  added  to  another  sample  of  the  same  firefly  extract,  a 
similar  increase  in  the  light  signal  was  produced.  The  amplitude  control  of  the 
pen  recorder  was  increased  for  the  second  record,  but  there  is  a  proportionately 
similar  increase  in  the  light  signal  emitted  from  the  test  solution  and  ATP  solution 
than  that  emitted  from  the  extract  alone. 
The  nature  of  the  light  signal  would  suggest  that  the  light  was  being 
emitted  from  both  the  test  solution  and  the  ATP  solution  in  the  same  pattern  of Figure  38. 
An  enlargement  of  the  lower  left  quadrant  of  Figure  376.  The  frog  heart 
trace  "A"  shows  the  qualitative  similarity  of  the  effect  of  the  stimulated  muscle 
solution  to  the  effects  of  two  ATP  solutions.  With  the  stimulated  muscle  solution 
there  is  an  increase  in  the  heart  rate  approximately  2  minutes  later.  This  is  not 
seen  with  the  ATP  solutions. 
The  inset  "B"  shows  the  light  emission  when  the  same  stimulated  muscle 
solutions  and  a  solution  of  5x  10-8  g/mI.  ATP  are  placed  in  contact  with  firefly 
extract.  There  is  a  proportionately  similar  increase  in  the  light  signal  emitted 
from  the  test  solution  and  ATP  solution  than  that  emitted  from  the  extract  alone. Stimulated 
10  g/mI  muscle  5x10-8g/ml 
ATP  solution  ATP 
Marker--11-1-1  - 
ýI -77- 
scintillation. 
From  these  results  it  is  concluded  that  ATP  is  present  in  the  test  solution 
and  that  its  presence  is  the  cause  of  the  stimulatory  effect  on  the  frog  heart. 
0 
w 
I Figure  39. 
DIAGRAM  SUMMARIZING  THE  IDENTIFICATION  PROCEDURE  OF  THE 
STIMULATING  SUBSTANCE  RELEASED  FROM  ACTIVE  SARTORIUS 
MUSCLE 
Light  absorption  peak 
at  265  mu  suggested  a 
purine  structure 
Protein 
Solution,  in  which 
sartorius  muscle 
has  twitched, 
stimulated  the 
frog  heart 
Caused  light 
emission  from 
firefly  extract 
Se  Adenosine  triphosphate 
Column  stimulated  frog  heart  in 
a  similar  fashion  to  the 
test  solution 
Stimulatory  effect 
on  heart.  abolished 
by  enzyme  Apyrase 
Column  fractions 
3,4  &5  from  the 
test  solution 
stimulated  the 
frog  heart 
Caused  light 
emission  from 
firefly  extract 
Stimulatory  effect 
on  heart  abolished 
by  enzyme  Apyrase 
Column  fractions 
3,4  &5  from  an 
ATP  solution 
stimulated  the 
frog  heart -  78  - 
AN  ESTIMATE  OF  THE  AMOUNT  OF ATP  RELEASED  FROM  ACTIVE 
SARTORIUS  MUSCLE 
It  was  possible  to  match  the  stimulatory  effect  of  the  test  solutions  to  the 
effects  of  known  concentrations  of  ATP  on  the  some  frog  heart  using  the  initial 
positive  inotropic  effect  as  a  measure  of  the  concentration  of  ATP  in  the 
stimulated  muscle  solution  (Figures  28  &  29).. 
Results 
The  effects  of  13  test  solutions  were  approximately  matched  to  the  effects 
of  known  concentrations  of  ATP  on  13  frog  hearts.  Two  test  solutions  were  matched 
to  ATP  solutions  using  both  the  frog  heart  and  the  firefly  technique;  one  solution 
was  matched  using  the  firefly  technique  only.  (Table  10). 
The  mean  output  of  ATP  estimated  from  14  sartorius  muscles  was  just  less 
than  6x  10-7  g  (range  2x  10-6  g  -2x  10-8  g).  No  accurate  estimate  of  ATP 
output  per  gramme  of  muscle  tissue  can  be  given,  since  the  muscles  were  not 
weighed  beforehand,  but  a  fairly  constant  size  of  frog  was  used.  An  approximate 
value  can  be  calculated  from  the  weights  of  other  sartorii  weighed  later  in  this 
work.  The  average  wet  weight  was  50mg  and  certainly  all  muscles  used  did  not 
weigh  more  than  100mg;  if  the  lower  figure  is  taken,  the  output  of  ATP  per  gramme 
of  wet  muscle  is  12,  ug.  Since  about  30%  of  the  weight  of  these  muscles  is 
contributed  by  extracellular  fluid  (Dydynska  and  Wilkie,  1963),  the  output  of  ATP 
per  g  of  dry  muscle  is  17,  ug  (0.027jimole).  The  intracellular  amount  of  ATP  has 
been  estimated  at  2-  4}amole  per  gramme  of  dry  muscle  (Marechal,  1964)  so  that 
there  is  roughly  a  1%  loss  of  intracellular  ATP  into  the  solution  bathing  the 
sartorius  muscle. 
It  can  be  seen  from  Table  10  that  in  10  hearts  out  of  13  the  test  solution 
produced  an  increase  in  the  heart  rate.  This  rate  increase  usually  reached  peak 
value  2  minutes  after  the  initial,  sharp  stimulatory  effect.  In  six  hearts  out  of 
13  the  matching  ATP  solution  had  no  effect  on  the  heart  rate,  one  solution -  79  - 
actually  producing  a  fall  in  heart  rate.  In  only  two  cases  did  the  matching  ATP 
solution  produce  a  greater  rise  in  rate  than  that  caused  by  the  stimulated  muscle 
solution.  An  increase  in  the  heart  rate  occurring  two  minutes  after  the  perfusion 
can  be  produced  with  higher  concentrations  of  ATP  (Figure  37a).  However,  the 
concentrations  of  ATP  required  to  match  the  initial  stimulatory  effect  of  the  test 
solutions  did  not  usually  produce  the  rate  effect  caused  by  the  test  solutions.  It 
is  probable  that  the  test  solutions  contained  other  material  liberated  from  active 
skeletal  muscle  which  acted  on  the  conducting  tissues  of  the  heart  rather  than  on 
the  myocardium  itself. Table  10. 
MEASUREMENT  OF  THE  AMOUNT  OF  ATP  RELEASED  FROM  THE  SARTORIUS  MUSCLE 
Heart  %  Increase  in  Cardiac  Output  %  Increase  in  Heart  Rate 
1  test  solution  32  7 
2.5x107g/ml.  ATP  40  4 
2  test  solution  24  7 
10-6  g/ml.  ATP  30  - 
3  5x108g/ml.  ATP  27  - 
test  solution  36  20 
10-7  g/ml.  ATP  33  - 
(test  solution  was  equivalent  to  5x  10 
8 
g/mi.  ATP  using  firefly) 
4  test  solution  56  4 
5.  Ox  10-7  g1ml.  ATP  60  5 
5  test  solution  . 
45  12 
107g/ml.  ATP  35  - 
6  test  solution  12  - 
107g/ml.  ATP  15  -9 
7,  test  solution  25  - 
5.0  x  10-7  g/m  I.  22  - 
8  test  solution  11  24 
5.0x108g/ml.  ATP  11  - 
9  test  solution  18  10 
5.0x107g/ml.  ATP  21  24 
10  test  solution  35  15 
5.0x107g/ml.  ATP  30  10 
11  test  solution  28 
107g/ml.  ATP  36  - 
12  1Ö  g/ml.  ATP  33  3 
test  solution  36  8 
(pooled  two)  bracketed 
2.5x1Ö7g/mI.  ATP  49  8 
13  test  solution  18  15 
5.0x108g/ml.  ATP  30  3 
(test  solution  was  equivalent  to  10-8  g/ml.  ATP  using  firefly) 
14  test  solution  equivalent  to  2.0  x  10  g/ml.  ATP  using  firefly -  80  - 
THE  SOURCE  OF  ATP  RELEASED  FROM  SKELETAL  MUSCLE 
Accidental  Sources  of  ATP 
Adenine  nucleotide  material  has  been  shown  to  be  present  in  abundance 
intracellularly  (Glick,  1946).  The  ATP  released  from  skeletal  muscle,  described 
here,  could  have  many  sources.  Damaged  muscle  cells  could  release  significant 
amounts  of  ATP  into  a  surrounding  bathing  solution.  Distortion  and  rupture  of 
connective  tissue  cells  during  the  contraction  process  could  also  result  in  some 
efflux  of  intracellular  ATP  into  the  bathing  solution. 
Evidence  from  penetration  of  the  frog  muscle  cell  with  micro-electrodes  has 
shown  that  even  after  repeated  punctures  of  the  same  cell,  the  resting  membrane 
potential  remained  around  80  mV  (Ling  and  Gerard,  1949).  This  suggests  that 
the  membrane  seals  itself  off  in  some  way  after  the  removal  of  the  microelectrode. 
The  utmost  care  was  taken  in  the  dissection  of  the  sartorius  muscle  in  this  work  and 
in  every  case  the  muscle  was  carefully  washed  and  left  to  soak  in  a  "washing" 
solution  for  10  minutes  before  the  period  of  stimulation.  The  contents  of  any 
grossly  damaged  cell  would  presumably  be  completely  washed  out  during  this 
procedure. 
Another  argument  against  cellular  damage  as  a  cause  of  the  presence  of 
ATP  in  the  test  solution  can  be  made  by  citing  the  results  obtained  concerning  the 
potassium  efflux  from  the  sartorius  muscle.  Any  gross  cellular  damage  would  allow 
large  amounts  of  intracellular  potassium  to  pass  into  the  surrounding  bathing 
solution.  In  fact  no  obvious  rise  in  the  potassium  level  in  resting  muscle  solutions 
was  found.  The  average  increase  of  25%  in  potassium  in  the  stimulated  muscle 
solutions  is  consistent  with  the  normal  potassium  efflux  associated  with  the 
propagated  action  potential  (Hodgkin  and  Horowicz,  1959). 
Red  blood  corpuscles  are  known  to  have  high  concentrations  of  ATP  in  their 
surrounding  membranes(Whittam,  1960).  If  any  red  blood  corpuscles  were  not 
initially,  washed  out  and  became  haemolysed  during  the  period  of  stimulation, -  81  - 
ATP  might  be  detected  in  the  bathing  solution. 
The  only  argument  presented  here  against  the  source  of  the  ATP  being 
ruptured  envelopes  of  haemolysed  red  blood  corpuscles  is  that  the  careful  washing 
procedure,  coupled  with  a  virtually  bloodless  dissection,  left  no  obvious 
collections  of  RBCs  within  the  muscle  bundles.  After  the  period  of  stimulation 
the  bathing  solution  was  slightly  opaque  (presumably  due  to  the  output  of  protein 
from  the  muscle),  but  contained  no  obvious  collections  of  red  blood  corpuscles. 
The  Sarcoplasmic  Reticulum  as  a  Source  of  ATP 
It  is  proposed  here  that  the  source  for  the  ATP  released  from  the  sartorius 
muscle  is  the  transverse  tubular  system  of  the  sarcoplasmic  reticulum.  The  nature 
of  this  system  will  now  be  described  briefly. 
Observations  under  the  electron  microscope  (Bennett  and  Porter,  1953; 
Porter  1956;  Edwards,  Ruske,  Sonza-Santos  and  Vellejo-Freire  1956;  Porter 
and  Palade  1957)  have  revealed  the  presence  of  an  intricate  system  of  internal 
tubes  in  skeletal  muscle  fibres.  This  system  has  been  given  the  name  "sarcoplasmic 
reticulum". 
Several  investigators  have  suggested  that  this  reticulum  may  provide  a  rapid 
pathway  for  the  inward  spread  of  the  depolarization  wave  from  the  external 
membrane  during  electrical  excitation  of  the  musc  le  fibre. 
A  summary  of  the  anatomy  of  this  system  is  given  . 
in  Figure  40. 
H.  E.  Huxley  (1964)  and  S.  Page  (1964)  have  shown  in  elegant  electron 
microscopic  studies  that  the  central  element  (T-system)  of  the  triad  formation  in 
frog  muscle  fibres  is  accessible  to  particles  as  large  as  ferritin  and  colloidal  gold 
(diameters  110  Ao  and  200  A0  respectively,  Figures  41  &  42).  This  gave  the  first 
direct  evidence  of  continuity  between  the  lumen  of  the  triad  tubules  and  the 
extracellular  space  in  frog  skeletal  muscle. 
IEndo  (1966)  has  recently  investigated  the  properties  of  the  sarcotubular 
system  in  frog  skeletal  muscle.  He  found  that  various  fluorescent  dyes  could  diffuse  freely --  A 
ý_- 
Figure  40. 
The  system  consists  of  two  types  of  channel  which  do  not  communicate  directly 
with  each  other  or  with  the  main  part  of  the  muscle  sarcoplasm.  One  part  of  this 
system  has  the  form  of  narrow  channels,  200A  -  300A  in  diameter,  running  along- 
side  each  myofibril  for  nearly  all  of  its  length.  In  the  case  of  the  frog  sartorius 
muscle  these  channels  are  interrupted  at  the  level  of  the  Z  lines.  Opposite  the 
I  bands  the  narrow  channels  open  out  into  a  broader  terminal  region  of  about 
1,000A  in  width. 
The  other  part  of  the  reticulum  has  transversely-orientated  tubules  and  is 
termed  the  "T-system".  These  tubules  occur  at  the  level  of  the  Z  lines  in  frog 
sartorius  muscle  and  are  possibly  continuous  for  considerable  distances  across  the 
muscle  fibre. 
Where  the  terminal  regions  of  the  longitudinal  system  come  into  contact  with 
the  transverse  system,  a  structure  known  as  a  "triad"  is  formed.  Thus  a  triad 
consists  of  a  central  channel  (part  of  the  T-system)  flanked  on  either  side  by  the 
terminal  vesicles  of  the  longitudinal  system. t-4ý- 
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Figure  38. 
A  longitudinal  section  of  frog  sartorius  muscle  (x50,000)  which  had  soaked 
for  one  hour  in  a  ferritin  solution  before  fixation.  The  ferritin  has  only  penetrated 
the  T,  -system  of  the  sarcoplasmic  reticulum.  Note  the  relationship  of  the  T-system 
of  tubules  to  the  position  of  the  dark  Z  line. 
(Figures  38  and  39  reproduced  by  kind  permission  of  Professor  H.  E.  Huxley  and  the 
Editor  of  "Nature".  ) u-ä 
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A  higher  magnification  (x  145,000)  of  the  "triad"  structures  seen  in  the 
previous  figure.  The  granules  of  ferritin  molecules  are  clearly  seen  in  the  lumen 
of  the  transverse  tubules. 
Figure  42b. 
A  longitudinal  section  through  a  transverse  tubule  at  the  same  magnification. 
Portions  of  the  T-system  can  be  seen  leading  away  from  this  triad  structure. 
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(Figure  42a  and  42b  reproduced  by  kind  permission  of  Professor  H.  E.  Huxley  and  the  Editor  of  "Nature"). -  82  - 
into  and  out  of  a  periodically  arranged  system  of  tubules  which  were  situated  at 
the  level  of  the  Z  line.  He  concluded  that  the  dyes  have  some  access  to  a 
component  of  the  triad  system.  The  molecular  weight  of  the  dyes  used  was  of 
the  order  600,  yet  he  found  in  a  single  muscle  fibre  preparation  that  they  could 
diffuse  into  and  out  of  the  fibre  within  a  period  of  two  minutes.  By  studying  the 
flow  rate  of  these  dyes  into  the  fibre  he  concluded  that  most  of  the  resistance 
offered  by  the  tubule  to  the  dye  was  evenly  distributed  along  the  length  of  the 
tubule.  There  did  not  seem  to  be  any  obstruction  to  the  diffusion  of  the  dye  at 
the  entrance  of  the  tubule. 
Endo  estimated  that  the  size  of  the  space  into  which  the  dyes  were 
diffusingwas  1%-  2%  of  the  fibre  volume.  This  figure  lies  between  the  figure  of 
0.2%  calculated  for  the  volume  of  the  central  canal  of  the  triad  system  and  the 
figure  of  5%  calculated  for  the  whole  triad  system  (Page,  1964;  Peachey  1965). 
During  the  process  of  muscular  contraction  the  T-system  must  undergo  a 
reduction  in  its  lumen  volume.  As  clear  entry  and  exit  of  large  molecules  to  and 
from  this  system  has  been  demonstrated,  it  is  possible  that  the  nucleotides  are 
squeezed  out  of  the  T-system  into  the  extracellular  space  where  they  are  free  to 
diffuse  to  the  local  arterioles.  The  "pumping"  action  proposed  here  implies  that 
the  muscle  should  be  able  to  contract  and  relax  before  the  most  effective  release 
of  ATP  is  achieved.  The  findings  of  Hilton  (1962)  in  his  human  forearm  experiments 
seem  to  support  this  hypothesis.  No  ATP  was  found  in  the  perfusates  of  muscles 
which  were  not  allowed  to  contract,  but  in  the  experiment  where  they  were 
allowed  to  contract,  a  great  amount  of  ATP  was  detected.  This  large  amount 
probably  has  two  components;  that  amount  which  was  released  from  damaged 
tissue,  since  the  method  employed  two  needles  embedded  into  the  contracting 
muscle  belly,  and  the  "physiological"  amount  released  from  muscle  which  was 
being  allowed  to  contract,  and  hence  was  pumping  adenosine  triphosphate  out 
from  the  sarcotubular  system. 
Other  evidence  to  support  this  hypothesis  is  readily  available.  Many  workers -  83  - 
(Caspersson  and  Thorell,  1942;  Engstrom,  1944;  Perry,  1952;  Hill,  1959  -  1960) 
have  tried  to  display  a  special  site  for  ATP  within  the  muscle  cell  in  relation  to 
the  actin-myosin  complex. 
Caspersson  and  Thorell  (1942)  used  the  technique  of  photographing  living 
skeletal  muscle  from  various  species  under  an  ultraviolet  microscope.  The  wave- 
length  was  adjusted  to  257  mµ  so  that  the  high  specific  absorption  of  the  purine 
ring  would  outline  the  position  of  the  adenylic  acids. 
They  found  that  in  living  muscle  fibres  before  exercise  a  clear  picture  of 
sharply  differentiated  light  and  dark  bands  running  across  the  muscle  fibres  was 
obvious;  after  vigorous  exercise  the  living  muscle  fibre  showed  that  the  sharp 
differentiation  between  these  bands  was,  in  their  own  words,  "more  or  less 
smudged  out".  In  resting  muscle  fibres  they  found  that  the  substances  which 
strongly  absorbed  the  UV  light  were  most  concentrated  nearest  to  the  I  band  of 
the  sarcomere.  In  muscle  which  had  been  fatigued  from  exercise  they  found  that 
the  A  band  of  the  sarcomere  showed  extremely  fine  longitudinal  striations.  These 
appeared  most  clearly  nearest  to  the  I  band  and  diminished  in  clarity  towards  the 
m  iddle  of  the  A  band. 
They  felt  that  the  only  explanation  for  such  a  picture  was  that  the  strongly 
absorbing  material  located  near  the  I  band  had  travelled  towards  the  middle  of  the 
A  band  through  a  very  fine  series  of  longitudinal  channels.  However,  it  is 
proposed  here  that  the  material  was,  in  fact,  moving  in  the  other  direction,  that 
is,  from  the  A  band  into  the  I  band.  The  corollary  to'this  view  is  that  the 
adenine  nucleotides  are  synthesized  in  the  A  band  and  pass  along  the  longitudinal 
tubules  into  the  I  band.  At  this  stage  a  transfer  mechanism  for  the  nucleotides 
to  pass  from  the  longitudinal  system  to  the  T-system  must  be  presumed,  although  no 
connections  between  the  systems  have  yet  been  demonstrated. 
A.  Engstrom  (1944),  using  a  microincineration  technique  for  locating 
phosphates,  showed  that  the  high  UV  absorption  of  the  isotropic  band  coincided 
in  position  with  his  newly-found  source  of  phosphate  ash.  In  frog's  muscle  nearly -84- 
one  third  of  the  total  phosphorus  is  in  the  form  of  adenine  nucleotide,  so  it  is 
likely  that  Engstrom  had  outlined  one  situation  of  adenine  nucleotides  in  skeletal 
muscle.  S.  V.  Perry  (1952)  has  shown  that  about  10%  of  the  total  adenine 
nucleotide  in  rabbit  muscle  is  bound  to  the  myofibrils  and  can  only  be  freed  by 
acid.  The  other  90%  of  adenine  nucleotide  is  free  and  occupies  the  sarcoplasmic 
space. 
D.  K.  Hill  (1959)'  provided  yet  another  means  of  approaching  the  problem 
of  localization  of  nucleotides  in  skeletal  muscle.  Hill  developed  a  method  of 
incorporating  tritiated  adenine  into  frog's  skeletal  muscle.  He  showed  that  the 
labelled  material  inside  the  muscle  cell  was  largely  adenosine  triphosphate.  He 
was  able  to  obtain  autoradiograms  from  freeze-dried  and  fixed  specimens,  -,,  by 
staining  for  the  striations  at  the  same  time,  he  could  locate  more  accurately  the 
position  of  the  adenine  nucleotides  with  reference  to  the  sarcomere.  He  found 
that  about  70%  of  the  nucleotide  lay  within  the  I  band  of  the  sarcomere  and  he 
noted  one  surprising  feature;  this  nucleotide  seemed  to  have  "a  transverse  freedom 
of  movement  within  the  muscle  fibre".  He  put  forward  the  suggestion  that  the 
facility  for  this  transverse  diffusion  could  be  provided  by  the  sarcoplasmic, 
reticulum.  . 
Summary  and  Conclusions  - 
A  combined  survey  of  the  works  considered  above  reveals  the  following 
chain  of  evidence:  - 
(a)  Adenine  nucleotides  and,  according  to  D.  K.  HiII,  principally 
adenosine  triphosphate,  are  found  to  be  concentrated  at  a  certain 
part  of  the  sarcomere;  namely,  at  the  Z  line  in  the  isotropic  band. 
(b)  Also  lying  in  this  region  of  the  sarcomere  is  the  transverse  tubule 
system  of  the  sarcoplasmic  reticulum. 
(c)  The  "transverse  freedom  of  movement"  of  the  adenine 
nucleotide  material  described  by  Hill  in  the  region  of  the  Z  line 
correlates  with  the  experiments  of  H.  '  E.  '  Huxley,  S.  Page  and -85- 
M.  Endo  who  have  all  demonstrated  the  free  movement  of  large 
molecules  within  the  transverse  tubular  system.  These  molecules 
are  also  able  to  pass  freely  between  the  extracellular  space  and 
the  transverse  tubules. 
(d)  Caspersson  and  Thorell  noted  that  the  pattern  of  adenine 
nucleotide  material  in  the  muscle  fibres  changed  after  the  muscle 
had  been  exercised.  Whereas  before  exercise  the  nucleotides  were 
concentrated  in  the  I  bands,  after  exercising  the  muscle  they  found 
that  the  A  band  showed  exceedingly  fine  longitudinal  striations, 
which  became  clearer,  when  the  I  band  region  was  approached. 
They  concluded  that  the  material  had  moved  from  the  I  band 
through  a  series  of  fine,  longitudinal  channels  towards  the  middle 
of  the  A  band. 
To  the  above  list  of  experimental  findings  can  now  be  added  the  evidence  from 
the  present  work  that  ATP  is  released  from  an  active  frog  sartorius  muscle. 
Since  adenine  nucleotide  material  is  present  in  the  region  of  the  Z  line  and 
has  been  shown  to  have  the  transverse  mobility  by  D.  K.  Hill  (1960),  and  since  the 
T-system  of  the  sarcotubular  reticulum  lies  at  the  position  of  the  Zline,  it  does 
not  seem  unreasonable  to  assume  that  the  adenine  nucleotides  are  lying  in  the  T 
tubes.  There  does  not  seem  to  be  any  obstruction  to  the  extracelluar  space  from 
the  T-system,  so  that  any  ATP  lying  in  the  Týtubules  would  be  easily  "pumped" 
out  by  contracting  skeletal  muscle. -  86  - 
THE  EFFECT  OF  APYRASE  ON  THE  FROG  HEART  RESPONSE  TO  ACh 
In  order  to  assay  the  small  amount  of  ACh  released  from  sartorius  muscle 
on  the  frog  heart  preparation,  elimination  of  the  stimulatory  effect  is  essential. 
From  the  identification  procedures  used  to  establish  that  the  stimulatory  substance 
in  the  solution  bathing  the  muscle  is  adenosine  triphosphate,  it  appears  that  the 
most  convenient  way  of  eliminating  the  ATP  effect  on  the  frog  heart  from  the 
test  solution  is  by  incubating  it  with,  apyrase  for  15  minutes. 
The  effect  of  apyrase  on  the  sensitivity  of  the  frog  heart  to  ACh,  however, 
was  not  known,  and  therefore  the  following  experiment  was  designed. 
A  frog  heart  was  perfused  with  a  finely  graded  series  of  ACh  concentrations 
and  a  concentration-response  curve  was  obtained.  The  same  series  of  solutions 
of  ACh  was  then  incubated  in  a  waterbath  at  30°C  for  10  minutes  and  a 
concentration-response  relation  on  the  some  frog  heart  was  again  obtained.  A 
controlled  series  of  incubated  ACh  solutions  alone  were  perfused  through  the  frog 
heart  and  concentration  response  curves  were  obtained  for  the  cardiac  output  and 
heart  rate. 
Figure  43  shows  the  percentage  inhibition  of  the  cardiac  output  and  heart 
rate  for  the  normal  ACh  series,  the  ACh  series  incubated  with  apyrase  and  the 
incubated  ACh  control  series.  In  this  particular  heart  the  threshold  concentration 
of  ACh  was  2.5  x  10-9  g/ml.  This  minimal  concentration  required  to  inhibit  the 
heart  remained  the  some  in  the  incubated  control  series,  but  the  threshold 
concentration  required  to  inhibit  the  heart  after  the  solutions  of  ACh  had  been 
incubated  with  apyrase  was  markedly  raised  to  above  7.5  x  10-9  g/ml.  ACh. 
This  has  been  found  in  2  other  heart  experiments. 
Figure  44  shows  part  of  a  recording  of  a  perfused  frog  heart  showing  the 
effect  of  incubating  two  solutions  of  ACh  with  apyrase.  The  cardiac  output  is 
easily  seen  to  be  reduced  when  the  solutions  of  10 
$ 
g/ml.  and  1.5  x  10-$  g/ml. 
of  ACh  after  incubation  with  apyrase  are  perfused  through  the  heart.  The  effect Figure  43. 
The  effect  of  apyrase  and  incubation  on  the  frog  heart's  sensitivity  to  ACh. 
(a)  The  percentage  output  inhibition  (ordinate)  is  plotted  against  the 
concentration  of  ACh  applied  to  the  heart  (abscissa). 
(b)  The  percentage  rate  inhibition  (ordinate)  is  plotted  against  the 
concentration  of  ACh  applied  to  the  same  heart  (abscissa). 
Note  that  the  response  of  the  heart  falls  when  ACh  which  has  been 
incubated  with  apyrase  is  perfused  through  the  heart.  This  effect  could  be  due  to 
(1)  destruction  of  ACh  by  apyrase 
(2)  alteration  of  the  sensitivity  of  the  myocardium  by  the  apyrase  in 
the  perfusate. 
It  is  likely  that  an  ATP-ase  such  as  apyrase  will  depress  the  sensitivity  of 
active  tissue  such  as  myocardium. Effect  of  Apyrase  and  Incubation  on  Heart  sensitivity  to  Ach. 
"b  Output  inhibition 
"-  Ach.  series  Incubated  with  Apyrase 
o-  Incubated  Ach.  series 
80" 
+.  Normal  Ach  series 
70" 
(a) 
+ 
I 
25=  50  7.5*  1.5- 
i  I! 
ý 
1Ü*  10,96°  i  ICs  1Ö10 
10'  los 
Effect  of  Apyrase  and  Incubation  on  Heart  sensitivity  to  Ach. 
"N  Rate  inhibition 
100"b 
90"/. 
"-  Ach  series  Incubated  with  Apyrase 
80"b 
°-  Incubated  Ach  series 
+-  Normal  Ach  series 
60% 
(b)  50% 
40"l. 
30%- 
20%- 
10%- 
}5M  i  }i3M 
1ßO  16' 
icr' s4-  N 
N0NV° 
O 
2-0  °Q 
.C 
o  äö  _V  o 
E  °  X o_  yE  <  NUö 
s  -3  ö}°  öco  0ON 
}  .  os 
3  '^  Op-0  0U  3 
^< 
-c 
C:  `  " 
-p 
4i 
0ä 
o  V 
sO 
"c 
o  0-8 
g:  8  cc  3 
OC  `~  C 
c 
N 
cm.  -  t-  0 
3°  "-  c°  ° 
oE2ö 
_ 
0  -0 
0  -  RA  :t 
° 
V 
C  Co 
z»  D  c}  o  ýp  tc 
xc 
N 
O 
-ö0ö 
o 
^  V 
YY/ 
os  Uv 
H  o  °s  '`  ý  :c  a  Ö 
s 
U 
. 
ä 
. 
pc  EO  22  Q1  O  Q  Z 
o  Co  sV°} 
OO  o  a  ~ 
U  OC  j 
00-  c-0 
t  Lpv  sC 
- 
ps 
a- 
<0uQo 
o 
°  ö  4-  } 
C  "  -  O 
- 
C 
-j 
,O 
nE  0°0  °) 
u 
^  N  Tr  C) 
t  O  Op  °'  o  ö  c-c 
o  - 
s 
0c' 
3  °0D 
FECc  ýA  LC 
Z 
pOC  4º 
sc  D-3 
am  c 
&-  0  -0  0 
0  O  V- 
..  V  i30Z0 -1 
-9b 
Mý 
W 
A- 
ii 
x 
LP 
aý 
ä 
e 
id 
uý 
II  'I 
it 
I 
1 
11 
Ill  1 
TiF 
4111  H.  T;  Ill  IT 
illilY  PIT! 
fill  11 
I  T! 
wM 
I 
l 
lll 
Pit 
ill 
I 
Hill,  Hill!  fill  Ill  I 
. 
Hill  if 
MM 
I 
8 
I 
it  ii 
II 
I 
T 
a 
I"a  to  sto 
'if  1 
F  T7 
so 
'  "I 
TI  TT  1;;  1 
. 
N  "ý  tN 
42;  O  SO  4  0  30  20  010  0  80  60  2  0.  0'  40  20  10  0 
I  IT! 
1-loo  A 
Tj  ilt 
Tljý  Tilt  ;lI 
1,  kill 
I I.  'o 
'I  c 
I  c  Wild  1  1, 
aS  L 
4ý  ýE 
ý  gýE 
`ý 
c 
`EII  tý  I  ý,  ý  v  '  er 
Q- 
C- 
w"qý 
c= 
0ý 
i 
iý 
f"ý 
C= 
fý;  0  y -  87  - 
of  these  solutions  of  ACh  when  incubation  alone  takes  place  are  seen  to  be  the 
same  as  the  normal  series. 
Discussion 
The  three  experiments  on  the  frog  heart  response  to  ACh  were  all  performed  on 
frog  hearts  which  were  very  insensitive  to  the  action  of  ACh.  However  the  apyrase 
does  seem  to  depress  the  response  of  the  frog  heart  to  ACh  quite  substantially, 
even  in  these  insensitive  hearts.  This  suggests  that  the  effects  of  incubating 
smaller  amounts  of  ACh  with  apyrase  would  be  more  profound  and  a  great  deal 
of  the  advantage  of  using  a  sensitive  preparation  to  ACh  is  wasted.  So  the 
problem  of  assaying  ACh  released  from  the  frog  sartorius  muscle  on  the  frog  heart 
is  for  from  being  solved. 
It  is  to  be  noted  here  that  incubation  of  pure  ACh  solutions  at  30°C  for  10 
minutes  surprisingly  does  not  cause  hydrolysis  of  ACh.  Diluted  solutions  of  ACh 
have  been  regarded  in  the  past  as  being  very  unstable,  but  this  view  has  to  be 
modified  in  the  light  of  these  findings. PART  II 
THE  ASSAY  OF  ACETYLCHOLINE  RELEASED  FROM 
THE  NEUROMUSCULAR  JUNCTION THE  ISOMETRIC  ' 
LEECH  MUSCLE  STRIP 
AS  AN  ASSAY  PREPARATION- 
FOR  ACETYLCHOLINE 
-ýý -  88  - 
INTRODUCTION 
The,  Pharmacology  of  Leech  Muscle 
In  1918  Fuehner  introduced  the  leech  (Hirudo  medicinalis)  as  a  suitable 
bio-assay  object  for  the  estimation  of  physostigmine  (eserine).  The  complementary 
actions  of  acetylcholine  and  eserine  enabled  the  eserine  tobe  estimated  in  small 
quantities  in  the  presence  of  acetylcholine. 
Minz  (1932)  used  the  leech  muscle  to  estimate  small  quantities  of 
acetylcholine.  Again  the  sensitivity  of  the  muscle  was  increased  by  having  the 
eserine  present. 
Feldberg  and  Krayer  (1933)  showed  that  the  anterior  part  of  the  body  wall 
musculature  was  2  to  4  times  as  sensitive  to  acetylcholine  as  the  posterior  body 
wall  musculature,  in  the  presence  of  eserine. 
All  of  the  above  investigations  emphasized  the  difficulties  encountered  with 
spontaneous  contractions  of  the  preparation  and  even  in  cases  where  spontaneous 
activity  was  at  a  minimum,  the  problem  of  adequate,  if  not  complete,  relaxation 
between  tests  was  never  really  solved.  The  concentrations  of  eserine  required, 
together  with  an  apparent  seasonal  variation  to  eserine,  seemed  to  raise  further 
difficulties.  For  instance  Feldberg  and  Krayer  noted  that  in  December  and 
January  a  concentration  of  5x  10 
6 
g/ml.  eserine  was  "without  influence"  on  the 
muscle,  but  in  February  and  March  this  same  concentration  of  eserine  produced 
powerful  contractions  so  that  they  had  to  dilute  the  eserine  to  5x  10 
7g 
ml.  in 
order  to  obviate  this  spontaneous  activity.  Minz  noticed  that  from  November  to 
March  varying  concentrations  of  eserine  (5  x  10-6  g/ml.  to  5x  10 
7 
g/ml)  only 
caused  a  slight  and  gradual  increase  in  tone.  He  allowed  the  eserine  to  exert  this 
effect  and  found  it  satisfactory'towork  on  top  of  this  arbitrary  baseline. 
Variations  in  the  dissection  of  the  leech  also  seemed  to  alter  the  experimental 
conditions.  Fuehner  (1918)  showed  that  if  the  ventral  wall  of  the  leech  was  not 
removed,  thus  leaving  the  main  chain  of  nervous  tissue,  small  spontaneous 
0 -  89  - 
contractions  are  likely.  Probably  for  the  same  reason  Minz  advised  against  the 
use  of  a  tube  of  muscle,  that  is,  simply  a  section  taken  from  the  middle  of  the 
body,  the  anterior  and  posterior  suckers  being  removed.  Minz  also  noted  that 
An  these  preparations  spontaneous  activity  was  initiated  by  slight  mechical 
stimulation,  even  when  changing  the  solutions. 
The  use  of  the  isotonic  preparation  of  the  leech  for  ACh  assay  became 
widespread  after  the  realization  that  ACh  was  a  chemical  transmitter  at 
neuronal  and  myo-neuronal  junctions;  but  Macintosh  and  Perry  in  "Methods 
in  Medical  research"  (1951)  remark  that  the  leech  muscle  strip  is  "a  valuable 
object  for  the  identification  of  ACh  and  for  rouch  quantitative  work  where 
, 
high  sensitivity  is  required.  Intolerably  slow  when  many  samples  must  be 
tested"  . 
The  problem  of  quicker  and  more  consistent  relaxation  was  approached  in 
one  way  by  M.  F.  Murnaghan  in  1958.  He  investigated  the  influence  of 
morphine  on  the  relaxation  of  the  eserinized  leech.  Paton  et  al.  had  shown  in 
-1957  that  the  addition  of  morphine  to  the  electrically  stimulated  guinea-pig 
,  ileum  had  the  effect  of  decreasing  the  output  of  ACh.  -  Mumaghan  found  that 
,a  specific  concentration  of  morphine  was  necessary  to:  - 
1.  facilitate  relaxation  and 
2.  have  no  appreciable  effect  on  the  sensitivity  of  the  muscle 
to  ACh  in  the  presence  of  eserine. 
Again  an  isotonic  system  was  used. 
In  1961  Szerb  devised  the  micro-leech  preparation  using  a  tiny  strip  of 
the  anterior  dorsal  muscle  and  testing  it  in  a  bath  of  volume  0.05  ml.  He  found 
that  with  an  isotonic  lever  system  undiluted  Locke's  solution  caused  fast 
spontaneous  movements.  However,  when  the  muscle  strip  was  mounted 
isometrically  after  the  optimum  tension  had  been  found  isotonically,  quicker 
relaxation  and  a  steady  baseline  were  obtained. -90- 
ýý. 
Anatomy  and  Physiology  of  Leech  Muscle 
The  structure  of  the  leech  muscle  (Hirudo  medicinalis)  has  recently  attracted 
the  attention  of  electron  microscopists  and  many  interesting  details  have  been 
brought  to  light  by  their  investigations. 
The  light  microscopy  of  the  muscle  fibres  of  worms  was  described  as  `early"  as 
1891  by  Apathy.  However,  most  of  his  observations  were  carried  out  on  Ascaris, 
only  a  few  results  from  Hirudo  were  obtained. 
The  muscle  fibre  of  Hirudo  represents  a  special  type  of  muscle.  Sometimes, 
it  is  difficult  to  make  a  clear,  distinction  between  smooth  and  striated  muscle. 
The  locomotory  muscles  in  annelids  are  designated  "helical  smooth",  showing  some 
features  of  both  smooth  and  straited  muscle.  In  leeches  all  muscles  appear  to  be 
of  this  type  (Mann,  1962). 
The  muscle  coat  consists  of  a  circular,  an  oblique  and  an  innermost 
longitudinal  layer.  The  longitudinal  fibres  are  very  long,  10  cros  up  to  20  cms, 
have  a  helical  course  around  the  fibre  axis,  have  a  high  degree  of  contractility 
and  are  rapid  in  action.  A  speed  of  two  contractions  per  second  has  been 
recorded  from  them.  Schwab  (1949)  states  that  the  individual  muscle  cells  have 
an  extension  of  5-  15  mm.  The  degree  of  shortening  is  said  to  range  from  80% 
as  a  maximum  to  50%  in  the  normal  ambulating  leech. 
When  the  muscle  is  viewed  under  the  low  power  of  a  light  microscope  the 
transverse  section  shows  large  collections  of  hollow  cells  which  are  compressed 
together  (Figure  45).  Each  cell  consists  of  a  cortex  of  the  contractile  element 
which  surrounds  the  sarcoplasmic  core  in  which  are  situated  the  nucleus  and  many 
mitochondria.  The  diameter  of  the  cells  in  a  transverse  section  can  vary  from 
I-  20  microns.  This  has  been  taken  to  indicate  that  the  very  long  cell  is  a 
tapering  one.  The  contractile  cortex  contains  longitudinal  myofilaments.  These 
are  arranged  into  discrete  bundles  which  are  seen  to  have  a  radial  formation  in 
the  transverse  section.  Also  present  in  the  transverse  section  are  the  so-called 
"cross  filaments"  so  clearly  demarcated  in  the  electron  micrographs  of  Röhlich Figure  45. 
(a)  Transverse  section  of  leech  muscle  strip  (X  120)  showing  large 
collections  of  hollow  muscle  cells  which  are  compressed  together.  The  pigmented 
cells  seen  at  the  lower  left  of  the  picture  are  cells  bordering  the  gut  which  take  up 
ingested  red  blood  corpuscles. 
(b)  The  lower  half  of  the  picture  shows  a  longitudinal  section  of  the  hollow 
muscle  cells  lying  just  under  the  epithelium  (X  300).  In  2  cells  the  central  nucleus 
can  be  seen  laying  in  the  clear  lymph  space  within  the  cell. 
The  lower  half  shows  a  collection  of  glandular  cells  used  for  lubricating 
the  leech  epithelium. 
Stain  :  methyleneblue. 
(Section  cut  and  stained  by  the  Histology  division,  physiology  Department, 
University  of  Glasgow). 
100»  (b)  loop  (a) -  91  - 
(1962).  These  elements  are  thought  to  have  either  the  function  of  being  supportive 
tissues  or  of  being  active  contractile  parts  which  serve  to  prevent  excessive 
thickening  of  the  fibre  during  its  longitudinal  shortening. 
Pucci  and  Afzelius  (1962)  have  displayed  an  orderly  sarcotubular  system  in 
5  leech  species.  This  system  seems  to  have  a  close  connection  with  the  cell 
membrane  or  sarcolemma. 
Thus  the  leech  musculature  used  for  the  assay  of  acetylcholine  is  an  advanced 
and  highly  organised  piece  of  tissue  with  the  reputation  of  exhibiting  some  specificity 
towards  acetylcholine  in  the  presence  of  eserine  without  obvious  interference  from 
other  substances(Maclntosh  and  Perry,  1951). -  92  - 
RESULTS 
When  the  leech  muscle  strip  was  mounted  isometrically  it  developed  tension 
as  soon  as  a  suitable  concentration  of  ACh  was  applied.  It  was  possible  to  allow 
ACh  solutions  to  act  for  as  little  as  45  seconds  on  the  muscle  strip  and  yet  obtain 
step-wise  responses  to  graded  concentrations  of  ACh.  Figure  46  shows  the  result 
of  allowing  each  solution  of  ACh  to  remain  in  contact  with  the  muscle  until  the 
maximum  tension  had  been  achieved.  Note  the  immediate  development  of 
tension  as  soon  as  the  ACh  solution  was  applied  to  the  muscle  at  zero  time.  The 
record  was  obtained  by  superimposing  the  records  of  5  responses  of  the  same  leech 
muscle  strip  to  concentrations  of  ACh  ranging  from  10 
9g/ml. 
to  10 
8g/ml. 
In 
each  case  the  records  of  developing  tension  are  well  separated,  so  that 
discrimination  between  each  response  to  a  differing  concentration  of  ACh  is  quite 
clear,  regardless  of  the  time  allowed  for  each  solution  to  be  in-contact  with  the 
muscle  strip.  After  a  period  of  45  seconds  the  records  are  well  separated.  Test 
solutions  were  drained  from  the  bath  at  this  point  and  the  tension  of  the  muscle 
strip  was  equated  with  the  concentration  of  ACh  applied.  The  effect  of  the  ACh 
on  the  leech  muscle  could  thus  be  obtained  in  45  seconds,  and,  with  the  lower 
concentrations  of  ACh,  couId  bewashed  out  in  just  as  short  a  time.  So  it  was 
possible  to  obtain  a  concentration-response  relationship  of  a  leech  muscle  strip 
to  ACh  very  rapidly.  Figure  47  shows  the  response  of  2  leech  muscle  strips  to 
graded  concentrations  of  ACh.  The  effect  of  each  test  solution  is  preceded  by  a 
bizarre,  but  constant,  increment  in  tension;  this  is  due  to  the  leech  muscle  strip 
lying  up  against  the  side  of  the  bath  momentarily  just  before  the  test  solution  of 
ACh  is  applied.  After  allowing  the  test  solution  to  remain  in  contact  with  the 
leech  muscle  for  45  seconds,  the  pen  recorder  motor  is  stopped  and  the  test 
solution  drained  from  the  bath.  Thereafter  the  leech  muscle  is  thoroughly  rinsed 
with  leech  solution  until  the  original  baseline  tension  is  obtained.  A  concentration- 
response  curve  is  then  obtained  by  plotting  the  tension  developed  by  the  muscle '0 
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Concentration  response  curves  of  a  single  leech  muscle  preparation  which 
was  kept  in  the  bath  of  leech  Ringer's  solution  for  24  hours,  hr  =  hours.  Con- 
centration  response  curves  to  acetylcholine  are  plotted  at  0,2  and  24  hours. 
Note  that  the  threshold  sensitivity  is  unaltered,  as  is  the  general  shape  of  the 
response  curve  after  24  hours. 3.8 
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Figure  49. 
Histogram  showing  seasonal  incidence  of  high  sensitivity  of  leech  muscle 
strips  to  ACh.  The  number  of  muscle  strips  tested  in  each  month  is  shown  at  the 
base  of  each  column.  The  total  height  of  each  column  indicates  the  percentage 
out  of  this  number  responding  to  10 
10 
g/ml.  ACh  or  lower  concentrations.  The 
height  of  the  stippled  columns  represent  the  percentage  sensitive  to  10 
11 
g/ml. 
ACh. 
Jan  Feb  Mar  Apr  May  June  July  Aug  Sept  Oct  Nov  Dec strip  after  45  seconds  against  the  concentration  of  ACh  producing  that  tension. 
It  was  found  that  the  sensitivity  of  the  leech  muscle  to  ACh  remained  constant 
over  many  hours,  and  it  is  to  be  noted  that  no  oxygenation  of  the  leech-Ringer's 
solution  was  necessary.  Figure  48  shows  concentration  response  curves  obtained 
from  a  single  leech  muicle  preparation  at  0,2  and  24  hours  and  the  concentration- 
response  curve  retains  its  original  shape,  which  makes  the  leech  muscle  strip  a 
useful  bioassay  object  for  ACh  during  any  prolonged  assay  experiment. 
Fifty  leech  muscle  strips  were  used  to  obtain  initial  and  "24  hour" 
concentration-response  curves.  Twenty-five  muscles  retained  their  sensitivity, 
8  of  these  actually  becoming  more  sensitive  after  24  hours.  The  other  25  muscles 
became  less  sensitive  after  24  hours;  the  greatest  loss  in  threshold  sensitivity  was 
from  10-11  g/ml.  ACh  to  10-9  g/ml.  ACh.  4 
Seasonal  Sensitivity 
Earlier  investigators  (Minz,  1932;  Feldberg  and  Krayer,  1933)  had  noticed 
a  seasonal  variation  to  the  anticholinesterase,  eserine.  It  was  possible  that  a 
seasonal  variation  to  ACh  might  also  exist. 
. 
One  hundred  and  seventy  leech  muscle  strips  from  separate  leeches  had  their 
response  to  threshold  concentrations  of  ACh  determined  in  the  presence  of  10-5  g/ml. 
eserine  over  the  period  July,  1964  to  December,  1966.  The  responses  of  muscles 
in  1964  were  measured  isotonically  using  a  Gimbal  lever  and  a  smoked  drum; 
all  other  muscles  had  their  responses  measured  isometrically..  Figure  49  shows 
the  variation  of  the  response  to  threshold  concentrations  of  ACh  for  each  month 
of  the  year.  An  incidence  of  low  sensitivity  appears  in  May  and  June,  whereupon 
the  sensitivity  appears  to  increase  gradually,  reaching  a  peak  in  November  and 
December,  then  dropping  sharply  again  in  the  period  February  and  March. 
The  Action  of  Morphine  on  the  Leech  Muscle  Strip 
The  method  of  relaxing  the  leech  muscle  with  the  use  of  morphine,  as 
advocated  by  Murnaghan  (1958),  prompted  the  initiation  of  some  experiments 
designed  to  study  the  action  of  ACh  and  morphine  on  leech  muscle. Murnaghan  cites  the  work  of  Paton  et  al.  (1957)  who  showed  that  morphine 
had  the  effect  of  depressing  the  output  of  ACh  in  guinea-pig  ileum.  The  rationale 
behind  Murnaghan's  original  method  for  relaxing  leech  muscle  was  presumably  that 
some  form  of  constant"intrinsic"  production  of  ACh  was  responsible  for  the  main- 
tenance  of  the  leech  muscle  tone;  . 
if  this  intrinsic  production  of  ACh  is  depressdd 
by  morphine,  the  muscle  will  lose  its  tone  and  relaxation  will  occur.  This  whole 
procedure,  of  course,  was  directed  at  facilitating  the  management  of  an  ISOTONIC 
system. 
When  the  leech  muscle  strip  was  prepared  for  an  assay  procedure  by  soaking 
in  morphine  solutions  (see  Methods),  it  was  noted  that  in  every  case  the  muscle 
had  almost  completely  relaxed  when  set  at  a  constant  length  in  the  bath.  In  three 
experiments  the  leech  muscle  was  set  up  in  the  bath  and  a  morphine  solution  was 
applied  to  the  muscle  in  the  presence  of  eserine.  The  alteration,  in  tension  was 
then  continuously  recorded.  Figure,  50  (lower  trace)  shows  the  effect  of  applying 
a  solution  of  5x  10-5  g/ml.  morphine  in  leech  Ringer's  solution  to  a  muscle  strip 
which  had  a  resting  tension  of  1.5  grammes.  The  tension  fell  to  0.5  grammes  two 
minutes  after  the  application  of  the  morphine  solution.  This  rate  of  tension  fall  was 
similar  to  that  found  in  the  other  two  experiments. 
Muscle  strips  which  had  been  left  to  soak  overnight  were  found  to  have 
relaxed  considerably  and  did  not  relax  further  when  morphine  solutions  were  applied 
to  them. 
The  Effect  of  Curare  on  the  Leech  Muscle  Strip 
Curare  selectively  blocks  the  action  of  ACh  on  leech  muscle  (Dale  et  al., 
1936).  This  blocking  action  of.  d-tubocurarine,  was  used  in  the  present  work  to 
identify  ACh  contained  in  test  solutions  obtained  from  active  and  resting  rat 
skeletal  muscle.  A  study  was  made  of  the  action  of  curare  alone  on  the  leech 
muscle  strip. 
In  every  experiment  used  to  assay  test  solutions  obtained  from  rat  hemidiaphragm 
muscles,  curare  was  applied  to  the  leech  muscle  strip  to  establish  that  the  action  of -  95  - 
test  solutions  was.  due  to  the  presence  of  ACh.  In  each  case  the  leech  muscle  was 
observed  to  relax  quickly  after  the  application  of  curare. 
Figure  51  shows  a  continuous  recording  of  the  tension  produced  by  a  leech 
muscle  strip  which  had  been  soaked  in  eserinized  leech  Ringer's  solution  overnight. 
Increasing  concentrations  of  ACh  from  10 
10 
g/ml.  to  10-$  g/ml.  cause  a  steady 
rise  in  the  muscle  tension  in  spite  of  vigorous  washing  between  doses.  The  tension 
rose  from  1.2  grammes  to  2.2  grammes.  When  a  solution  of  10-5  g/ml.  curare  was 
put  into  the  bath  the  tension  of  the  leech  muscle  strip  fell  from  2  grammes  to  1 
gramme  in  a  period  of  two  minutes. 
In  Figure  50  (lower  trace,  last  test)  the  application  of  curare  to  another 
leech  muscle  strip  shows  the  some  rate  in  fall  of  tension:  a  fall  of  1  gramme  over 
a  period  of  two  minutes. 
An  unexplained  finding  occurred  with  two  muscle  strips;  after  soaking  the 
muscle  overnight  in  eserinized  Ringer's  solution,  the  application  of  curare  did  not 
block  the  action  of  ACh. 
The  Comparison  of  the  Action  of  Morphine  and  Curare  on  a  Single  Leech  Muscle 
Strip. 
In  one  experiment  the  action  of  morphine  and  curare  was  compared  on  the 
some  leech  muscle  strip.  In  this  case  the  relaxation  caused  by  morphine 
proceeded  at  the  some  rate  as  that  caused  by  curare.  It  had  already  been  noted 
that  after  a  muscle  strip  had  been  allowed  to  soak  overnight  and  had  reached  a 
low  level  of  tension,  the  application  of  curare  or  morphine  did  not  promote  further 
relaxation. 
Figure  50  shows  a  continous  recording  of  the  tension  developed  by  a  leech 
muscle  strip  which  had  an  initial  low  tension.  With  the  baseline  steadily  rising, 
a  series  of  responses  to  graded  concentrations  of  ACh  was  initiated.  After  a 
concentration  of  10 
8 
g/ml.  ACh  was  put  into  the  bath  and  its  effect  seen  and 
washed  out,  the  leech  muscle  strip  started  to  develop  a  steadily  increasing  tension. 
This  tension,  reached  a  constant  value  as  seen  in  the  lower  trace.  After  a L  d)  OC  " 
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satisfactory  control  with  leech  Ringer's  solution,  morphine  in  a  concentration  of 
5x  10-5  g/ml.  was  put  into  the  bath.  This  caused  the  expected  rapid  fall  in 
tension.  After  two  minutes  the  morphine  was  drained  out  of  the  bath  and  the 
muscle  strip  was  washed  and  then  soaked  in  Ringer's  solution  for  15  minutes. 
During  this  time  the  muscle  strip  regained  most  of  its  original  tension.  After  a 
satisfactory  control,  a  solution  of  10 
5 
g/ml.  d-tubocurarine  was  put  into  the 
bath.  This  caused  a  similar  fall  in  the  tension  of  the  leech  musclestrip  to  that 
seen  with  the  morphine  solution,  i.  e.  a  loss  of  1  gramme  of  tension  in*a  period 
of  two  minutes. -  97  - 
DISCUSSION 
It  was  found  that  the  leech  muscle  strip  showed  two  types  of  contraction 
(expressed  by  development  of  tension);  a  "quick"  type  which  is  always  produced 
by  a  concentration  of  ACh  well  above  the  amount  causing  a  threshold  response  in 
the  leech  muscle,  and  a  second  type  of  slow,  steady  contraction,  not  obviously 
initiated  by  any  ACh  applied  to  the  muscle  strip.  The  quick  type  of  contraction 
could  produce  an  increase  in  tension  of  1  gramme  in  less  than  30  seconds,  while  the 
slow  contraction  produced  a  tension  of  no  more  than  100  milligrammes  in  1  minute. 
It  was  found  that  a  perfectly  satisfactory  response  curve  could  be  achieved 
in  spite  of  the  simultaneous  occurrence  of  a  slow  contraction  (or  a  steady  increase 
in  "tone");  the  slow  contraction  did  not  seem  to  have  any  effect  on  the  response 
of  the  leech  muscle  to  concentrations  of  ACh  well  above  the  amount  causing  a 
threshold  response,  as  manifested  by  the  quick  type  of  contraction.  Thus  any 
assay  can  be  confidently  undertaken  on  an  isometric  leech  muscle  preparation  even 
when  the  baseline  is  not  a  horizontal  one. 
The  interpretation  of  the  response  of  the  leech  muscle  to  "threshold" 
concentrations  of  ACh  has  proved  throughout  this  work  to  be  difficult  (Figure  47). 
In  some  cases  the  first  sola  ion  of  ACh  applied  to  the  muscle  produced  an  increase 
in  tension  which  was  extremely  difficult  to  wash  out.  Occasionally  it  was 
impossible  to  restore  the  original  tension  of  the  muscle  strip  (Figure  48).  The  rate 
of  increase  in  tension  was  equivalent  to  that  of  the  slow  contraction  and  it  seemed 
that  the  initial  small  dose  of  ACh  applied  to  the  muscle  strip  could  set  off  a  slow 
type  of  contraction  which  was  unaffected  by  immediate  and  prolonged  washing. 
This  effect  could  be  misinterpreted  and  taken  to  mean  that  a  quick  contraction  had 
been  initiated  by  a  very  small  concentration  of  ACh  (see  the  effect  of  10-11  g/mI. 
ACh  in  Figure  50  . 
However  the  effect  of  a  quick  contraction  is  easily  and  rapidly 
washed  out. 
The  response  of  the  leech  muscle  to  the  drugs  curare  and  morphine  has  suggested -  98  - 
the  following  theoretical  scheme  for  the  behaviour  of  the  leech  muscle  in  the 
presence  of  ACh  when  low  concentrations  of  ACh  are  applied. 
A  "store"  of  ACh  is  postulated.  The  nature  and  situation  of  this  store  need 
not  be  discussed  at  this  stage,  but  the  main  reason  for  this  postulate  is  that  there 
seems  to  be  a  constant  source  of  ACh  within  the  muscle  which  is  available  to 
maintain  the  muscle  tonus.  This  ACh  will  be  termed  "intrinsic"  as  opposed  to 
"extrinsic"  ACh  applied  to  the  outside  of  the  muscle.  In  order  to  diminish  or 
abolish  muscle  tone,  either  the  synthesis  of  intrinsic  ACh  can  be  blocked  by 
morphine,  or  its  peripheral  action  on  the  muscle  fibre  can  be  blocked  by  curare 
(Figure  52). 
Extrinsic  ACh  can  take  two  pathways.  It  can  pass  into  the  ACh  store  if  the 
store  is  deficient,  or  it  can  pass  directly  to  the  muscle  fibre  and  cause  a  quick 
contraction;  or  it  can  pass  along  both  pathways,  contributing  to  the  store  of 
intrinsic  ACh  and  causing  a  quick  contraction  of  the  leech  muscle  fibre. 
In  a  muscle  which  has  fully  repleted  stores  of  ACh,  all,  or  nearly  all,  of  the 
extrinsic  ACh  contributes  to  the  quick  contraction  of  the  leech  muscle  (Figure 
On  the  other  hand,  if  extrinsic  ACh  is  applied  toa.  leech  muscle  with  greatly  dim  in)  shed 
stores,  then  all,  or  nearly  all,  of  it  will  contribute  to  the  replenishment  of  these 
stores  (Figure  52)  ;  if  the  concentration  of  ACh  applied  is  a  small  one,  then  only 
after  the  stores  have  been  repleted  will  a  quick  contraction  be  produced.  If  the 
amount  of  extrinsic  ACh  is  large,  only  a  certain  amount  of  it  can  be  utilized  by 
the  stores,  the  remainder  "spills  over"  causing  a  quick  contraction  of  the  muscle 
fibres.  This  should  be  taken  as  the  true  response  to  threshold  concentration  of 
acetylcholine  of  that  particular  leech  muscle  strip.  From  this  point  onwards  the 
stores  are  slowly  incorporating  applied  extrinsic  ACh.  '`-  The  baseline  may 
indicate  that  the  muscle  tone  is  still  gradually  rising,  but  the  increasing  doses  of 
extrinsic  acetylcholine  are  now  producing  a  graduated  series  of  quick  contractions, 
thus  giving  rise  to  a  satisfactory  concentration-response  relationship. 
In  an  isotonic  system  where  a  muscle  strip  has  been  allowed  to  contract  fully, A  Leech  muscle 
fibre 
Ach  Store 
replet(l 
MaotamtIca  ä 
muxla  tann 
Morphira  Curvy 
blocks  bloß. 
synthasis  rvoept' 
Normal  situation  before  soakinq  in 
morphine  solutions 
Extrinsic  Ry  ýa  Ach  -  --l.  ta,.  LJ 
Figure  52.  Diagram  to  represent  the  "store"  hypothesis  of  ACh  in  leech  muscle. 
The  leech  muscle  fibre  is  represented  by  an  upright  rectangle.  The  ACh  store 
is  represented  by  a  shaded  circle  when  replete  and  a  "crenated"  circle  when  depleted 
of  ACh. 
A.  (Upper  diagram)  shows  that  a  steady  production  of  ACh  from  fully  repleted 
stores  is  responsible  for  maintaining  muscle  tone.  This  process  can  be  blocked  by 
morphine  or  curare. 
A.  (Lower  diagram)  shows  the  effect  of  applying  extrinsic  ACh  to  the  leech 
muscle  in  which  the  stores  are  fully  replete.  Muscle  tone  is  fully  maintained  by 
ACh  from  the  store;  extrinsically-applied  ACh  is  not  taken  up  by  the  store  and  has 
its  total  effect  on  the  leech  muscle  directly. 
B.  (Upper  diagram)  shows  that  with  a  depleted  ACh  store  there  is  poor 
maintenance  of  muscle  tone. 
B.  (Lower  diagram)  shows  that  when  extrinsic  ACh  is  applied  to  a  muscle 
with  depleted  stores  of  ACh  most  of  it  is  taken  up  by  the  stores,  while  only  a  fraction 
of  the  applied  ACh  has  a  direct  effect  on  the  leech  muscle  fibre. 
Directly-acting  ACh  causes  a  quick  contraction,  ACh  liberated  from  the  store 
causes  a  slow  contraction  ("tone"). -  99  - 
the  time  taken  to  return  to  its  original  baseline  with  continuous  fluid  exchange  may 
be  30  minutes  or  longer.  At  threshold  doses  of  ACh  it  is  difficult  to  know  whether 
this  prolonged  washing  procedure  is 
(a)  diminishing  the  intensity  of  a  minimal  quick  contraction  or 
(b)  depleting  the  intrinsic  stores  of  ACh,  so  that  the  underlying 
muscle  tone  was  being  altered. 
If  the  situation  was  (a),  then  the  washing  procedure  might  not  completely  wash  out 
the  effect  of  the  quick  type  of  contraction,  and  the  next  dose  of  ACh  would  have 
its  effect  superimposed  on  the  previous  effect.  If  the  situation  was  (b),  then  the 
depleted  ACh  stores  would  take  up  some  of  the  externally  applied  ACh  in  the  next 
solution  and  the  baseline  would  shift  once  again,  confusing  the  true  threshold 
response  of  the  muscle  to  ACh. 
With  the  isometric  system,  any  ACh  causing  a  quick  contraction  can  be 
washed  out  of  the  muscle  strip  so  much  more  quickly  that  it  becomes  obvious  when 
the  muscle  tone  is  altering;  it  has  been  found  that  with  vigorous  washing  over  a 
short  time  course  the  baseline  tension  does  not  alter  if  the  postulated  stores  of 
ACh  are  fully  replete.  The  quick  contraction  produced  by  a  concentration  of 
ACh  just  above  threshold  value  can  be  quickly  and  easily  washed  out. 
Comparison  to  the  Micro-Leech  Preparation 
Although  both  leech  preparations  are  set  up  isometrically,  the  micro-leech 
preparation  requires  more  skill  and  experience  compared  to  the  simple  dissection 
and  mounting  procedure  adopted  here. 
With  the  present  system  the  test  solution  is  only  allowed  to  come  into  contact 
with  the  muscle  strip  for  45  seconds  before  the  washing  procedure  is  started. 
Probably  this  means  that  centrally-situated  muscle  fibres  in  the  strip  do  not  receive 
any  ACh.  If  only  a  small  proportion  of  leech  muscle  fibres  are  responding  to  the 
ACh,  then  this  system  is  a  pharmacological  equivalent  of  the  micro-leech 
preparation  of  Szerb  (1961). 
The  micro-preparation  was  intended  for  exceedingly  small  test  samples.  This -100- 
would  have  the  effect  of  concentrating  any  ACh  released  from,  say,  a  cervical 
ganglion  preparation  stimulated  in  0.1  ml.  of  fluid.  However  when  other  inter- 
fering  substances  are  likely  to  be  concentrated  as  well,  no  application  for  this 
method  can  be  found  in  assaying  ACh  output  from  the  neuromuscular  junction. 
SUMMARY 
1.  An  isometric  leech  muscle  preparation  has  been  devised  for  the  quantitative 
assay  of  ACh. 
2.  The  preparation  is  simple  to  set  up  and  can  maintain  a  steady  tension  over 
a  period  of  24  hours. 
3.  The  sensitivity  of  the  preparation  to  ACh  can  also  remain  constant  through- 
out  a  24  hour  period. 
4.  A  seasonal  variation  to  ACh  is  evident,  the  most  sensitive  period  occurring 
during  November  and  December. 
5.  Two  types  of  contraction  seem  to  occur  in  leech  muscle  (in  response  to 
ACh).  A  slow  contraction  can  take  place  which  is  postulated  to  be 
caused  by  the  production  and  release  of  an  intrinsic  supply  of  ACh.  A 
fast  type  of  contraction  occurs  in  response  to  suitable  concentrations  of 
ACh  applied  to  the  muscle  externally. 
6.  At  "suprathreshold"  concentrations  of  ACh  the  muscle  tone  (slow 
contraction)  does  not  interfere  with  the  fast  response  of  the  leech  muscle 
strip.  Thus  a  concentration-response  relationship  can  be  established 
despite  the  simultaneous  occurrence  of  a  slow  contraction. ASSAY  OF  ACETYLCHOLINE 
RELEASED 
FROM  RAT  DIAPHRAGM -  101  - 
INTRODUCTION 
The  release  of  ACh  had  been  studied  extensively  by  several  workers  with  the 
use  of  the  nerve-muscle  rat  hemidiaphragm  preparation  (Bulbring,  1946).  It  was 
used  initially  in  this  work  to  test  the  efficacy  of  the  isometric  leech  muscle  as  a 
reliable  assay  preparation  for  ACh,  since  values  for  the  amount  of  ACh  released 
from  rat  diaphragm  are  already  well  established  (Krnjevic  and  Mitchell,  1961; 
Krnjevic  and  Straughan,  1963;  Mitchell  and  Silver,  1963). 
The  Assay  Procedure 
Since  all  test  solutions  were  to  be  subsequently  assayed  on  the  leech  muscle 
preparation,  it  was  convenient  to  stimulate  the  muscles  in  mammalian  tissue  fluid 
substitutes  which  were  easily  converted  by  dilution  to  a  Ringer's  solution  suitable 
for  leech  muscle.  Eleven  hemidiaphragms  were  stimulated  in  leech  Ringer's 
solution  so  that  no  dilution  was  necessary.  This  unphysiological  procedure  was 
adopted  as  a  preliminary  test  for  the  leech  assay  technique  rather  than  for  the 
accurate  measurement  of  the  ACh  release  from  rat  diaphragm  muscle. 
Where  stimulation  took  place  in  Locke's  solution  the  conversion  to  leech 
solution  for  assay  was  accomplished  by  diluting  1:  1.4  with  distilled  water.  It  was 
found  at  a  later  stage  in  the  work  that  the  leech  muscle  did  not  lose  any  sensitivity 
to  ACh  when  suspended  in  a  medium  of  Krebs'  solution  which  had  been  diluted 
1:  1.4  with  distilled  water.  This  allowed  the  hemidiaphragm  muscles  to  be 
stimulated  in  continuously-oxygenated  Krebs'  solution  which  could  then  be 
converted  simply  to  "modified  Krebs'  solution"  for  the  assay  on  the  leech. 
In  the  unoxygenated  series  (Table  11)  assay  of  the  test  solution  was  performed 
by  matching  their  effects  on  the  leech  muscle  with  known  amounts  of  ACh  - 
chloride  made  up  in  leech  Ringer's  solution.  Where  possible,  "bracketing"  of  the 
test  solution  between  the  effects  of  known  concentrations  of  ACh  was  carried  out 
and  the  effect  of  the  test  compared  to  the  concentration-response  curve  obtained 
at  the  start  of  the  experiment. Rate  of  stimulation 
10/s.  o  for  20  min 
20%.  o  for  20  min 
20/sec  for  20-min 
10/NO  for  20  sin. 
20/..  o  for  20  min 
Table  of  ACh.  output  from  Rat  Dianhraam 
Volume  of  Bathing  solution  Type  of  Rin  zrer'e 
solution 
4  al 
4  ml 
Locke  mammalian 
Locks  mammalian 
4  oil  LEECH 
2.  Locks  mammalian 
2  s4  Lecke  aammaliaf 
20/sec  for  20  min  2  ml  LEECH 
Unoxygenated  Series 
Table  11. 
Output  of  ACh. 
per  hemidiavh. 
2.2  x  10'89 
2.2's  10'8g 
1.5  x  10-8g 
1.5  x  10'8g 
c.  8  x  10-8g 
2.0  x  10'8g 
1.4  x  10'89 
, 
0.8  x  10'8g 
0.8  x  10'89 
2.8  x  10-8g 
1.0  x  10-8g 
2.0  x  10-8g 
1.0  x  10-8g 
1.0  x  10-8g 
"3.0 
x  lo'g 
2.0  x  10'8g 
2.0  x  10-8g 
2.0  x  10'89 
7.  x  10'99 
7x  10'99 
5x  10'99 
3x  10-9g 
"7x 
10'99 
7x  10-9g 
7x  10'99 
7x  10'9g 
7x  10'9g 
2.8  x  10-9g 
5x  10'99 
5x  10'99 
5x  10'99 
2.5  x  10-9g" 
2.5.  x  10'9g 
4x  10'99 
2.5  x  10"9g Täblel2. 
OUTPUT  OF  ACh  FROM  RAT  HEMIDIAPHRAGMS  INTO  KREBS' 
SOLUTION  (ng) 
Stimulation  took  place  at  20/sec  for  20  minutes  followed  by  a  period  of  5 
minutes  soaking.  Resting  solutions  were  obtained  by  soaking  the  muscle  for  a 
period  of  25  minutes.  Dotted  lines  connect  values  successively  obtained  from 
the  some  hemidiaphragm. 
Muscle 
Resting 
(2  ml) 
Resting 
+02(2ml) 
Stimulation 
in  2  ml 
Stimulation 
in  4  ml 
1  12....  ..... 
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17 -102- 
In  the  oxygenated  series  (Table  12)  where  the  muscles  were  rested  or  stimulated 
in  oxygenated  Krebs'  solution,  a  more  rigid  procedure  was  adopted.  An  initial 
concentration-response  relationship  was  obtained  for  ACh  in  the  leech  muscle 
strip  to  be  used  for  the  assay.  The  leech  muscle  lay  in  Krebs'  soltuion  diluted 
1:  1.4  with  distilled  water.  After  conversion  of  the  test  solution  by  diluting  1:  1 
.4 
with  distilled  water,  its  effect  was  "bracketed"  between  the  effect  of  two  known 
concentrations  of  ACh.  The  test  solution  was  then  diluted  by  half  with  converted 
Krebs'  solution  and  again  "bracketed"  between  the  effects  of  known  concentrations 
of  ACh.  The  leech  muscle  was  then  soaked  in  curare  for  20  minutes.  The  test 
solutions  were  again  applied  to  the  'leech  muscle  strip. 
An  example  of  an  assay  procedure  is  shown  in  Figure  53.  The  leech  muscle 
strip  was  bathed  in  Krebs'  solution  diluted  1:  1 
.4  with  distilled  water.  The  rat 
hemidiaphragm  was  stimulated  at  20  impulses  per  second  in  2  ml.  Krebs'  solution 
for  20  minutes.  The  upper  trace  of  Figure  53  shows  the  initial  concentration- 
response  relationship  of  the  leech  muscle  to  ACh.  The  threshold  response  occurred 
when  a  concentration  of  5x  10 
10 
g/ml.  ACh  was  applied  to  the  leech  muscle. 
The  lower  trace  shows  the  response  of  the  leech  muscle  to  "bracketing"  concentrations 
of  ACh  and  to  the  test  solution  after  it  had  been  converted  to  modified  Krebs' 
solution  by.  diluting  1:  1.4  with  distilled  water.  The  effect  of  the  test  solution  (T) 
was  "bracketed"  between  the  effects  of  5x  10-9  g/ml.  ACh  and  2.5  x  10-9  g/ml. 
ACh.  Three  minutes  later  the  test  solution  diluted  by  half  (T/2)  gave  an  effect 
which  was  "bracketed"  between  the  effects  of  10-9  g/ml.  and  2.5  x  10 
9 
g/ml. 
ACh.  After  the  leech  muscle  had  soaked  in  a  solution  of  10-5  g/ml.  curare  for 
20  minutes,  the  response  to  these  solutions  was  abolished. 
A  graphic  record  of  the  result  of  this  assay  procedure  is  shown  in  Figure  54 
The  initial  concentration-response  curve  has  been  obtained  by  plotting  the  tension 
developed  by  the  leech  muscle  strip  against  the  concentration  of  ACh  applied  (+). 
The  tensions  developed  by  the  leech  muscle  in  response  to  the  "bracketing" 
solutions  of  ACh  lie  close  to  the  initial  concentration-response  curve  obtained 0 
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Initial  concentration-response  relation  for  action  of  ACh  on  tension  of  an 
isometric  leech  muscle  strip  (+).  Test  solution  from  rat  hemidiaphragm  undiluted 
(T)  and  diluted  by  half  (T/2)  have  given  tensions  equivalent  to  concentrations  of 
3x  10-9  g/ml.  ACh  and  1.5  x  10-9  g/ml,  respectively.  Each  test  "bracketed" 
between  tests  with  ACh  at  same  time  in  experiment  (0  0,  see  Figure 
Diaphragm  stimulated  at  20  impulses/sec  for  20  minutes  in  2  ml.  Krebs'  solution; 
solutions  diluted  1:  1 
.4 
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21  hours  previously. 
The  test  solution  (T)  was  found  to  be  equivalent  to  3x  10  9/m  I.  ACh. 
The  test  solution  diluted  by  half  gave  a  response  equivalent  to  1.5  x  10-9  g/ml. 
ACh.  Since  the  hemidiaphragm  was  originally  stimulated  in  a2  ml.  volume 
which  was  diluted  to  2.8  ml.,  the  output  of  ACh  from  the  muscle  was 
3x2.,  8x  10-9  g,  i.  e.  8.4ng. 
Identification  of  ACh 
Only  one  test  was  used  for  the  identification  of  ACh.  (see  General 
Discussion).  When  the  leech  muscle  was  soaked  in  a  solution  of  10-5  g/mI. 
d-tubocurarine  for  20  minutes  this  completely  blocked  the  action  of  known  amounts 
of  ACh  applied  to  the  muscle  strip.  The  action  of  curare  on  the  test  solution, 
however,  was  not  so  well  defined.  In  every  case  the  tension  of  the  curarized 
leech  muscle  strip  had  returned  to  its  original  baseline  after  a  period  of  45  seconds 
in  contact  with  the  test  solution;  however,  in  most  cases  the  baseline  tension 
fluctuated  immediately  after  the  application  of  the  test  solution  (Figure  55).  An 
interfering  substance  invoking  an  extremely  quick  contraction  of  the  leech  muscle 
was  present  in  the  solution  which  had  surrounded  a  twitching  hemidiaphragm.  This 
finding  was  present  in  results  reported  by  Krnjevic  and  Mitchell  in  1961  (see 
Discussion). 
Applications  of  diluted  test  solutions  to  the  leech  muscle  strip  aided  the 
identification  of  the  ACh.  In  each  case  the  test  solution  diluted  by  half  caused 
approximately  the  same  effect  as  half  the  concentration  of  ACh  which  matched  the 
effect  of  the  undiluted  test  solution  (Figure  54).  Dilution  of  the  test'solution  would 
also  reduce  the  effect  of  any  interfering  substances  present  which  might  alter  the 
sensitivity  of  the  leech  muscle  preparation  to  ACh. 
The  Effect  of  Increased  Potassium  Concentration  on  the  Leech  Muscle 
In  order  to  exclude  potassium  as  the  cause  of  the  residual  quick  contraction 
provoked  by  the  test  solution  when  applied  to  the  curarized  leech  muscle  strip, 
graded  concentrations  of  K+  in  leech  solution  were  applied  (Figure  56).  Normal C 
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Leech  Ringer's  solution  contained  3mM  of  K+.  When  a  concentration  of  6mM  K 
was  applied  to  the  muscle,  relaxation  occurred.  Further  addition  of  a  solution 
containing  8mM  K+  applied  immediately  afterwards  produced  a  further  relaxation 
of  the  leech  muscle.  While  this  excluded  K+  as  a  cause  of  the  early  contraction 
effect,  it  stressed  the  importance  of  excluding  substances,  released  from  active 
skeletal  muscle,  other  than  ACh  which  could  distort  bioassay  estimations  (see 
Discussion). -  105  - 
RESULTS 
The  ACh  output  of  53  hemidiaphragm  muscles  was  measured  on  the 
isometric  leech  muscle  preparation  (Tables  11  and  12).  The  muscles  were 
stimulated  indirectly  at  10  impulses/sec  or  20  impulses/sec  in  2  ml.  or  4  ml. 
of  leech  solution,  Locke's  solutions  or  continuously-oxygenated  Krebs'  solution. 
The  spontaneous  release  of  ACh  from  14  muscles  was  measured;  nine  muscles 
were  soaked  in  2  ml.  of  unoxygenated  Krebs'  solution  and  five  muscles  were 
soaked  in  2  mi.  of  continuously-oxygenated  Krebs'ssolution. 
The  ACh  Release  into  2  ml.  Volumes  of  Locke's  and  Kreb's  Solutions 
A  comparison  of  the  Tables  "A"  and  "B"  in  Figure  57  shows  that 
the  ACh  output  from  hemidiaphragms  stimulated  at  20/sec  for  20  minutes 
in  2  ml.  of  Locke's  solution  is  significantly  less  (.  05>P> 
. 
01)  than  that 
released  under  the  some  conditions  of  stimulation  into  2  ml.  of  Krebs' 
solutions.  The  mean  output  into  2  ml.  Locke's  solution  was  Eng  while 
the  mean  output  into  Krebs'  solution  was  14ng.  This  difference  could  be 
attributed  to  either  the  type  of  Ringer's  solution  surrounding  the  active 
muscle  or  the  fact  that  continuous  oxygenation  took  place  in  the  Krebs' 
solution  during  the  period  of  stimulation,  whereas  the  Locke's  solution  was 
bubbled  with  oxygen  beforehand,  but  not  during  the  stimulatory  period. 
Both  Ca  ++ 
and  Mg  ++  ions  affect  the  ACh  release  at  the  endplate 
region,  Ca  increasing  the  output,  and  Mg  depressing  it  (Fatt  and 
Katz,  1952).  The  Ca  + 
concentrations  in  the  Locke's  and  Krebs'  solutions 
were  2.2  mM  and  2.5  mM  respectively.  This  small  difference  is  not  likely 
to  reduce  the  output  into  Locke's  solution.  No  Mg  ++ 
was  present  in  the 
Locke's  solution,  while  1.2  mM  Mg++  was  contained  in  the  Krebs'  solution. 
This  difference  would  encourage  a  greater  release  of  ACh  into  the  Locke's 
solution  than  into  the  Krebs'  solution,  the  reverse  of  the  results  obtained. Figure  57.  Output  of  ACh  (ng)  from  hemidiaphragm  muscle  stimulated  at  a 
frequency  of  20/sec  for  20  minutes. 
"A"  "B"  IIC'I 
Locke's  Solution  Krebs'  Solution  Leech  Solution 
2  ml.  volume  2  ml.  volume  2  ml.  volume 
7  18  5 
7  17  5 
7  8  5 
7  11  2.5 
7  13  2.5 
3  11  4 
10  2.5 
population  -6  20 
population  -7  range 
D  -1  52  mean  -6 
7S  22 
range  2.5  -7+ 
.  .  .  population  -9  mean  -4S.  D.  0.98 
range  8-  22 
± 
mean  -  14  S,  D.  4.69 
"D"  "Ell  "P 
Locke's  Solution  Krebs'  Solution  Leech  Solution 
4  mI.  volume  4  ml.  volume  4  ml.  volume 
20  15  30 
14  23  20 
8  31  20 
8  35  20 
28  24 
population  -4  10  17 
20  15  range  20  -  30 
+ 
10  17  mean  -  24  S.  D.  -  4.58 
10  12 
population  -9  population  -9 
range  8-  28 
+  range  12  -  35 
+ 
mean  -  14  S.  D.  -  6.56  mean  -  21  S.  D.  -  6.70 -106- 
It  is  to  be  noted  here  that  even  less  ACh  is  released  into  2  ml.  of 
leech  solutions  than  into  2  ml.  of  Locke's  solution  (compare  Tables  "A" 
and  "C",  Figure  57. 
The  ACh  Release  into  4m1.  Volumes  of  Locke's  and  Krebs'  Solutions 
Tables  "D"  and  "E"  of  Figure  57  show  that  the  mean  output  of  ACh 
from  hemidiaphragm  muscles  into  4ml.  volumes  of  Locke's  and  Krebs'  solutions 
was  14ng  and  21ng  respectively.  This  significant  difference  (P<.  05)  suggests 
that  lack  of  oxygenation  during  stimulation  of  the  muscle  in  the  Locke's 
solution  has  an  important  influence  upon  the  release  of  ACh  from  the  rat 
diaphragm.  However,  the  mean  output  of  24ng  into  a4  ml.  volume  of 
unoxygenated  leech  solution  is  similar  to  that  put  into  oxygenated  Krebs' 
solutions  (Table  "F",  Figure  57)  suggesting  that  some  other  factor,  such  as 
tonicity  of  the  bathing  solution,  may  be  operative  in  the  regulation  of  the 
release  of  ACh. 
The  Comparison  of  Amounts  of  ACh  Released  into  2  ml.  and  4  ml.  of  Locke's 
Solution 
The  mean  output  of  ACh  into  2  ml.  of  Locke's  solution  was  6ng  (Table 
"A").  Under  the  same  conditions  of  stimulation  and  oxygenation  the  mean 
output  into  4  ml.  of  Locke's  solution  was  14ng  (Table  "D").  This  difference 
is  highly  significant  (P<.  01)  and  strongly  suggests  that  the  volume  of 
surrounding  fluid  affects  the  quantity  of  ACh  released  from  an  active  hemi- 
diaphragm  muscle. 
The  Comparison  of  Amounts  of  ACh  Released  into,  2  ml.  and  4  ml.  of  Krebs' 
Solution 
. 
Tables  "B"  and  "E"  of  Figure  57  show  the  comparisons  of  ACh  release 
into  continuously-oxygenated  Krebs'  solutions  of  2  ml.  and  4ml. 
_volumes. 
Themean 
,.  -ý -107-ý 
I 
amounts  released  into  the  2  ml.  and  4  ml.  volumes  were  14ng  and  21  ng 
respectively.  This  clear  difference  (P<O.  1)  again  suggests  that  the  greater  the 
volume  of  fluid  surrounding  the  muscle,  the  greater  is  the  output  of  ACh  from  the 
muscle,  other  circumstances  remaining  constant.  This  phenomenon  could  have 
many  explanations  (see  Discussion);  only  three  are  listed  at  this  point. 
1.  A  diffusion  gradient  for  ACh  will  tend  to  approach  equilibrium  more 
quickly  in  a  smaller  volume  of  surrounding  bathing  solution.  This 
would  result  in  less  diffusion  of  released  ACh  into  the  surrounding 
solution. 
2.  Every  impulse  delivered  down  the  motor  nerve  might  not  liberate  a 
normal  amount  of  ACh  from  the  nerve  terminal. 
3.  All  of  the  impulses  delivered  down  the  motor  nerve  may  not  reach 
the  endplate.  This  type  of  nerve  block  can  be  produced  by  anoxic 
conditions,  which  might  occur  more  quickly  in  a  small  volume  of 
fluid  (see  Discussion). 
In  the  present  work  only  the  existence  of  the  last  of  these  possibilities  could 
be  tested.  Hemidiaphragms  were  stimulated  at  a  different  frequency  and  their 
outputs  measured. 
ACh  Output  from  Muscles  Stimulated  at  20/sec  and  10/sec  into  4  ml.  Volumes  of 
Locke's  Solution 
Hemidiaphragms  were  stimulated  at  a  frequency  of  10/sec  and  their  outputs 
were  compared  with  those  having  been  stimulated  at  20/sec.  Figure,  58  gives 
comparative  tables  for  these  results.  Tables  "P"  and  "Q"  of  Figure  58  show  that 
the  mean  outputs  of  ACh  into  41ml.  volumes  of  Locke's  solution  from  muscles 
stimulated  at  a  frequency  of  10/sec  and  20/sec  were  16ng  and  14ng  respectively. 
The  mean  outputs  of  ACh,  into  2  ml.  volumes  of  Locke's  solution  when  the  muscles 
were  stimulated  at  10/sec  and  20/sec  were  5.5ng  and  Eng  respectively  (Tables  "R" 
and  "S"). 
From  these  figures  it  can  be  concluded  that  under  these  experimental  conditions Figure  58.  Output  of  ACh  from  hemidiaphragm  muscles  stimulated  at  frequencies 
of  10/sec  or  20/sec  for  20  minutes. 
11  1311  IIQ  II 
Locke's  Solution  Locke'sSolution 
frequency  10  sec  frequency  20  sec 
4  ml.  volume  4  ml.  volume 
22  20 
22  14 
15  8 
88 
15  28 
population  -5 
10 
20 
range  8-  22 
mean  -  16  S.  D.  -  5.29 
10 
population  -9 
range  8-  28 
mean  -  14  S.  D.  -  6.56 
Locke's  Solution  Locke's  Solution 
frequency  10  sec  frequency  20  sec 
2  ml.  volume  '2  ml.  volume 
77 
77 
57 
37 
population  -47 
range  3-73 
mean  -  5.5  S.  D.  -  1.66  population  -6 
range  3-7 
mean  -6S.  D.  -  1.52 
0 Figure  59.  The  output  of  ACh  (ng)  from  hemidiaphragms  resting  or  stimulated 
in  2  ml.  Krebs'  solution. 
Resting  Muscle  Resting  Muscle  Stimulated  Muscle 
Solutions  Solutions  Solutions 
Oxygenated  Unoxygenated  Oxygenated 
7  12  18 
17  8  17 
4  12  8 
5  10  11 
2  11  13 
population  -5 
3  10 
range  2-  17 
3 
5 
11 
20 
mean  -7  6  22 
population  -9  population  -9 
range  3-  12  range  8-  22 
mean  -8  mean  -  14 -108- 
varying  the  frequency  of  stimulation  from  10/sec  to  20/sec  does  not  alter  the 
amount  of  ACh  released  from  active  hemidiaphragm  muscles. 
The  Spontaneous  Release  of  ACh  from  the  Hemidiaphragm 
Fourteen  hemidiaphragm  muscles  were  soaked  in'2  ml.  volumes  of  Krebs' 
solution  for  a  period  of  25  minutes.  No  significant  difference  (P>5)  was  found  in 
the  output  of  ACh  between  solutions  which  were  not  oxygenated  and  those  which 
were  oxygenated  (Figure  59).  The  spontaneous  release  of  ACh  from  muscles 
resting  in  2  ml.  is  half  of  that  liberated  from  muscles  stimulated  in  2  ml.  of  Krebs' 
solution.  It  is  interesting  to  note  that  the  mean  resting  release  of  ACh  into  2  ml. 
volumes  of  Krebs'  solution  was  7ng  and  ; that  the  mean  output  of  muscles  stimulated 
at  a  frequency  of  20/sec  into  2  ml.  of  Locke's  solution  was  6ng  (see  Discussion). -109- 
DISCUSSION 
Output  of  ACh  from  Stimulated  Muscles 
The  output  of  ACh  into  2  ml.  of  oxygenated  Krebs'  solution  is  probably 
significantly  less  than  the  output  into  4  ml..  Also,  the  output  into  2  ml.  of 
unoxygenated  Locke's  solution  is  significantly  less  than  the  output  into  4;  ml. 
The  output  into  leech  solution  was  also.  found  to  be  greater  into  the  larger  volume 
of  surrounding  solution.  This  constant  finding  could  have  many  causes. 
The  greater  volume  of  fluid  surrounding  the  muscle  will  increase  the 
diffusion  gradient  of  ACh  so  that  the  smaller  volume  of  bathing  solution  would 
impair  the  diffusion  of  released  ACh  from  within  the  musculature  into  the 
surrounding  solution.  The  diffusion  pathway  may  a  Iso  be  distorted  because  the 
. 
hemidiaphragm  is  unsupported  in  the  surrounding  fluid  during  stimulation. 
Unknown  substances  may  be  released  during  muscle  activity  which  interfere 
with  the  assay  procedure.  These  interfering  "metabolites"  would  exist  in  a  higher 
Tconcentration  in  the  2  ml.  solutions  and  might  have  a  depressant  effect  on  the 
sensitivity  of  the  leech  muscle  to  ACh.  The  experiment  performed  showing  that  an 
`increase  in  the  K+  concentration  in  the  solution  surrounding  the  leech  muscle 
causes  relaxation  of  the  leech-muscle  strip  is  one  example  of  an  interfering 
substance  which  would  have  to  be  considered.  It  has  been  established  that  K+ 
comes  out  of  the  stimulated  muscle  into  a  surrounding  bathing  solution  (see  section 
on  K+  release  from  sartorius  muscle),  so  that  any  test  solution  obtained  from  a 
stimulated  hemidiaphragm  muscle  would  be  likely  to  have  a  raised  K+  concentration. 
. 
When  this  solution  is  applied  to  the  leech  muscle  strip,  any  contraction  caused  by 
,  ACh  present  in  the  solution  would  be  offset  by  the  effect  of  relaxation  produced  by 
the  high  K+  concentration.  However,  in  this  work  the  test  solutions  were  diluted 
by  half  with  modified  Krebs'  solution  so  that  the  higher  level  of  K+  would  be 
diluted  somewhat. 
The  undiluted  stimulated  muscle  solutions  did  not  have  their  effects  on  the -  ino- 
leech  muscle  ,  completely  blocked.  The  effects  of  test  solutions  diluted  by 
half  were  completely  blocked  by  curare.  Although  this  effect  of  incomplete 
blocking  was  not  commented  on  by  Kmjevic  and  Mitchell  (1961),  nevertheless 
their  specimen  trace  of  the  action  of  the  test  solution  on  an  isotonic  leech 
muscle  strip  clearly  shows  that  the  action  of  the  test  solution  was  not  completely 
blocked  by  curare,  while  the  matching  ACh  solution  had  its  effect  completely 
abolished.  Krnjevic  and  Mitchell  comment:  -  "when  simple  solutions  of  ACh 
were  compared  with  those  in  which  the  muscle  contracted,  it  was  found  that  the 
latter  caused  irregular  variations  in  baseline,  and  also  in  ACh  sensitivity".  They 
suggested  that  "disturbing  factors"  were  released  mainly  during  contraction  of  the 
muscle  fibres.  A  biologically  active  substance,  ATP,  has  been  shown  to  be 
released  from  active  skeletal  muscle  (this  Thesis,  Part  I);  however,  investigations 
in  the  present  work  have  shown  that  ATP  in  low  concentrations  does  not  affect 
the  leech  muscle. 
The  stimulation  of  a  muscle  in  2  ml.  volume  of  solution  would  presumably 
induce  a  state  of  hypoxia  more  quickly  than  stimulation  of  the  muscle  in  4  ml., 
if  oxygenation  throughout  the  stimulatory  period  was  inadequate.  Krnjevic  and 
Miledi  (1957,1958,1959)  have  described  a  type  of  failure  of  neuromuscular 
propagation  occurring  during  repetitive  stimulation  of  the  phrenic  nerve.  They 
showed  that  the  most  likely  sites  for  this  "pre-synaptic  block"  were  either  points 
where  the  nerve  to  the  muscle  branches,  or  the  narrow  region  just  before  the 
terminal  expansion  of  the  nerve  fibres.  They  found  that  this  block  could  be 
overcome  if  the  stimulation  was  either  stopped  or  reduced  in  rate.  They  concluded 
that  the  block  was  probably  caused  by  anoxia  of  the  intramuscular  portion  of  the 
motor  nerve. 
When  the  muscle  is  stimulated  in  a  volume  of  2  ml.,  early  pre-synaptic 
block  may  occur,  thus  reducing  the  number  of  impulses  releasing  ACh  from  the 
nerve  terminals.  Since  the  ACh  output  into  4  ml.  of  unoxygenated,  Locke's 
solution  was  significantly  lower  than  the  output  into  4  ml.  oxygenated  Krebs' solution,  under  the  present  experimental  conditions  the  oxygen  content  of  the 
Locke's  solutions  may  have  been  inadequate. 
Comparison  of  the  output  of  ACh  from  muscles  stimulated  at  10/sec  or 
20/sec  in  2  ml.  or  4  ml.  of  Locke's  solution  showed  that  the  output  did  not 
significantly  increase  at  the  higher  frequency  of  stimulation.  This  would  again 
suggest  that  early  pre-synaptic  block  was  occurring  as  xi  result  of  hypoxia.  If 
this  were  so,  a  frequency  of  20/sec  would  be  converted  into  an  effective 
frequency  of,  say,  10/sec  or  less,  thus  giving  a  falsely  low  reading  of  ACh 
output  for  the  frequency  of  20/sec. 
Once  again  it  would  have  to  be  considered  that  the  low  output  of  ACh 
obtained  with  the  high  frequency  of  stimulation  might  be  due  to  the  hypoxic 
muscle  tissue  releasing  substances  into  the  test  solution  which  would  tend  to 
depress  the  sensitivity  of  the  leech  muscle  strip  to  ACh,  hence  reducing  the 
value  obtained  for  the  ACh  output  in  the  assay  procedure. 
A  disturbing  finding  in  this  work  was  that  the  ACh  output  from  resting 
hemidiaphragm  muscles  into  2  ml.  volumes  of  Krebs'  solution  was  about  the 
same  (7ng)  as  the  output  from  hemidiaphragms  stimulated  "at  20/sec'in  2  ml. 
volumes  of  Locke's  solution  (6ng).  (Compare  Table  "A"  in  Figure  574with 
Figure  59).  It  must  be  concluded  from  this  that  all,  or  nearly  all,  `  of  the 
impulses  were  blocked  when  a  hemdiaphragm  was  stimulated  in  2  ml.  of  Locke's 
solution  at  a  frequency  of  20/sec. 
The  only  set  of  results  obtained  here  that  can  be  compared  with  results 
of  other  workers  are  those  obtained  from  stimulating  the  muscles  in  4  ml.  volumes  of 
continuously-oxygenated  Krebs'  solution.  Krnjevic  and  Straughan  (1963)  found  a 
mean  release  of  35ng  after  a  period  of  20  minutes  stimulation  at  a  frequency  of 
20/sec  into  a3  ml.  volume  at  37°C.  The  mean  release  found  here  using  the 
same  frequency  of  stimulation,  over  the  some  period  of  time,  was  21ng  (Figure  57 
Table  "E").  A  reduction  in  output  might  be  expected  since  the  present  experi- 
ments  were  performed  at  room  temperature. -  112  - 
Krnjevic  and  Mitchell  (1961)  stimulated  hemidiaphragm  muscles  at  room 
temperature  for  5  minutes  at  a  frequency  of  5/sec  and  calculated  an  ACh. 
release  of  10- 
17 
mole/impulse/nerve  ending.  If  this  rate  of  ACh  release  is 
transferred  to  the  present  conditions  of  stimulation  (20/sec  for  20  minutes),  in 
a  rat  hemidiaphragm  muscle  with  an  estimated  10,000  nerve  terminals  (Krnjevic 
and  Miledi,  1958),  the  total  output  of  ACh  from  the  muscle  would  be  343ng 
if  every  impulse  reached  the  nerve  endings  and  the  synthesis  of  ACh  was  adequate. 
The  total  amount  of  ACh  actually  released  from  the  muscle  in  Krnjevic  and 
Mitchell's  experiments  is  calculated  below: 
Stimulation  frequency  =  5/sec  for  5  minutes.  Number  of  impulses  =  1,500. 
If  10-17  mole/impulse/nerve  ending  ACh  was  released,  then  the  total 
amount  of  ACh  released  in  a  muscle  with  10,000  nerve  endings  =  1,500  x 
10-17  x  104  pmole=2l.  4  ng. 
This  figure  agrees  with  the  mean  output  found  in  the  present  work  when  a 
muscle  was  stimulated  in  4  ml.  Krebs'  solution  at  20/sec  for  20  minutes.  From 
a  comparison  of  the  durations  of  stimulation,  it  would  seem  that  the  bulk  of  ACh 
may  be  released  from  the  muscle  in  the  first  5  minutes  of  stimulation  at  a 
frequency  of  20/sec.  Thereafter  it  may  be  postulated  that  the  rate  of  synthesis  of 
ACh  at  the  nerve  terminal  is  unable  to  keep  up  with  the  amounts  of  ACh  released 
initially. APPENDIX -  ll3  - 
SEPARATION  OF  ACETYLCHOLINE  FROM  OTHER  TISSUE  PRODUCTS  BY 
MOLECULAR  SIEVE  CHROMATOGRAPHY' 
The  following  section  describes  the  behaviour  of  small  concentrations  of 
ACh  in  a  Sephadex  column  (see  Methods).  This  method  of  separation  was  initially 
adopted  in  this  work  in  order  to  isolate  ACh  from  other  substances  which  may  be 
present  in  the  stimulated  muscle  solution  and  which  might  prevent  an  accurate 
estimation  of  ACh  on  the  frog  heart. 
Since  a  very  small  amount  of  ACh  released  into  a  test  solution  was 
anticipated,  small  concentrations  of  ACh-chloride  were  put  through  the  column. 
In  order  to  detect  the  ACh  in  the  fractions  from  the  column,  a  bioassay  technique 
was  needed.  The  isometric  leech  preparation  and  the  frog  heart  perfusion  system 
were  used  for  this  purpose  (see  Methods). 
Results 
By  adjusting  the  volumes  of  the  fractions  collected  from  the  column,  it  was 
found  that  about  75%  of  ACh  put  into  the  column  could  be'recovered  in=  a3  ml'. 
fraction  coming  4.5  ml.  after  the  initial  blue"dextran  fraction,  i.  e.  this  4.50. 
volume  contained  no  blue  dextran  and  very  little  ACh;  ` 
In  ten  experiments  2  ml,  of  a'solution  of  ACh=chloride  together  with  0.1  ml. 
blue'dextran  were  put  through  a  column  which  had  been  packed  in  and  was 
continuously  eluted  with,  leech  Ringer  's'solution.  'The  blue  dextran  fraction  was 
followed  through  the  column  and  the  3  ml,  containing  itJwas  collected:  The  next 
2  ml.  'fraction  collected  (fraction'  1)  contained  no  ACh.  '  The  next  2.5  ml. 
fraction  (fraction  2)  contained  a  very  small  amöünt 
pof  AChýand  the  following 
3  ml.  fraction  (fraction  3)  contained  the  bulk  of  the  ACh  originally  put  into  the 
'column.  No  ACh  was  found  in  any  subsequent  fraction. 
Figure  60  shows  an  assay  of  these  fractions  on  the  leech  muscle  preparation. 
2  ml.  of  2.5  x  10-8  g/ml.  ACh-chloride  were  put,  into  the  column.  Fraction  1  (F1) 
did  not  affect  the  leech  muscle.  Fraction  2  (F2)  matched  the  effect  of  a -  114  - 
concentration  ä  2.5  x  10-9  g/ml.  ACh.  Fraction  3  (F3)  gave  an  effect  which  lay 
between  the  effect  of  1.5x  10-8  g/ml.  and  10 
8 
g/ml.  of  ACh.  When  diluted  by 
half  (F3/2),  fraction  3  matched  the  effect  of  5x  10-9  g/ml.  of  ACh.  The 
percentage  recoveries  of  ACh  in  fractions  2  and  3  were  12%  and  75%  respectively. 
An  example  of  an  assay  of  the  column  fractions  on  the  perfused  frog  heart 
is  shown  in  Figure  61  . 
After  2x  10 
7 
g/ml.  of  ACh  were  mixed  with  blue 
dextran  and  put  through  the  column,  the  usual  fractions  were  collected.  Fraction  1 
did  not  affect  the  heart.  The  effect  of  perfusing  fraction  2  through  the  heart  was 
matched  by  the  effect  of  5x  10 
9 
g/ml.  ACh.  Fraction  3  matched  the  effect  of 
3.5  x  10-8  g/ml.  ACh.  The  calculated  percentage  recovery  in  this  case  was 
6.25%  in  fraction  2  and  50%  in  fraction  3. 
Table  13  shows  a  compilation  of  results  for  the  standardization  of  the 
behaviour  of  ACh  in  the  column,  using  the  isometric  leech  preparation  and  the 
frog  heart  perfusion  system  for  the  estimation  of  the  small  amounts  of  ACh  in  the 
eluted  fractions.  It  can  be  seen  from  this  table  that  there  is  a  wide  scatter  of 
results  obtained  for  the  estimated  amounts  of  ACh  eluted  into  fractions  2  and  3. 
This  is  mainly  due  to  the  fact  that  the  estimation  of  the  ACh  was  performed  by 
direct  matching  with  known  amounts  of  ACh  in  both'  r  the  frog  heart  and  the  leech 
preparation.  This  is  not  an  accurate  procedure  and  further  work  is  needed  in 
order  to  determine  more  precisely  the  distribution  of  ACh  between  fractions  2  and 
3.  '  However,  in  no  case  out  of  13  columns  tested  was  ACh  detected  in  any  other 
fractions  but  2  and  3,  and  as  such  this  method  can  certainly  be  adopted  for 
complete  separation  of  ACh  from  substances  of  very  large  molecular  weight,  or 
a  partial  separation  of  ACh  from  substances  of  smaller  molecular  weight. Figure  60. 
The  development  of  tension  of  a  leech  muscle  strip  to  concentrations  of 
ACh  contained  in  fractions  from  a  Sephadex  column.  The  lower  trace  is  a  direct 
continuation  of  the  upper  one.  D=  change  of  solution  in  the  leech  bath  S= 
recording  motor  switched  to  slow  speed.  The  tension  in  grammes  is  shown  at  the 
left  of  the  trace.  Each  test  solution  is  allowed  to  act  for  45  seconds. 
Calculation  of  Percentage  ACh  Recovery 
2  ml.  of  2.5  x  10 
8 
g/ml.  ACh  are  put  into  the  column.  Thus  the  total 
amount  of  ACh  put  into  the  column  =5x  10-8  g.  Assay  of  fraction  3  (F3)  shows 
that  it  contains  a  concentration  of  1.25  x  10-8  g/ml.  ACh.  Since  this  fraction 
has  a  volume  of  3  ml.,  the  total  amount  of  ACh  contained  in  fraction  3  is 
3x1  . 
25  x  10-8  g=3.75  x  10-  g.  Percentage  recovery  in  fraction  3  is 
3.75  x  10-8  x  100 
=  75.  Assay  of  fraction  2  (F2)  shows  that  it  has  a  concentration 
5x108 
of  2.5x  10-9  g/ml.  ACh.  Since  fraction  2  has  a  volume  of  2.5  mi.,  the  total 
amount  of  ACh  contained  in  fraction  2  is  2.5  x  2.5  x  10-9  g=6.25  x  10-9  g. 
6.25  x  10-9  x  100  The  percentage  recovery  in  fraction  2  is 
5x  10- 
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Assay  of  column  fractions  for  ACh  on  the  frog  heart. 
The  lower  trace  is  a  direct  continuation  of  the  upper  one.  An  initial 
concentration  of  2  ml  of  10-7  g/ml.  ACh,  made  up  in  frog  Ringer's  solution,  was 
put  through  a  column  continuously  eluted  with  frog  Ringer's  solution.  The  usual 
fractions  were  collected  and  then  perfused  through  a  frog  heart. 
Fraction  1  had  no  effect  on  the  heart.  Fraction  2  matched  the  effect  of 
5x  10-9  g/mI.  ACh.  The  effect  of  fraction  3  was  matched  by  a  concentration  of 
3.5x  10-8  g/mI.  ACh. 
Calculation  of  Percentage  Recovery 
2  ml.  of  10-7  g/ml.  ACh  areput  into  the  column.  Thus  the  total  amount 
of  ACh  put  into  the  column  =2x  10-7  g.  Assay  of  fraction  3  shows  that  it  contains 
concentration  of  3.5  x  10-8  g/ml.  Since  this  fraction  has  a  volume  of  3  ml.,  the 
total  amount  of  ACh  contained  in  fraction  3  is  3x3.5  x  10-8g  =  1.05  x  10-ßg. 
Percentage  recovery  in  fraction  3  is  1.05  x  10-7  x  100 
=  509/6  Assay  of  fraction 
2x10-7 
2  shows  that  it  has  a  concentration  of  5x  10-9  g=1.25  x  10-$  g.  Percentage 
recovery  in  fraction  2  is  1.25  x  10-8  x  100 
=  6.25% 
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+' GENERAL  DISCUSSION -115- 
A  PHYSIOLOGICAL  ROLE  FOR  THE  RELEASE  OF  ATP 
FROM  CONTRACTING  MUSCLE 
ATP  as  the  Mediator  of  the  Local  Autoregulation  Reflex 
In  1880  Gaskell  put  forward  the  proposition  that  local  vasodilatation  resulted 
from  some  product  of  muscular  activity.  Anrep  and  V.  Saalfeld  (1935)  found  that 
potent  vasodilator  substances  appeared  in  the  venous  blood  emerging  from  a 
contracting  muscle.  Since  that  time  the  local  regulation  of  bloodflow  through 
skeletal  muscle  has  been  attributed  to  many  products  of  metabolism.  The  adenine 
nucleotides  have  long  been  known  to  be  powerful  vasodilators  (Drury  and  Szent- 
Gyorgyi,  1929;  Wedd,  '  1931;  Wedd  and  Drury,  1934;  Gillespie,  1934;  Fleisch  and 
Weger,  1937;  Folkow,  1949;  Green  and  Stoner,  1950;  Winbury 
-et  al.  1953; 
Wolf  and  Berne,  1956)  and  it  was  suggested  by  Rigler  (1932)  and  by  Bildings  and 
Maegraith  (1937)  that  ATP  possessed  vasodilator  properties  potent  enough  for  its 
consideration  as  a  normal  vasodilator  metabolite..  In  view  of  the  importance  of 
ATP  in  muscle  metabolism  and  the  close  correlation  between  metabolic  activity 
of  skeletal  muscle  and  its  bloodflow,  ATP  has  been  considered  as  a  potential 
candidate  for  the  'role  of  mediating  the  local  autoregulation  reflex  (Folkow,  1949; 
Hilton,,  1959;  Folkow  and  Oberg,  1961;  Kjellmer  and  Odelram,  1965). 
Folkow,  Haeger  and  Kahlson  (1948)  observed  that  intro-arterial  injection 
of  10 
7g 
of  ATP  was  sufficient  to  produce  a  significant  vasodilatation  in  the 
hindlimbs  of  a  cat.  Folkow  (1949),  investigating  the  vasodilator  action  of  ATP  in 
various  regions,  found  that  the  threshold  dose  for  the  vasodilator  effect  on  muscular. 
cutaneous  and  intestinal  vessels  of  the  cat,  and  coronary  vessels  of  the  dog,  ranged 
from  -5  x  10 
8g 
to  10-7  g  of  ATP  injected  intra-arterially. 
The  release  of  adenine  nucleotides  during  muscular  contraction  has  never,  up 
to  the  present  work.,  been  consistently  established.  Hilton  and  Greengard  (1962) 
searched  for  evidence  that  ATP  is  released  from  skeletal  muscle.  The  method  that-:: 
they  used  to  detect  the  ATP  was  a  fluorimetric  one  developed  by  Greengard  (1956); -116- 
it  enabled  them  to  detect  concentrations  of  less  than  10-7  /ml  ATP.  They  perfused 
the  gastrocnemius  muscle  of  the  cat  with  Locke's  solution  and  found  no  evidence  of 
release  of  ATP  during  muscular  contractions.  They  tried  collecting  the  fluid  which 
was  seeping  out  of  the  muscle  during  stimulation,  but  again  did  not  detect  ATP.  They 
perfused  human  forearm  muscles  with  Locke's  solution  in  vivo  through  two  needles 
embedded  in  the  muscle  bellies,  allowing  the  muscles  to  have  their  own  blood  supply, 
and  found  in  one  experiment  that  ATP  was  present  in  the  perfusate  in  a  concentration 
of  3x  10-6  g/ml  during  the  contraction  period.  However,  when  the  muscles  were 
held  under  tension  with  a  minimum  of  contraction  taking  place,  no  ATP  was  found  in 
the  perfusate.  Hilton  attributed  this  to  the  fact  that  less  tissue  damage  was  occurring 
in  the  isometric  preparation  and  felt  reasonably  certain  that  ATP  was  not  released  from 
contracting  muscles  in  amounts  which  could  cause  a  significant  degree  of  hyperaemia. 
It  is  difficult  to  estimate  the  dilution  occurring  in  any  perfusion  experiments, 
particularly  in  one  of  this  type,  where  the  size  of  the  vascular  bed  is  not  a  constant 
factor.  Also,  the  greater  the  vasodilatation,  the  greater  the  dilution  will  be  of  the 
vasodilators  in  the  collected  perfusates.  In  the  experiments  of  Hilton  and  Greengard 
dilution  of  ATP  beyond  the  threshold  of  their  methodiof  detection  may  have  occurred. 
In  the  present  work  some  frog  hearts  have  been  found  to  be  sensitive  to  concentrations 
of  10-9  g/ml  ATP. 
ATP  as  a  Humoral  Stimulator  of  the  Heart 
The  stimulating  effect  of  ATP  on  frog  heart  shown  in  this  work  is  in  accordance 
with  the  findings  of  Buday,  Carr  and  Miya  (1961)  who  showed  that  low  concentrations 
of  ATP  (8  x  10 
IA) 
produced  an  increased  *systolic  force  in  the  frog  heart  with  a 
concurrent  bradycardia.  This  confirmed  the  earlier  investigations  on  perfused  frog 
hearts  (Ostern  and  Parnas,  (1932);  Gillespie,  (1934);  Meyer  (1951)  and  Porro, 
(1952).  ). 
On  intravenous  injection  ATP  is  rapidly  destroyed,  persumably  in  the  lungs 
(Folkow,  1949).  Although  ATP  is  destroyed  in  the  circulation,  this  destruction  does 
not  appear  to  occur  in  the  blood.  Folkow  (1949)  mixed1mg  of  ATP  with  1  ml  of  whole -117- 
blood  and  allowed  the  mixture  to  stand  for  two  minutes  at  370  C.  This  procedure  did 
not  change  the  vasodilator  properties  of  the  ATP  when  injected  intra-arterially  into 
cat  and  dog. 
If  indeed  ATP  is  released  into  the  bloodstream  in  vivo,  from  contracting 
skeletal  muscle,  it  is  possible  that  this  is  an  additional  humoral  aid  to  the  force  of 
contraction  of  the  myocardium  during  muscular  exercise.  The  destruction  of  ATP  in  the 
lungs  would  seem  to  indicate  that  no  recirculation  of  the  ATP  was  possible;  however 
the  release  of  ATP  into  the  blood  returning  to  the  right  atrium  from  the  limb  muscle 
beds  ("the  muscle  pump")  may  be  an  important  factor  in  augmenting  the  force  of 
contraction  of  the  right  atrium  and  so  eventually  increasing  the  cardiac  output. -118- 
THE  IDENTIFICATION  AND  RELEASE  OF  ACh  FROM  SKELETAL  MUSCLE 
Conditions  of  Stimulation 
For  the  estimation  of  ACh  released  per  impulse  per  motor  nerve  ending,  it 
is  obviously  of  vital  importance  to  ensure  that  every  impulse  delivered  down  the 
nerve  should  reach  the  nerve  terminal.  The  presynaptic  block  discovered  by 
Krn:  jevic  and  Miledi  (1957,1958,1959)  which  is  shown  to  occur  at  high 
frequencies  of  stimulation  presents  a  difficult  problem.  The  block  can  be  partial 
or  complete  and  is  thought  to  be  precipitated  by  anoxia.  If  ACh  release  is 
measured  from  muscles  which  have  been  stimulated  indirectly  at  high  frequencies, 
any  calculation  of  the  ACh  output  based  on  the  assumption  that  every  impulse 
reaches  the  nerve  terminal  is  erroneous.  Lower  frequencies  of  stimulation  would 
solve  this  problem,  but  of  course,  the  amount  of  ACh  produced  would  never  be 
sufficient  for  any  quantitative  estimation. 
A  convenient  method  of  recording  the  number  of  impulses  which  did  reach 
the  nerve  terminal  is  based  on  the  curarized  muscle  preparation.  While  the  muscle 
fibres  are  paralysed,  activation  of  the  nerve  terminals  is  still  possible  and  release 
of  ACh  is  unimpaired.  A  microelectrode  can  thus  be  inserted  near  to  an  endplate 
region.  This  maneouvre  allows  monitoring  of  the  endplate  potentials  to  take  place 
without  any  danger  of  breaking  the  microelectrode.  Thus  release  of  ACh  could  be 
directly  related  to  the  number  and  size  of  the  endplate  potentials  produced,  rather 
than  to  the  number  of  impulses  delivered  down  the  nerve;  the  problem  of 
presynaptic  block  would  then  be  avoided. 
Presence  of  Interfering  Substances 
Since  the  bulk  of  electrophysiological  evidence  concerning  the  neuro- 
muscular  junction  has  been  obtained  from  the  post-synaptic  region,  any  attempt 
to  correlate  the  pharmacological  events  with  electrical  events  places  great 
importance  on  the  general  theory  of  receptor  sites.  If  a  receptor  site  on  the 
post-synaptic  membrane  has  a  molecular  configuration  suitable  for  the  ACh -  119  - 
molecule,  other  molecules  of  similar  shape  could  become  attached  to  the 
receptor  site  indiscriminately.  An  obvious  example  of  this  is  given  by  every 
competitive  blocking  drug  acting  at  the  neuromuscular  junction.  Whittaker 
(1963)  has  given  a  most  comprehensive  review  of  the  substances,  allied  to  ACh, 
which  can  act  as  potent  depolarizing  agents  at  cholinergic  receptor  sites.  Any 
parallel  release  of  other,  unknown,  substances  along  with  ACh  at  the  nerve- 
muscle  junction  which  could  act  as  alternative  depolarizing  agents  at  the  same 
receptor  sites  cannot  be  excluded.  Since  the  bioassay  systems  used  to  estimate 
the  amounts  of  ACh  are,  by  definition,  cholinergic  systems  containing  ACh 
receptor  sites,  the  assay  procedure  by  itself  may  be  misleading  in  that  the 
unknown  substances  will  also  combine  with  receptors  as  well  as  the  ACh  in  the 
test  solution.  Interference  of  this  sort  not  only  obscures  the  quantitative 
estimation  of  ACh,  but  also  raises  the  inevitable  question  of  whether  it  is  just 
ACh  which  is  involved  in  the  natural  transmission  process. 
Identification  of  ACh 
The  small  amounts  of  ACh  available  for  bioassay  are,  of  course,  insufficient 
for  exclusive  chemical  analysis.  Recourse  has  thus  to  be  made  to  other,  indirect, 
methods  of  identification.  Chang  and  Gaddum  (1933)  described  the  following 
regime: 
1.  Inhibition  of  cholinesterase  in  the  test  solution  (leech  muscle,  frog 
heart,  denervated  skeletal  muscle,  cat  blood  pressure  etc.  )  usually 
increases  the  response  obtained. 
2.  The  presence  of  blood  or  tissue  extract  decreases  or  destroys  the 
activity  of  ACh,  and  this  destruction  is  prevented  by  cholinesterase 
inhibitors. 
3.  ACh  is  quickly  destroyed  by  hydrolysis  in  an  alkaline  medium. 
4.  Boiling  for  several  minutes  in  weakly  acid  solution  does  not  destroy 
ACh. 
5.  Atropine,  curare  and  nicotine  individually  block  certain  specific -  120- 
pharmacological  actions  of  ACh,  but  they  do  not  interfere  with  the 
release  of  ACh  at  nerve  terminals. 
6.  The  responses  of  various  biological  indicators  to  ACh  bear  a  definite 
quantitative  relation  to  each  other,  and  the  chemical  mediator 
being  studied  must  give  these  same  relative  values  before  it  can  be 
accepted  as  ACh. 
Any  substance  capable  of  attaching  itself  to  the  cholinergic  receptor  site  and 
producing  a  depolarizarion  of  the  membrane  is  likely  to  be  acted  upon  in  the  same 
way  as  ACh  by  cholinesterase,  an  alkaline  medium  or  an  anticholinesterase. 
Blocking  agents  which  effectively  block  ACh  will  almost  certainly  have  some 
blocking  effect  on  any  substance  which  can  act  on  the  same  receptors.  A 
quantitatively  similar  response  on  different  tissues  produced  by  the  chemical 
mediator  being  studied  could  conceivably  be  mimicked  by  a  related  compound; 
the  graded  response  is  a  function  of  the  density  of  the  receptors,  so  that  any 
substance  capable  of  combining  with  the  cholinergic  receptor  could  produce  a 
quantitatively  similar  response  in  various  biological  indicators.  The  identification 
of  ACh  released  from  rat  diaphragm  in  this  work  involved  only  the  use  of  curare. 
This  certainly  blocked  the  action  of  the  substance  in  the  test  solutions  which 
caused  the  leech  muscle  to  contract;  the  other,  conventional,  piece  of  evidence 
to  suggest  that  ACh  was  present  in  these  solutions  was  that  the  dilution  by  half  of 
the  test  solutions  was  equivalent  to  half  of  the  ACh  solution  matching  the  undiluted 
test  solution;  however,  again  this  is  a  function  of  the  density  of  the  receptor 
sites  in  the  leech  muscle,  not  a  precise  identification  of  ACh  contained  in  any 
test  solutiön. 
The  insurmountable  problem  in  the  positive  identification  of  very  small 
amounts  of  ACh  would  appear  to  be  that  the  cholinergic  receptors  in  one  piece  of 
tissue  are  used  to  identify  the  depolarizing  agent  released  from  another  tissue  which 
is  cholinergically  innervated.  Less  traditional  techniques,  such  as  gas  chromato- 
graphy,  mass  spectroscopy,  electron  spin  resonance  and  other  powerful  tools  now  in -  121  - 
routine  use  by  the  physicists  may  be  used  in  future  in  order  to  establish 
positively  that  it  is  ACh  which  is  released  from  the  neuromuscular  junction. 
Future  Work 
Although  the  molecular  seive  chromatography  procedure  was  standardized 
for  ACh  in  this  work,  no  immediate  use  of  this  technique  was  made.  It  is 
proposed  to  combine  this  separation  technique  with  the  leech  and  frog  heart 
assay  procedures  for  the  estimation  of  ACh  released  from  the  rat  diaphragm.  In 
order  to  have  an  accurate  estimation  of  the  number  of  impulses  actually  reaching 
the  nerve  terminal,  the  rat  diaphragm  preparation  will  be  curarized  and  the 
endplate  potentials  will  be  continuously  monitored.  An  accurate  correlation 
of  the  number  of  impulses  and  the  amounts  of  ACh  released  is  needed  before 
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Release  of  adenosine  triphosphate  from  active  skeletal  muscle 
By  T.  FORRESTER.  Institute  of  Physiology,  University  of  Glasgow  and  the 
Boyd  Medical  Research  Institute,  Glasgow 
In  a  previous  communication  (Boyd  &  Forrester,  1965)  it  was  shown  that 
active  frog  sartorius  muscle  liberates  a  substance  which  has  a  pronounced 
stimulatory  effect  on  the  perfused  frog  heart  preparation  of  Boyd  & 
Eadie  (1961). 
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Fig.  1(a).  The  response  of  a  frog  heart  to  perfusion  with  ATP  and  with  Ringer's 
solution  in  which  a  twitching  sartorius  muscle  was  bathed.  (b)  The  emission  of 
light  from  firefly  tail  extract  when  exposed  to  ATP  and  the  stimulated  muscle 
solution  used  in  (a)  above. 
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It  has  now  been  established  that  this  stimulatory  effect  was  not  due  to 
changes  in  the  potassium  or  the  calcium  concentrations  in  the  Ringer's 
solution  bathing  the  twitching  sartorius  muscle,  nor  was  it  due  to  release 
of  catechol  amines  from  the  muscle,  since  the  effect  was  not  blocked  by 
adrenergic  blocking  agents. 
It  appears  that  the  stimulatory  effect  on  the  heart  is  produced  by 
adenosine  triphosphate  (ATP)  released  from  active  muscle.  The  evidence 
is  as  follows  : 
1.  The  action  of  ATP  on  the  frog  heart  is  qualitatively  similar  to  that 
of  the  stimulated  muscle  solution  (Fig.  1  a). 
2.  In  a  chromatography  procedure  the  stimulatory  substance  is  eluted 
through  a  Sephadex  column  in  the  same  fractions  as  adenosine  triphosphate. 
3.  The  enzyme  `apyrase'  catalyses  the  reaction  ATP-AMP  (Kaltkar, 
1943).  Adenosine  monophosphate  does  not  stimulate  the  heart.  When  a 
solution  of  ATP  is  incubated  with  apyrase,  its  stimulatory  action  on  the 
heart  is  greatly  modified.  When  a  stimulated  muscle  solution  is  incubated 
with  apyrase,  its  stimulatory  action  is  also  modified  in  the  same  manner. 
4.  Using  a  modification  of  the  luciferase  method  of  assaying  the  ATP. 
(Strehler  &  McElroy,  1957)  it  has  been  shown  that  the  stimulated  muscle 
solution  causes  light  to  be  emitted  from  a  firefly  tail  extract  (Fig.  1  b). 
The  time  course  of  the  emitted  light  from  the  test  solution  was  similar 
to  that  of  a  known  solution  of  ATP  in  a  similar  concentration. 
From  these  results  it  is  concluded  that  ATP  is  released  from  active  frog 
skeletal  muscle  in  vitro. 
This  work  was  financed  in  part  by  an  M.  R.  C.  grant.  The  cost  of  equipment  was  defrayed 
from  the  D.  C.  Andrews  Fund  and  the  Rankin  Fund  of  the  University  of  Glasgow. 
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An  Isometric  leech  muscle  preparation  with  stable  sensitivity  for 
the  assay  of  acetylcholine 
By  T.  FORRESTER.  Institute  of  Physiology,  University  of  Glasgow 
The  change  in  length  of  a  strip  of  muscle  from  the  anterior  dorsal  wall 
of  the  leech  (Hirudo  medicinalis)  is  commonly  used  as  a  specific  test  for 
acetylcholine.  This  has  the  disadvantage  that  completion  of  a  test  with 
washing  out  of  acetylcholine  may  take  as  long  as  30  min,  whilst  the  initial 
and  final  lengths  of  the  strip  may  be  completely  different.  This  makes  the 
determination  of  an  accurate  concentration-response  relation  very 
difficult. 
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Fig.  1.  The  tension  developed  by  an  isometric  leech  muscle  strip  when  exposed  to 
graded  concentrations  of  acetylcholine.  Note  the  stability  of  the  base  line.  Thre- 
shold  concentration  of  acetylcholine  was  10-9  g/ml.  which  caused  an  increase  in 
tension  of  50  mg  in  45  sec.  D,  bath  drained  and  refilled.  S,  paper  drive  stopped. 
With  an  isometric  system  the  effect  of  a  test  solution  of  acetylcholine 
can  be  seen  and  washed  out  in  less  than  1  min,  and  a  constant  base  line  is 
more  easily  achieved  (Fig.  1).  This  makes  it  possible  to  obtain  finely 
graded  responses  to  small  steps  of  concentration  (Fig.  1).  Concentration 
response  curves  constructed  at  intervals  over  a  period  of  24  hr  show  that 
the  sensitivity  of  the  leech  muscle  to  acetylcholine  does  not  alter  signi- 
ficantly. 
The  preparation  in  use  at  the  present  time  consists  of  a  muscle  strip  of 
roughly  40  x2  mm  mounted  in  a2  ml.  bath.  Tension  developed  by  the 
muscle  strip  in  response  to  a  dose  of  acetylcholine  is  measured  by  a  tension 
transducer  (type  FTO  3  C,  Grass  Instrument  Co.  ).  Amplification  was 
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10-'  7.5  x  10'9 adjusted  so  that  a  change  of  tension  of  50  mg  could  easily  be  recorded 
(Fig.  1). 
The  minimum  concentration  of  acetylcholine  causing  significant  in- 
crease  in  tension  in  different  muscle  strips  varied  from  10-11  g/ml.  to 
10-8  g/ml.  of  acetylcholine.  Most  preparations  had  a  threshold  response  at 
about  10-9  g/ml.  acetylcholine  (Fig.  1). 
The  specificity,  sensitivity  and  reproducibility  of  the  concentration- 
response  relation  of  this  isometric  preparation  makes  it  very  suitable  for 
the  assay  of  concentrations  of  10-9  g/ml.  to  5x  10-9  g/ml.  of  acetylcholine,  a 
range  in  which  most  other  conventional  procedures  are  somewhat  un- 
reliable. 
The  identification  of  acetylcholine.  Raising  the  pH  of  a  test  solution, 
heating  to  90°  C  and  readjusting  the  pH  and  temperature  is  said  to  destroy 
acetylcholine.  However,  when  this  is  done  with  a  control  solution,  the 
leech  muscle  relaxes  quickly.  This  effect  could  mask  the  action  of  acetyl- 
choline  which  was,  in  fact,  still  present  in  the  solution.  A  more  satis- 
factory  test  consists  of  soaking  the  preparation  in  10-5  g/ml.  D-tubocurarine 
for  ten  minutes.  This  abolishes  the  leech  muscle  response  to  acetylcholine 
and  can  be  reversed  by  washing  for  30  min. 
This  work  was  financed  in  part  by  an  M.  R.  C.  grant.  The  cost  of  equipment  was  defrayed 
from  the  D.  C.  Andrews  Fund  and  the  Rankin  Fund  of  the  University  of  Glasgow. [From  the  Proceedings  of  the  Physiological  Society,  23-24  September  1966] 
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Purification  of  chemical  transmitter  substances  by  column' 
chromatography 
By  I.  A.  Bovu  and  T.  FORRESTER.  Institute  of  Physiology,  University  of 
Glasgow 
Release  of  chemical  transmitter  substances  from  biological  tissue  is 
usually  accompanied  by  the  release  of  many  other  substances  which  can 
interfere  with  the  quantitative  estimation  of  the  transmitter. 
A  column  chromatography  procedure  was  developed  in  an  attempt  to 
separate  acetylcholine  released  from  active  skeletal  muscle  from  other 
factors,  such  as  protein  and  nucleotides  (Forrester,  1966a). 
A  column  of  Sephadex  (type  G-25,  Pharmacia,  Sweden)  was  used.  This 
column  can  separate  completely  substances  of  molecular  weight  5000  and 
over  from  substances  of  smaller  molecular  weight.  Generally,  the  smaller 
the  molecule,  the  more  slowly  it  is  eluted  through  the  column. 
The  dimensions  of  the  column  are  important,  since  these  determine  the 
extent  to  which  various  components  of  smaller  molecular  weight  in  the 
test  solution  can  be  separated.  If  the  column  is  too  large,  excessive  dilution 
of  the  various  components  occurs  which  is  inconvenient  if,  for  example, 
they  are  to  be  assayed  subsequently.  If  the  column  is  too  small,  inadequate 
separation  of  the  components  occurs. 
A  glass  tube  of  internal  diameter  14  mm  with  a  sintered  glass  base  was 
packed  with  Sephadex  G-25  suspended  in  Ringer's  solution  to  a  height  of 
13.5  cm.  A  substance  with  molecular  weight  greater  than  5000,  which  is 
visible  (e.  g.  blue  dextran),  is  used  to  standardize  the  column.  If  2  ml.  of  a 
mixture  of  blue  dextran  and  a  known  concentration  of  acetylcholine  is  put 
through  this  size  of  column,  the  blue  dextran  is  eluted  into  a  fraction  of 
exactly  3  ml.,  while  almost  100  %  of  the  acetylcholine  is  recovered  in  a 
later  fraction  of  3  ml.  clearly  separated  from  the  blue  dextran  by  a  fraction 
containing  neither  substance. 
The  separation  and  recovery  of  acetylcholine  are  independent  of  its 
concentration;  assay  of  the  fluid  eluted  through  the  column  for  acetyl- 
choline  on  an  isometric  leech  preparation  (Forrester,  1966b)  showed  that 
this  method  may  be  used  to  extract  concentrations  of  acetylcholine  as  low 
as  10-9  g/ml.  from,  for  example,  a  tissue  perfusate. 
In  the  specific  problem  for  which  this  technique  was  developed,  the  test 
solution  obtained  from  active  skeletal  muscle  contained  protein,  acetyl- 
choline  released  from  nerve  endings  and  nucleotides.  The  chromatography 
procedure  removes  the  protein  so  that  spectrophotometric  identification 
of  nucleotides  in  later  fractions  is  possible;  the  liberated  acetylcholine  is 
[P.  T.  O. 2 
recoverable  only  slightly  diluted  and  almost  free  of  nucleotide  material  so 
that  its  quantitative  estimation  is  facilitated. 
This  work  was  financed  in  part  by  an  M.  R.  C.  grant. 
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The  assay  of  ACh  released  from  the  neuromuscular'  junction  was 
attempted  using  the  frog  sartorivs  muscle  as  the  source  of-ACh  and  the 
frog  heart  preparation  of  Boyd  and  Eadie  (1961)  as  the  bioassay  object. 
It  was  theoretically  possible  to  measure  the  small  quantity  of  ACh 
(10-10  g/ml.  )  which  was  expected  to  be  released  from  the  sartorius 
muscle  stimulated  at  2  impulses/second  for  30  minutes,  since  30%  of 
frog  hearts  are  sensitive  to  concentrations  of  10 
11 
g/ml.  ACh  between 
the  months  of  December  and  March  (Boyd  and  Pathak,  1965). 
At  the  onset  of  the  project  an  unusual  finding  was  encountered. 
Ringer's  solution  in  which  twitching  muscles  were  bathed  always 
produced  a  marked  increase  in  the  force  of  contraction  of  the  frog 
heart.  Solutions  obtained  from  resting  muscles  augmented  the 
contractions  to  a  lesser  degree.  Solutions  from  indirectly-stimulated 
muscles  paralysed  by  curare  had  a  similar  stimulatory  action'  to 
solutions  obtained  from  resting  muscles.  It  was  also  found  that  a 
similar  stimulatory  effect  was  produced  when  fluid  which  had  surrounded 
an  active  rat  hemidiaphragm  was  perfused  through  the  frog  heart. 
The  stimulatory  effect  was  not  due  to.  changes  in  the  potassium  or 
calcium  in  Ringer's  solution  bathing  the  twitching  sartorius  muscle,  nor 
was  it  due  to  release  of  catecholamines  from  the  muscle,  since  the -2- 
effect  was  not  blocked  by  adrenergic  blocking  agents.  The  stimulatory 
effect  on  the  heart  is  produced  by  adenosine  triphosphate  released  from 
active  skeletal  muscle  in  vitro,  the  evidence  being  as  follows:  - 
1.  The  action  of  ATP  on  the  frog  heart  is  qualitatively 
similar  to  that  of  the  stimulated  muscle  solution. 
2,  '  In  a  chromatography  procedure  the  stimulatory  substance 
is  eluted  through  a  Sephadek  column  in  the  same 
fractions  as  ATP. 
3.  The  enzyme  "apyrase"  catalyses  the  reaction  ATP  - 
AMP.  Adenosine  monophosphate  does  not  stimulate  the 
heart.  When  a  solution  of  ATP  is  incubated  with 
apyrase,  its  stimulatory  action  on  the  frog  heart  is 
greatly  modified.  When  a  stimulated  muscle  solution 
is  incubated  with  apyrase,  its  stimulatory  action  is 
also  modified  in  the  same  manner. 
4.  Using  a  modification  of  the  luciferase  method  of 
assaying  ATP,  it  has  been  shown  that  the  stimulated 
muscle  solution  causes  light  to  be  emitted  from  a 
firefly  tail  extract.  The  time  course  of  the  emitted 
light  from  the  test  solution  was  similar  to  that  of  a 
known  solution  of  ATP  in  a  similar  concentration. 
-lt  is.  suggested  that  ATP  is  normally  released  from  active  skeletal -3- 
muscle  in  vivo  and,  being  a  powerful  vasodilator,  may  be  the  mediator 
of  the  local  autoregulation  reflex.  It  is  further  suggested  that  ATP  may 
be  released  into  the  bloodstream  in  vivo  in  order  to  augment  the  force 
of  contraction  of  the  myocardium  during  muscular  exercise. 
In  order  to  increase  the  accuracy  of.  the  quantitative  estimation 
of  ACh  and  also  to  aid  in  its  identification,  another  method  of  bio- 
assay  was  developed  using  the  isometric  leech  muscle  preparation. 
This  preparation  was  convenient  to  set  up,  showed  constant  sensitivity 
and  stability  over  a  long  period  of  time  and  enabled  a  concentration- 
response  relationship  for  ACh  to  be  obtained  within  30  minutes  or  less. 
This  encouraged  greater  accuracy  in  the  quantitative  estimation  of 
ACh.  A  seasonal  variation  in  the  sensitivity  of  the  leech  muscle  to 
ACh  was  also  apparent,  the  period  of  greatest  sensitivity  being  in 
November  and  December. 
The  output  of  ACh  released  from  active  and  resting  rat  hemi- 
diaphragm  muscles  was  studied  using  the  isometric  leech  muscle  pre- 
paration.  Results  for  the  resting  outputof  ACh  agreed  with  those  of 
previous  workerss,  but  the  amounts  ofACh  recovered  from  muscles  stim- 
ulated  indirectlywer  considerably  less  than  those  previously  obtained.  The 
total  amount  ofACh  released  from  the  muscle.  into  a  solution  surrounding  the 
muscle  was  found  to  be  reduced  in  a  smaller  volume  of  surrounding  bath- 
ing  solution.  This  evidence,  together  with  the  fact  that  no  alteration -4- 
in  output  occurred  when  the  muscles  were  stimulated  at  a  different 
frequency,  suggests  that  nerve  conduction  block  was  occurring  to  an 
unknown  degree  and  that  this  block  was  precipitated  by  anoxia. 
The  behaviour  of  small  concentrations  of  ACh  was  studied  in"a 
molecular  sieve  column  chromatography  procedure.  This  was  done  by 
eluting  Ringer's  solution  containing  ACh  through  a  Sephadex  column 
and  assaying  the  subsequent  fractions  on  the  frog  heart  and  the  leech 
muscle.  By  this  method  the  separation  of  ACh  from  other  produces 
of  muscle  metabolism  can  be  effected,  either  in  solutions  which  have 
surrounded  active  muscles,  in  tissue  perfusates  or  in  tissue  extracts. 
It  is  concluded  from  this  work  that  before  any  accurate 
quantitative  study  of  ACh  released  from  the  neuromuscular  junction 
can  be  undertaken,  the  conditions  of-stimulation  must  be  rigidly 
controlled.  Also,  the  release  of  other  substances  from  active  skeletal 
muscle  into  a  solution  bathing  the  muscle,  for  example,  adenosine 
triphosphate,  may  interfere  with  the  assay  procedure  and  so  may 
result  in  the  wrong  interpretation  of  the  amounts  of  ACh  actually 
released  from  the  neuromuscular  junction. 